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A large body of evidence has shown that excess salt intake is associated with hypertension 
and nutrition related non-communicable diseases (NCDs). Global salt intake is high with 
populations consuming as much as twice the World Health Organization (WHO)’s 
recommended intake of 5g/day. Low- and middle-income countries (LMICs) are 
disproportionately affected due to the nutrition transition taking place in those countries 
that is associated with an influx of highly processed foods that are becoming more 
affordable, and accompanied by changing lifestyles and changing dietary preferences. This 
has increased the availability and intake of energy dense nutrient poor (EDNP) foods that 
are particularly high in salt in LMICs. 
This thesis outlines six studies that sought to provide a systematic approach towards finding 
evidence, building advocacy and developing strategies to curb excess salt intake and rising 
hypertension in Ghana. Data used in studies that comprise the thesis were collected in the 
WHO’s Study on global AGEing and adult health (WHO-SAGE); a multi-country 
longitudinal study conducted in six LMICs namely China, Ghana, India, Mexico, Russia and 
South Africa (SA). Within each country, the WHO-SAGE study has recruited a nationally 
representative sample of predominantly 50+ year old participants. In the two WHO-SAGE 
countries from the African continent, namely Ghana and SA, a nested sub sample was 
additionally selected in Wave 3 to provided 24hr urine samples for the analysis of sodium 
(Na), potassium (K), creatinine (Cr) and iodine (WHO-SAGE Salt and Tobacco study). This 
thesis is largely based on data from the salt sub-study, and the PhD candidate was heavily 
involved in the planning and data collection for the Ghana sub-study. This thesis reports 
analyses from WHO-SAGE datasets from Ghana for Waves (W) 1 (2007/8), 2 (2015) and 3 
(2019) and makes comparisons with corresponding WHO-SAGE data from South Africa 




In order to understand the context of the food environment in terms of food intake, it was 
important to identify food sources in LMICs that contribute most to dietary salt 
consumption. A systematic literature review was conducted to evaluate the dietary sources 
of salt in LMICs (Study 1). The review identified that breads, meat and meat products, 
bakery products, instant noodles, salted preserved foods, milk and dairy products, and 
condiments were major sources of salt in LMICs. The data summarized in this review is 
useful to inform development of health and consumer education programmes  and policy 
directives related to reduction in the production and consumption of such foods, provide 
evidence to advocate for reformulation of these foods to be lower in salt, and identification 
of alternative food sources.   
 
In addressing population salt reduction, identification of consumer knowledge, attitudes 
and behaviours (KAB) are critical to influence food literacy and identify interventions 
required to drive food behaviour change. We examined the KAB of the Ghanaian main 
survey sample in WHO-SAGE W2 and compared the data with that of the W2 South African 
sample (Study 2). Comparison between the two countries is of interest because South Africa 
has a long history of nutrition education related to its Food Based Dietary Guidelines that 
encourage reduction of salt added to foods (discretionary salt) and avoidance of salty foods, 
as well as mass media campaigns targeting improved awareness of the association between 
salt and raised blood pressure - while Ghana does not. Ghana has only focused on the 
iodine-related message that iodised salt helps prevent iodine deficiency disorders. South 
Africans were more likely than Ghanaians to add salt to food at the table (OR 4.80, CI 4.071–
5.611, p < 0.001) but less likely to add salt to food during cooking (OR 0.16, CI 0.130–0.197, 
p < 0.001). Surprisingly, despite greater exposure to consumer education strategies on salt 
reduction, South Africans were less likely to take action to control their salt intake (OR 0.436, 
CI 0.379–0.488, p < 0.001). The findings emphasized a need to intensify consumer awareness 




An important component of this thesis was the quantification of population salt intake in 
Ghana, using the gold standard methodology of 24hr urinary sodium measurements, and 
its association with blood pressure (BP) (Study 3). BP was measured in triplicate and 24hr 
urinary Na, K and Cr levels were determined. Median salt intake was 8.3g/day (IQR 7.5) 
and approximately two-thirds of participants had potassium intakes below the WHO 
recommended level of 90mmol/day. Despite a lack of association between salt and BP, Na: 
K ratios above 2mmol/mmol were positively associated with the slope of increasing BP with 
age. This study highlights an urgent need for salt reduction policy in Ghana, that is 
accompanied by strategies to increase dietary K intake. 
 
A follow-up study (Study 4) was conducted in participants who were 50+ years old at 
baseline in the WHO-SAGE Ghana W1 survey (data collected in 2007/9) and who 
participated in the WHO-SAGE Ghana W3 survey (data collected in 2019). Assessment of 
BP change over time showed that diastolic BP decreased by 9.7mm Hg and pulse pressure 
(PP) increased by 9.5mm Hg. Hypertension prevalence remained consistently high (W1: 
52.0%, CI = 0.48-0.55; W3: 48.8%, CI = 0.45-0.52) in the cohort. Hypertension awareness 
increased by 37% with no differences among hypertensives who were on antihypertensive 
medications nor those that were both on antihypertensive medications and had controlled 
BP. Reduction in DBP was associated with increasing age, living in rural areas and having 
health insurance while increased awareness of hypertension was associated with residing 
in urban areas, having health insurance and increasing body mass index (BMI). The data 
highlights the need to intensify the treatment of hypertension. 
 
 Universal iodization of salt and its compatibility salt reduction has been widely discussed 
in contemporary public health research.  A comparative study assessed urinary iodine 
excretion (UIE) among a sample of adults from Ghana and SA – both countries with national 
salt iodization programmes but only one (SA) that has implemented mandatory salt 
legislation (Study 5). Comparing data from the salt sub study in W3 in both countries, 
associations between salt and iodine intakes could be assessed. In Ghana, median Na 
v 
 
excretion was equivalent to a salt intake of 10.1g/day (IQR 7.6) while median UIE was 182.4 
µg/l (IQR 162.5), with a weak correlation (r = 0.1501, p < 0.0011) between salt intake and UIE. 
In SA, salt and iodine values were both lower (median salt = 5.6g/day (IQR 5.0) and median 
UIE = 100.2 µg/l (IQR 129.6) with a moderate positive association (r = 0.4050, p < 0.0001) 
between salt intake and UIE.  
An important part of the thesis was to disseminate and translate the novel findings for 
uptake by policy makers in Ghana. As well, as conventional outputs such as publications in 
international, peer reviewed journals, participatory action research (Study 6) was 
undertaken to discuss the evidence from this thesis and develop a road map for advocacy 
and support for salt reduction interventions in Ghana. To achieve this objective a 
stakeholder meeting involving representatives from government agencies, academia, Non-
Governmental Organizations (NGOs), Civil Society Organizations (CSOs) and international 
partners was organized in Ghana in February 2019. The conference reached a consensus 
with recommendations that are being considered for inclusion in the revision of Ghana’s 
national NCD policy. 
Overall, this thesis provided a synthesis of the literature and has conducted original 
research to provide a basis for action for salt reduction interventions in Ghana. It has 
identified that a multisectoral approach is essential to address discretionary salt use and the 
high intake of salt from other food sources and that there is a need to intensify efforts in the 
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Hypertension prevalence, risks factors for hypertension 
and salt reduction strategies 
1.1 Introduction 
This chapter provides an overview of the global burden of hypertension, its scope, 
measurement, risk factors and management through a narrative literature review. It 
gives an insight into hypertension in low- and middle-income countries (LMICs) with 
reference to Ghana. It further explains the link between hypertension and salt intake by 
reviewing literature on the role of sodium (Na) and potassium (K) vis-a-vis vascular 
conditions and discusses population salt reduction strategies and interventions. This 
chapter also highlights the gaps in the literature which will be addressed in subsequent 
chapters of this thesis. 
1.2 Hypertension 
Cardiovascular diseases (CVDs) are one of the major health concerns facing 
governments and nations globally. CVDs accounts for the greatest number of deaths 
every year, with 17.9 million death globally in 2016, representing 31% of all global deaths 
[1]. Though age-standardized CVD mortality rates have decreased globally between 
2006 and 2016 - more than three-quarters of these deaths have been attributed to heart 
disease and stroke and increased numbers of deaths related to these causes are expected 
to reach 23.3 million by 2030 [1, 2]. CVD burden continues to be relatively higher in 
LMICs compared to high-income countries (HICs) due to adverse lifestyle-related 
factors associated with the nutrition transition and poor-quality care [1, 3]. Risk factors 
for CVD, including hypertension, hypercholesterolemia and high body mass index 
(BMI) are among the major contributors to higher disability-adjusted life years [4].  
Hypertension is serious medical condition in which blood pressure (BP) is consistently 
elevated in the blood vessels [5] and is now considered to be one of the most important 
independent risk factors for developing CVD [5-7]. Of the 17 million CVD deaths in 2008, 
complications of hypertension accounted for 9.4 million [8, 9]. Evidence from clinical 
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research studies and randomized controlled trials (RCTs) attributed the decline in stroke 
mortality to hypertension treatment and control strategies [10]. Similarly, posthoc meta-
analysis of 123 studies emphasized that systolic blood pressure (SBP) should be reduced 
to less than 130 mm Hg to reduce CVD [11]. The relationship between hypertension, 
coronary artery disease (CAD) occurrence and premature death is well established [12-
14]. Data from several studies have described hypertension as the most prevalent risk 
factor for stroke and has been reported in about 64% of patients with stroke [15, 16]. 
Findings suggest that at ages 40 – 69y, each 20 mm Hg increase in SBP or each 10-mm 
Hg increase in diastolic blood pressure (DBP), is associated with more than two-fold 
increase in stroke death [15]. 
Prolonged hypertension is also a risk factor for developing heart failure unless other 
mitigating factors such as reduction in excess salt intake exist [16]. In the Framingham 
Heart Study, which incorporated 5,143 participants, hypertension preceded the onset of 
heart failure (HF) in more than 90% of all newly diagnosed HF patients in a 20-year 
follow-up [17]. Further analyses indicated that hypertension was the most attributable 
risk factor to HF and responsible for 39% of cases in men and 59% in women. At age 80, 
the lifetime risk of developing HF was about 20% in the Framingham cohort, and this 
risk doubled for participants with BP of 160/100 mm Hg compared with those with 
140/90 mm Hg [18]. However, among populations with either acute or chronic HF, 
increased SBP is associated with greater negative health outcomes [13, 16]. 
Globally, hypertension has been increasing over time; the number of people living with 
hypertension increased from 600million in 1980 to 1billion in 2008 [19], while in 2015 one 
in four men and one in five women had hypertension [20] making it challenging to 
achieve World Health Organization’s (WHO) target of a 25% decline by 2025 [21].  
1.3 Hypertension in LMICs 
Over 75% of global CVD deaths are occurring in LMICs whose populations have 
marginal access to integrated primary health care programmes and effective or equitable 
health care services to address CVDs [1, 22]. Additionally, CVDs were more prevalent 
among younger, middle-aged groups in LMICs. For example, in sub-Saharan Africa 
(SSA) half of CVD deaths occurred among the 30–69 age bracket [23]. A projected 
3 
 
economic loss of $3.7 trillion attributed to CVDs was estimated between 2011 and 2015, 
representing about 50% of the NCD economic burden and 2% of Gross Domestic Product 
(GDP) across LMICs [24]. 
Populations in LMICs may experience a higher burden of hypertension in comparison 
to the global average due to factors such as the ongoing nutritional transition, increasing 
trends in sedentary lifestyle, inadequate health care systems and the non-control of 
modifiable risk factors LMICs. Projections estimate that three-quarters of the world's 
hypertensive population will reside in LMICs within the next decade [25]. China, for 
example, reported 20% all deaths were from hypertension in 2005 [26] The overall 
prevalence of hypertension in China has risen substantially between 2002 and 2010 – 
from around 20% to 34% [27-29] while a 68% increase in hypertension within sub SSA 
by 2025 has been predicted [30]. Despite the interventions and use of innovative 
approaches, BP levels remain high in several LMICs [31]. Findings from a systematic 
review of hypertension prevalence across LMICs reported a pooled hypertension 
prevalence (for all 242 studies) of 32.3% [32]. A recent systematic review and meta-
analysis of hypertension prevalence in older adults from 15 African countries indicated 
a prevalence range of 22.3% to 90.0% [33]. 
Health systems in many LMICs do not have the capacity to diagnose and manage 
hypertension successfully [34, 35]. As the means of diagnosing hypertension becomes 
possible in LMICs, along with the absence of adequate prevention and control measures, 
the former can account for rapid increase in the prevalence of hypertension [36]. For 
example, evidence from a series of cross-sectional studies conducted over a period 25y 
in India indicated rising hypertension levels from 29.5% in 1992-1994, to 36.0% in 2015 
[37, 38]. In many countries in Africa, more than 40% (and up to50%) of adults are 
estimated to be hypertensive however, many individuals are living with undiagnosed, 
untreated and/or uncontrolled hypertension [39, 40]. 
1.4 Hypertension awareness, treatment and control in LMICs 
Though many national and global organizations have endorsed the importance of 
identification and control of hypertension [41, 42], poor access to available and effective 
medicines, together with challenges in rolling out screening programmes and the burden 
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of already stretched healthcare services remain barriers to hypertension control. Other 
setbacks include limited knowledge about prevention and management of hypertension 
among health practitioners and patients alike, and non-adherence to treatment among 
hypertensives [43].  Additionally, lack of governmental commitment in many LMICs to 
comprehensive public health policies to manage hypertension compounds the 
difficulties [44]. Despite global efforts to combat hypertension, treatment and control 
rates are very low in LMICs [45].    
LMICs disproportionately share low levels of hypertension awareness, treatment and 
control with rising hypertension [45, 46]. In a Chinese population-based screening 
project that recruited 1,738,886 participants, 44·7% (95% CI 44·6-44·8) of the 
hypertensives were aware of their diagnosis, 30·1% of whom (95 CI 30·0-30·2) were 
taking antihypertensive medications, and only 7·2% (95% CI 7·1-7·2) had achieved BP 
control [47]. Similarly, a Vietnam cross-sectional survey involving 9,832 adults reported 
that only 48.4% of hypertensives were aware of their hypertension, 29.6% were receiving 
treatment for the condition and only 10.7% had controlled BP [48]. A community-based 
study of 1,203 elderly participants from two sites in Bangladesh and three sites in India 
reported that, of those with hypertension, only 45% were aware of their hypertension, 
40% were on antihypertensive medication and 10% had the condition controlled [49]. 
Evidence from SSA indicated that, of those with hypertension only 27% (95% CI, 23%-
31%) were aware of their condition. Overall, 18% (95% CI, 14%-22%) of hypertensives 
were receiving treatment across the studies, and only 7% (95% CI, 5%-8%) had controlled 
BP [50].  
1.5 Measurement of Hypertension 
Different guidelines are available worldwide regarding how BP is classified. Most 
guidelines classify hypertension as SBP ≥ 140 mmHg and/or ≥ DBP  90 mmHg in 
individuals 18y and older, apart from in the most elderly (<150/90mm Hg for 80y+) based 
on an average of two or more measurements taken after the participant has been seated, 
legs uncrossed, for about 3 minutes.  This cut-off is based on the existing evidence which 
shows that treatment of patients to reduce BP below these values is beneficial in reducing 
the risk of developing NCDs [51]. This guideline is supported by the American Heart 
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Association, American College of Cardiology, Centres for Disease Control and 
Prevention, American Society of Hypertension and the International Society of 
Hypertension [42, 52]. However, RCTs (2014 evidence-based guidelines for management 
of hypertension in adults) recommended a new target <150/90mm Hg for ages 60+y due 
to physiological changes taking place among that age group [53]. Tables 1.1 and 1.2 are 
the hypertension classifications. 
       Table 1. 1 BP classification 




Normal <120 And <80 
Elevated 120-129 Or <80 
Stage 1 hypertension 130-139 Or 80-89 
Stage 2 hypertension ≥140 Or ≥90 
















Table 1. 2 Definition and classification of office BP levels according to the 2018 ESH/ESC 






The BP category is defined by the highest level of BP, whether systolic ordiastolic. Isolated 
systolic hypertension should be graded 1, 2 or 3 accordingto systolic BP values in the ranges 
indicated; ESH, European Society of Hypertension; ESC, European Society of Cardiology [42]. 
1.6 Risk factors for Hypertension 
In most cases, hypertension has no identifiable physiological cause and is generally 
classified as primary, essential or idiopathic. In a few cases, a weakened renin-
angiotensin system, increased adrenal medulla catecholamine secretion or increased 
adrenal cortex aldosterone secretion may result in renal alterations that could result in 
some form of hypertension [55, 56]. There are many known lifestyle risk factors that are 
associated with hypertension among various populations [39, 57] such as ageing, poor 
diet, excessive alcohol intake, lack of physical activity excess weight and exposure to 
persistent stress and are summarized further in Figure 1.1




Optimal <120 And <80 
Normal 120-129 and/or 80-84 
High normal 130-139 and/or 85-89 
Grade 1 
Hypertension 
140-159 and/or 90-99 
Grade 2 
Hypertension 
160-179 and/or 100-109 
Grade 3 
Hypertension 
≥180 and/or ≥110 
Isolated 
Hypertension 


























































The association between age and risk of hypertension is well known [58-62]. Rising BP 
is regarded as a common occurrence as people age with raised BP more prevalent among 
older people. Longitudinal data from the Framingham Heart Study, which followed 
participants for three decades, demonstrated a continuous rise in SBP between the ages 
of 30 and 84 years or over. Diastolic blood pressure however, has a varying pattern with 
ageing, increasing until the fifth decade and slowly decreasing from the age of 60 to at 
least 84 years of age. This causes a steep rise in pulse pressure with ageing [63]. In 
support, SBP was found to progressively increases with age, leveling at an average of 
about 140 mm Hg by age 80y [64]. The prevalence of hypertension is more than doubled 
in the elderly than in the young population with more than two-thirds of individuals 
aged 65 and above being hypertensive [65, 66]. In recent years, metabolic syndrome and 
hypertension are increasingly seen in the middle-aged and young populations. Among 
young adults (18-39 years), approximately 20% of men and 15% of women have 
diagnosed hypertension with an expected increase in prevalence due to rising rates of 
obesity [67]. Stiffening of blood vessels with age is conventionally associated with 
occurrence of systolic hypertension [68]. The wall of large arteries, thicken and lose 
elasticity over time, resulting in an increase in pulse wave velocity which increases both 
systolic and pulse pressure, Therefore, aging-related hypertension is characterized by a 
significant increase in systolic blood pressure with no change or even a decrease in 
diastolic blood pressure [69, 70].Aging also causes an overall decline in cardiac output, 
heart rate, stroke volume, intravascular volume, renal blood flow and plasma renin 
activity, all of which are indicative of increasing BP [69]. Subsequently, the kidneys 
become less efficient at excreting salt loads, thereby compounding the effect of ageing 
on rising BP [70]. 
1.6.2 Gender 
Though several studies have showed conflicting results, men generally are at a greater 
risk of hypertension than premenopausal women of the same age [71, 72, 73]. Men have 
greater prevalence of hypertension from 20 until age 65 where the gap between the 
genders is narrowed, yet more women over age 75 remain hypertensive [74]. NHANES 
data which studied 10,380 people from 1999 to 2006, indicated a 36.3% prehypertensive 
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status, of which men had a much higher prevalence of prehypertension prevalence 
compared with women [75]. This finding is further supported by a recent meta-analysis 
of 250,741 individuals (120,605 men and 130,136 women) from 13 countries, where the 
the pooled prevalence of prehypertension was 40% among men vs. 33% among women 
[76]. These data further demonstrated that young women between 20-40y were relatively 
protected from developing hypertension compared with their male counterparts. There 
is substantial evidence that male and female hormones, particularly testosterone and 
estrogen may be responsible for gender-associated differences in BP status, but the 
underlying mechanisms for such occurrence needs further study [77-78]. Estrogen has 
the potential to regulate endothelial vasodilation, inhibit sympathetic and renin-
angiotensin system (RAS) activity, enhance the production of endothelin, reduce 
oxidative stress, increase antioxidant production and reduce inflammation - all of which 
may alter BP (79-81). After menopause, where estrogen levels fall a rapid increase in the 
prevalence of hypertension to about 75% is evident in women [82]. The difference in 
hypertension prevalence across age and sex may be partially attributed to true biological 
differences; however, gender-specific differences in access to care may also partially 
account for this [83]. 
1.6.3 Area of Residence 
Residential location often influences exposure to environmental risk factors associated 
with lifestyle and access to healthcare. Generally, urban residence is associated with a 
higher risk of hypertension compared to rural dwelling. Evidence from several LMICs 
suggest higher prevalence of hypertension in urban areas [84-86]. That notwithstanding, 
data from the Chinese Health and Retirement Longitudinal Study 2015 indicated that 
rural residents were more likely to have undiagnosed hypertension compared to their 
urban peers [87]. Comparably, Pakistan’s National Diabetes Survey, 2016–2017, reported 
hypertension prevalence to be 44.3% and 46.8% for urban and rural dwellers, 
respectively [88], while hypertension prevalence among Zambian adults in the rural 
setting (46.9%) was double that observed in urban areas (22.9%) [89].  
Despite contradictory findings, hypertension has increased in both urban and rural areas 
over time. A general increase in hypertension prevalence from the previous decade was 
reported between 2000 and 2016, ranging from 13-70% in rural, and 12-65% in urban 
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settings [90-94] necessitating urgent public health interventions by both local and 
international health bodies [57, 95].  
1.6.4 Heredity 
Several studies have identified associations between genetic polymorphisms and the 
development of hypertension [96, 97]. It is estimated that heredity contributes 30–60% 
to the pathogenesis of essential hypertension [98-100]. The interaction between genes 
and environment, may influence risks of hypertension among different populations 
[101]. Genetic predisposition for increased BP spanning the lifetime has been 
investigated in a number of studies showing that higher genetic risk scores in childhood 
had significantly higher DBPs and were more likely to be hypertensive in adulthood 
compared to those with a lower risk score [102, 103].  
Several twin and family studies that have relied on both conventional office BP 
measurements and ambulatory BP (ABP) measurements have shown substantial genetic 
contributions to individual differences in BP [104-106]. Various SNPs have been found 
to influence hypertension in many pediatric populations studied recently [107, 108]. 
In terms of ABP, heritability estimates ranging from 22% to 62% for SBP and from 38% 
to 63% DBP have been reported [106, 109, 110]. In a study to explore the familial 
aggregation and heritability of hypertension among the extended family, hypertension 
distribution was found in first, second and third-degree relatives with hypertension 
prevalence reducing as level of relatedness declined [101]. Similarly, twin studies have 
demonstrated the heritability of SBP and DBP based on studies conducted in over 4000 
twin pairs from seven countries. Findings from this study showed a range of 52-66% 
heritability in SBP and 44-66% in DBP, with differences in sex and shared family 
environments [104]. 
1.6.5 Diet 
1.6.5.1 Salt consumption 
Several nutrients have different impacts on BP, however, many meta-analyses have 
established well-known effects of Sodium (Na) and potassium (K). 
Sodium, consumed as salt (NaCl) is considered to be a major risk factor in cardiovascular 
events [111-113]. Sodium is required by the body to ensure acid-base balance, maintain 
plasma volume, and transmit nerve impulses [114, 115]. Though essential, Na is needed 
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only in small quantities by the human body [116].  Sources of Na can be described as 
discretionary (salt added to food during cooking or at the table) or non-discretionary 
(salt present in foods, which is inherent, or which were added during food processing) 
[117-119]. While low amounts of Na are naturally found in vegetables, oils and cereals, 
meat and fish products contain relatively higher amounts. Food processing plays a large 
role in the amount of Na present in foods [114]. Processed foods contribute the most to 
salt consumption worldwide, with breads, meat and meat products, bakery products, 
instant noodles, salted preserved foods, milk and dairy products providing more than 
70% of all salt consumed in westernized diets [120]. In LMICs, a much greater 
contribution of salt in the diet is provided through discretionary sources [121, 122].  
There is a strong evidence from various studies showing a positive and direct 
relationship between salt consumption and BP. The International Study of Sodium, 
Potassium, and Blood Pressure (INTERSALT), involving over 10,000 participants aged 
20-59y from 32 countries provided both within and between population estimates of 
24hr Na excretion and found a significant positive relationship between 24hr Na 
excretion and SBP. Adjusting for underestimation, Na intake higher by 100 mmol/d was 
accompanied by a corresponding higher SBP/DBP by about 3-6/0-3 mm Hg. This 
relationship was found for both normotensives and hypertensives participants [123].  In 
the International Population Study on Macronutrients and BP (INTERMAP) studies, 
significant positive associations between 24hr urinary Na excretion and urinary Na/K, 
and BP were reported among 4,680 participants from 17 populations across five 
countries [124].  
Population-wide intervention studies have demonstrated that reduced salt consumption 
results in a corresponding decline in population-level BP. In a 2-year study, extensive 
health education to reduce salt intake, particularly from foodstuffs known to contribute 
significantly to salt in the diet of that population, resulted in approximately 50% 
reduction in salt intake between intervention and control villages and was associated 
with a decrease of 13/6mm Hg in BP in the intervention group [125]. Another 
intervention study conducted in two communities in northeastern Japan demonstrated 
a decline in salt consumption by 2.3 g/day through dietary counselling and an associated 
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reduction of 3.1 mm Hg in systolic BP [126]. Conversely studies that did not achieve 
significant reduction in salt intake failed to accomplish declines in BP [113, 127]. 
A meta-analysis of randomized trials demonstrated that a long-term gradual decline in 
salt consumption resulted in substantial reductions in BP, in both hypertensive and 
normotensive individuals, irrespective of gender, age and ethnicity, with a variation in 
the gradient of the decline in BP within different populations, and indicative of a dose-
response relationship [128, 129]. Similarly, the Dietary Approaches to Stop Hypertension 
(DASH)-sodium trial showed a dose-response relationship with BP reduction [130].  
The WHO recommends <2gNa/day, equivalent to 5g salt/day beyond which there is risk 
for developing CVDs. However, global mean Na intake is almost twice the WHO 
recommendation [131]. Sodium intakes exceed the recommended levels in almost all 
countries with small differences by age and sex [132]. Some studies have emphasized a 
U-shaped relationship between Na intake and CVD mortality which has raised a debate 
about the optimal lowest intake of salt [133, 134]. The Prospective Urban Rural 
Epidemiology (PURE) study suggested that salt reduction efforts should be limited to 
only populations where salt intake exceeds 12.7 g/day. However, the findings from the 
PURE study have been widely criticized for their methodological flaws, such as using 
spot urine samples instead of 24hr collections and procedural biases [135-139]. 
Reduction of salt consumption in countries such as United Kingdom (UK) [140] and 
Finland [141]) have refuted claims of the PURE study [142] by demonstrating public 
health benefits [143, 144]. In England, mean population level salt intake declined from 
9.5 g/day to 8.1 g/day between 2003 and 2011 which, in turn, resulted in substantial 
decline in population BP and mortality from stroke and ischaemic heart disease [145]. 
The body of evidence to support global salt reduction to 5g/day is considered 
overwhelming [146]. 
Some studies have suggested that the association between Na consumption and 
development of hypertension may be due to the degree of salt sensitivity among 
populations [147]. Most excess salt consumed is excreted from the body by the kidneys 
or as sweat. Yet, for some people, response to limited or large intake of salt results in 
differential changes in BP (‘salt sensitive’) [148]. Several mechanisms including blunted 
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activity of the renin–angiotensin–aldosterone system (RAAS) and dysfunctional or 
defective Na+/Ca2+ transport and exchange system, have been suggested to be implicit 
in this phenomenon [149] as such, individuals respond to salt intake differently 
irrespective of their hypertension status [150]. In populations where BP changes are 
parallel to changes in their salt consumption, a higher BP is needed to sufficiently excrete 
Na [151]. In that sense, salt sensitivity may be associated with raised cardiovascular 
morbidity and mortality [152, 153]. The causes underpinning salt sensitivity trait have 
not been investigated thoroughly [154], but there is evidence suggesting genetic 
proposition may play a role [153, 155]. Other factors include race/ethnicity, age, gender, 
BMI and diet [148, 156]. Salt sensitivity is particularly common in older adults, people of 
African descent and people with hypertension or other related diseases [157]. 
1.6.5.2 Potassium 
Potassium is an important micronutrient required for regulating and maintaining body 
fluid volume and acid-base balance [158]. An inverse relationship has been established 
between K intake and BP, and more generally with CVDs risks [159, 160].  A recent meta-
analysis of 11 cohort studies reported an increased K intake was associated with reduced 
risk of stroke [161].  In another meta-analysis of 32 randomized controlled trials, SBP and 
DBP were reduced by 4.9 mm Hg and 2.7 mm Hg, respectively, when K consumption 
was increased by 75mmol/day (median) in both hypertensive and normotensive 
populations [159]. Not all studies are consistent; however, a meta-analysis including 
only hypertensive participants showed no association between increased K and BP, 
[162]. In response to the large body of evidence that supports a beneficial role of dietary 
K intake on blood pressure regulation, the WHO suggests an intake of at least 90 
mmol/day (3510 mg/day) from food sources for adults and downward adjustment for 
children based on their energy requirements []. Many populations around the world 
consume less than the recommended amount of K, thus making the achievement of the 





1.6.5.3 Na/K Ratio 
Both Na and K intakes are associated with BP regulation, however the ratio between 
these two cations may be more important than either one alone. Several mechanisms 
have been suggested as means by which the interaction between Na and K may control 
BP. One such, is molecular mechanisms implicated in the retention of sodium and loss 
of K (Fig. 1.2).  
 
Figure 1. 1 Molecular Mechanisms Implicated in the Retention of Sodium and Loss of Potassium 
by the Kidneys in Primary Hypertension. Solid arrows indicate an increase or stimulation, and 
the broken arrow indicates inhibition. Numbers on the left denote the approximate percentage 
of reabsorption of filtered sodium in each nephronal segment during normal conditions. Several 
influences acting on the luminal sodium transporters and the basolateral sodium pump 
stimulate sodium retention and potassium loss. Promotion of sodium reabsorption by the 
activated epithelial sodium channel (ENaC) generates a more negative luminal membrane 
voltage (Vm) in the collecting duct that enhances potassium secretion through the luminal 
potassium channel and promotes kaliuresis. NHE-3 de-notes sodium–hydrogen exchanger type 
3, ACE angiotensin-converting enzyme, NKCC2 sodium–potassium2 chloride cotransporter, 
and NCC sodium–chloride cotransporter. PST 2238 (rostafuroxin) antagonizes the effect of 
digitalis-like factor on the sodium pump [164]. 
 
Furthermore, renal vascular K channels could be implicit in the regulating BP [165]. 
Reabsorption of Na and K secretion in the distal nephron is fundamental in the long-
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term control of arterial pressure [166]. As such, even in hypertensives, a high K diet could 
significantly reduce the thickening of arterial walls, thus reducing BP [167]. 
The interdependency between Na and K and their effect on BP is well known [164]. 
Several studies have demonstrated that a high K intake lessens the effect of high salt 
intakes on BP levels thereby reducing CVD risk [168-170].  To improve dietary Na/K 
ratio, many studies have assessed dietary strategies such as the DASH diet, either with 
or without salt restriction [130, 171, 172]. The DASH diet recommends 2300mg of sodium 
intake per day.   
The Na/K ratio may be better placed and can be used for dietary approaches meant to 
reduce BP across populations [173]. Proportions of Na and K is an essential metric in 
relation to the presence and development of CVDs and death [167, 172]. Evidence is also 
provided by experimental RCTs [175, 176]. A reduction in the urinary Na/K molar ratio 
from 3.09 to 1.00 results in a 3.36 mm Hg reduction in population systolic BP [173, 177].  
In support, the WHO has emphasized that attaining the targets for both Na and K 
consumption levels would result in an Na/K molar ratio of about 1.00 [163]. Relatively, 
Na/K molar ratios less than 2 predicted the least probability for CVD occurrence [169]. 
At the same time, a lowered Na/K ratio is indicative of a higher quality diet [178] with 
dietary approaches to reduce BP shown to be effective and used as evidence to provide 
global recommendations for upper limits of Na and minimum K consumption levels 
[179]. 
1.6.5.4 Iodine Intake 
Iodine is a trace element that is found in most vegetables and seafood and is very 
important for optimal functioning of the thyroid gland. Iodine is required for normal 
physical growth, particularly during pregnancy and infancy. Due to the absence of 
iodine in a large variety of everyday foods, it has become a public health concern 
particularly for children and lactating mothers [180]. Globally, approximately 2 billion 
people are living with iodine deficiencies (ID), out of which about 50 million show severe 
manifestations [181]. Inadequate iodine has been implicated in increased risk of 
stillbirths, abortions, perinatal mortality, congenital abnormalities, cretinism impaired 
growth [181, 182]. Iodine deficiencies cause irreparable but preventable brain damage 
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and are associated with lower intelligent quotient (IQ) among children born to mothers 
who were iodine deficient during pregnancy [183, 184]. Urinary iodine is mostly used in 
assessing population iodine intake with a recommended median urinary iodine 
concentration (UIC) of ≥100μg/l [180]. 
The WHO upon its evaluation of the global magnitude of the ID, and in keeping with its 
mandate of monitoring each country’s progress towards addressing global iodine 
deficien.cy disorders (IDD), as a public health concern, launched the universal salt 
iodization (USI) programme in 1991[185]. Over the years, various food vehicles such as 
bread, milk [186], water [187] and, most widely, salt have been used for iodine 
fortification. To meet the iodine requirements of a population it is recommended to add 
20 to 40 parts per million (ppm) of iodine to salt (assuming an average salt intake of 10 
g per capita/day). Most countries have implemented the USI and ID have been greatly 
reduced, with 66% of households worldwide using iodized salt [188, 189]. 
While USI strategies are emphasized by the WHO, member countries are encouraged to 
ensure its compatibility with salt reduction, so that both public health goals of reducing 
salt intake and maintaining optimal iodine consumption are achieved [190]. 
1.6.6 Physical Activity 
The relationship between physical activity and CVDs in general has been well 
established [191-194]. Large prospective studies from HICs have demonstrated an 
inverse relationship between self-reported physical activity and cardiorespiratory 
fitness, and hypertension [195, 196]. In the Aerobic Center Longitudinal Study (ACLS), 
participants who maintained or improved fitness (metabolic equivalents (METS), 0.46-
5.64) had a 26% and 28% lower risk of incident hypertension, respectively, compared 
with those who lost fitness overtime (METS < 0.46) [197]. Similarly, in another study, 
participants with reduced cardiorespiratory fitness over 5y of follow-up, had an 
increased risk of hypertension compared to participants with improved 
cardiorespiratory fitness [198]. 
Several studies have shown positive impacts of physical activity on hypertension 
management with associated declines in BP as high as 5–7 mm Hg for both SBP and DBP 
[199, 200]. For the most part, physical activity has been linked with acute substantial 
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declines in SBP, with its most profound impacts were well demonstrated in 
hypertensives [201].  
The decline in BP with physical activity may result from mitigation in peripheral 
vascular resistance, which may be due to neurohormonal and structural responses, with 
reductions in sympathetic nerve activity and increased arterial lumen diameters [202]. 
Figure 1.3 depicts the effect of physical inactivity on hypertension. 
 
Figure 1. 2 Hypothesized considerations by which physical inactivity may influence risk for 
hypertension and cardiovascular complications [203] 
 
Other explanations for BP decline included beneficial impacts on oxidative stress, 
inflammation, endothelial function, arterial compliance, body mass, renin-angiotensin 
system activity, parasympathetic activity, renal function, and insulin sensitivity [192]. 
Variability in types and intensity of physical activity together with environmental and 
hereditary aspects may result in significant between and within-study variation in 




Alcohol consumption is a risk factor for several disease conditions including certain 
cancers, liver cirrhosis and CVDs [205]. The relationship between alcohol consumption 
and BP has been investigated in several epidemiological studies. Regular consumption 
of alcohol was found to increase BP even among men who reported moderate 
consumption. Women who reported excessive alcohol consumption were three times 
more likely to be hypertensive, and heavy consumers had a 70% probability of 
developing hypertensive [206-208]. Longitudinal studies indicated that, compared with 
abstainers, drinking frequency of 2 or more times per week was associated with a 
significant increase in the risk of hypertension in both genders [209]. The link between 
high levels and specific patterns of alcohol consumption (such as binge drinking) and 
growing risk of hypertension is also well established [206, 209, 210]. Additionally, among 
the youth, increased risks for hypertension have been reported for females consuming 
more than 14 drinks per week, and for men consuming between 15–28 drinks per week, 
together with monthly heavy drinking [211]. However, there is some evidence that 
indicates moderate consumption of alcohol may have health benefits [212, 213].  
Due to the immense burden that alcohol use poses on society, particularly in SSA where 
consumption rates have been consistently high since 2005 [214, 215], monitoring and 
surveillance at both local and international levels are recommended within [216]. 
1.6.8 Body weight and obesity 
A linear association between obesity (BMI ≥ 30) and hypertension has been documented 
in several epidemiological and clinical studies [217, 218]. Obesity is a worldwide 
epidemic with a global fatality rate of at least 2.8 million people annually [219], and a 
major risk factor for hypertension [220-223]. It is established that this association exists 
from early in life at around age 8–11y [224]. In a systematic review involving 30,044 
individuals across 13 African countries, obese participants were more than twice as 
likely to be hypertensive [225]. Data from a 30y follow-up in the Framingham Heart 
Study, indicated that more than three-quarters and two-thirds of primary hypertension 
in males and females, respectively, was attributed to excess weight gain [226]. The 
Tecumseh Study also reported higher waist/hip ratio in the hypertensive participants 
compared to the non-hypertensive group. Additionally, familial predisposition to 
hypertension was associated with excess weight accumulation, suggesting an 
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association between the mechanisms that cause a rise in BP and those that stimulate 
increased food intake or sedentary living [226]. Clinical studies have emphasized the 
importance of maintaining a BMI of <25 kg/m2, as a prudent way to prevent primary 
hypertension and have demonstrated weight loss to be an effective strategy in 
hypertension reduction [218, 228]. 
Despite the enormous evidence implicating the role of excess weight gain in higher BP, 
not all obese persons are hypertensive. Yet, individuals identified as obese 
normotensives have higher BP than their age-matched peers who have lower body 
weight [229]. Not only the amount of excess weight is important, but the distribution of 
body fat, with visceral abdominal fat being a better predictor hypertension than BMI 
[230]. 
Mechanisms linking obesity to hypertension are not well established. However, studies 
have shown that blood volume and osmosis taking place in the kidneys play important 
roles in the development of hypertension [231]. Obese populations may have relatively 
higher likelihood of being hypertensive due to the increased presence of 
hyperinsulinemia. This may trigger the stimulation of the sympathetic nervous system, 
which in turn, may cause a rise in BP either through vasoconstriction or increased Na 
retention [232]. Other mechanisms postulated included activation of the renin–
angiotensin–aldosterone system, abnormal levels of certain adipokines such as leptin, 
altered spectrum of cytokines and the role of perivascular adipose tissue damage [233-
235]. Given the rising trends of obesity worldwide [219], body weight management 
may be an effective remedy for hypertension prevention. 
1.6.9 Smoking 
Though it is overwhelmingly established that cigarette smoking causes various adverse 
cardiovascular events [236-238], studies on the association between cigarettes smoking 
and hypertension have produced conflicting results [239-242]. The nicotine in cigarettes 
has been described as an adrenergic agonist, with a sympathomimetic ability to raise the 
heart rate and BP levels [243]. Smoking has a direct association with endothelial damage 
[14], which in turn, plays an essential role in development of hypertension [244, 245]. In 
a case control study measuring ambulatory systolic BP in hypertensive smokers and 
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non-smoking hypertensives, smokers recorded a higher mean daytime ambulatory SBP 
than nonsmokers [246]. A meta-analysis involving 16,980 participants from 18 countries 
across Africa showed that smoking was positively associated with hypertension [247]. 
However, findings from some epidemiological studies have provided contrasting 
findings. A five-year follow-up study conducted among Japanese men found that the 
adjusted mean change in BP of current smokers was lower than in nonsmokers [248]. 
The findings suggest that weight loss/gain may be a possible mediator of the association 
between smoking and BP. 
Other epidemiological studies have reported no dose-effect association between 
frequency of smoking and SBP or DBP [249]. Another study on the effect of smoking on 
BP and resting heart rate found no causal relationship between smoking amount in 
current smokers and SBP nor DBP [250]. Smoking analyses are important in salt and BP 
studies, as smoking affects taste perception [241], and preference for salty food items 
[252]. 
1.7 Salt reduction strategies and interventions 
Population salt reduction has remained high on the agenda of the United Nations (UN), 
the World Health Assembly (WHA) and WHO because of the looming pandemic of 
CVDs due to the persistent risk factors including increasing salt intake. In view of this, 
in 2011, world leaders pledged through a political declaration of the high-level meeting 
of the UN General Assembly on the Prevention and Control of NCDs, to decrease 
population’s access to poor diets. Subsequently, in 2013, the WHA approved 9 global 
voluntary targets for the prevention and control of NCDs, which included a 30% relative 
reduction in the intake of salt by 2025 [129]. In line with these projections, various 
policies, programmes, strategies and interventions have been developed which included 
actions and expectations from governments, civil societies, manufacturers, retailers, 
consumers, and the general public [57]. Though many countries are taking action to halt 
increasing salt consumption, more intensive effort is required, especially in LMICs 
where the risk of morbidity and mortality from hypertension far outweigh that present 
in HICs [253]. 
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In addition to population salt consumption, many studies report on community 
knowledge, attitudes and behaviours in relation to salt use, and food sources that 
contribute most salt to the diet [122, 123, 132, 254]. These resources inform the planning 
of programmes and strategies to address excessive salt use. For example, in 2003/2004, 
in the UK, a salt reduction programme was initiated following a baseline study which 
determined salt consumption levels and food sources thereof. That study assisted in (1) 
setting a target for population salt intake and developing a salt reduction strategy; (2) 
setting progressively lower salt targets for different categories of food, with a clear time 
frame for the industry response (3) working with the industry to reformulate food to 
contain less salt; and (4) conducting consumer awareness campaigns. As a result, the salt 
content in many processed foods was reduced substantially from 9.5 to 8.1 g per day 
(p<0.05) over a 7year period [138]. For each gram of salt eliminated from the usual UK 
diet, it has been estimated that 4,147 lives could be saved annually through a decline in 
stroke and heart attack mortality [255]. 
Periodic collection of information and monitoring of population salt intake is essential 
to track changes in salt content and sources of food. In the UK salt reduction programme 
[138], periodic assessments were carried to assess whether manufacturers and retailers 
were adhering to the voluntary reformulation targets and to determine whether there 
was a need to adjust the targets [256, 257]. Mongolia with an intervention that aimed to 
lower salt content in factory meals resulted in a 2.8g/day reduction in salt intake, 
alongside improvements in consumer awareness, and an average of 1.6% reduction of 
salt content in bread among 10 bakeries in the country. These pilot salt reduction 
activities were influential in the drafting of the Mongolian National Salt Reduction 
Strategy, 2015−2025 [258].  
Interventions through voluntary commitment and pledges from food industries are 
effective ways of reducing salt in the diet. This involves robust leadership from 
government, good partnership with the food industry, and availability of accurate 
information on the Na content of targeted foods, and the publication of monitoring data 
to encourage action by food industries [259]. For instance, in Kuwait, an agreement was 
reached between the Kuwaiti Ministry of Health and food industries to voluntarily 
reduce the salt content in bread and cheese over a 10y period. Prior to this, the ministry, 
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in partnership with food industries, embarked on an education campaign on approaches 
for reducing salt content for the overall benefit to the country. The targeted 10% 
reduction in the salt content of bread was met in the first quarter of the 10year period 
with an accompanying 1.7% decline in hypertension among adults in Kuwait between 
2010 and 2014 [260]. The success story of Kuwait has motivated other countries in the 
Gulf particularly, Bahrain, Oman, Qatar, Saudi Arabia and the United Arab Emirates to 
initiate similar interventions [261]. Similarly, in the UK, voluntary salt reduction 
methods were associated with a 20−30% reduction of the salt content in processed foods 
which led to approximately 6000 fewer CVD deaths [138, 262].  
Legislation on levels of salt permitted in foods and meals have been used in a few 
countries to promote reformulation. Food industries are mostly the target of this 
approach, where clear and gradual targets for maximum salt levels in specific foods are 
set to be reached within define time. Salt targets need to be achievable but also 
sufficiently stringent to result in the magnitude of population salt reduction that has 
been planned [263]. This involves setting the maximum levels of Na content of each food 
category and ensuring that the Na content of all food items within each category falls 
below the maximum level. Another method is to have weighted average targets for each 
food category. Using this approach, Na content level of food items within a certain food 
category can be altered to meet the overall average for that category. This latter approach 
is preferred by most countries but monitoring and surveillance required to ensure 
compliance is often unattainable and costly. Efforts such as food reformulation requires 
effective engagement with government, academia and industry and food supervision by 
international authorities to encourage uptake. Ideally and in many populations, initially 
targets are set for foods that contribute most salt to the diet [264] while other foods can 
be included later [259]. In South Africa (SA), the government passed new mandatory 
regulations specifying the maximum Na limits permitted in various categories of 
processed foods. The legislation was implemented in June 2016 with a further reduction 
of Na content in those foods and which came into effect by June 2019. The legislation 
included mechanisms to ensure compliance and enforcement, such as random and 
frequent chemical analysis of food products, and punitive measures for food 
manufactures that did not comply with the regulations [264].  
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As well as instituting salt reduction goals for the food industry, other interventions such 
as taxes on high-salt products, clear food labelling and effective health communication 
approaches have been shown to be beneficial [265]. Hungary introduced a public health 
product tax on salty snacks and condiments with Na content > 1g per 100g and > 5g per 
100g, respectively. Similarly, in Portugal a value added tax is in place for salty foods 
[266]. Though the evidence is substantial in terms of the effectiveness of higher taxes on 
the control of tobacco use, the evidence of the impact of such strategies on salt intake is 
not yet well established [267]. 
Nutrition labelling (ie providing the list of the main nutrients in a food product) has been 
described as an effective way to influence for consumer food selection towards healthier 
choices that contain less salt. This approach requires food industries to declare the 
content of salt in their food products, thereby giving consumers the option to compare 
the salt content in similar products and make better choices. Labelling is most effective 
when carried out in conjunction with consumer education, communication and 
marketing strategies that explain the labels and its health implications. Many countries 
have mandatory regulations that specify type and number of nutrients to be labelled, 
whether the information appears on ‘front-of-pack’ or ‘back-of-pack’, ‘the use of 
signposting such as colour codes to indicate the salt content in in food products, and 
whether the label provides further information to the consumer [259]. Labelling policies 
in Finland have influenced the food industry to reduce the salt content of products to 
avoid a “high salt” label. This policy resulted in 20−25% decline in the levels of salt in 
bread, meat products, cheeses and ready meals [268], and other food products [269]. As 
a result of the labelling policies and other salt reduction actions, a 4g salt/day decline in 
population salt consumption in Finland between 1979 and 2007 was reported [270, 271]. 
There have been suggestions for ‘shelf labelling’ at the point of purchase. This involves 
displaying warning signs in supermarkets and stores about the nutrient content of foods, 
so that consumers can make healthy choices. This intervention is presently being used 
in supermarkets in Marshall Islands (52). Another option is Australia’s FoodSwitch app 
which makes use of mobile phone applications allowing the retrieval of nutrient content 
information at the point of purchase and providing comparative alternatives to a food 
product based on the level of salt by scanning the bar code [272]. 
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To target food consumed outside the home; in hotels, restaurants and cafés, menu 
nutrition labelling has been suggested, where regulations will require the hospitality 
industry to provide information relating nutrient composition and quantities on the 
menu or at a noticeable area within the premises. This has been successful in New York 
City where high-salt warning labels have been attached to menu items and information 
provided on levels of salt in composite meals [273]. 
Educating and communicating the health benefits of salt reduction is the most used 
intervention because of its relative ease and cost effectiveness [24]. When implemented 
successfully, this intervention has a high potential of changing dietary practices, by 
augmenting the desire for improved and reduced salt products, and generally enhancing 
the total health and wellbeing of populations. Education and communication 
approaches work better when they are implemented comprehensively within an overall 
environment that supports healthy eating [259]. A successful example is available from 
Vietnam where salt intake levels, consumer knowledge, attitudes and practice improved 
following a nutrition education campaign resulting in a 2.2g/day reduction in salt intake, 
with most of the population showing an increased understanding of the health risks 
associated with higher salt intake and embracing actions to reduce their salt intake [274]. 
Similarly, a school-based cluster randomized control trial involving 28 primary schools 
and their families in Changzhi, northern China, resulted in SBP reduction of 2.3 mm Hg 
and 9.5 mm Hg in adults (<60y) and older adults (60+y), respectively, after an 8-lesson 
(40 minute each) programme on salt reduction [275]. Effective communication for salt 
behaviour change has also been demonstrated in Australia in an 18-month study which 
involved comprehensive consultation with key stakeholders and the larger community. 
Through the use the Communication for Behavioural Impact (COMBI) framework, the 
‘FoodSwitch’ app and the provision of a salt substitute, a significant decline of 0.8g/day 
of urinary salt equivalent excretion was achieved, together with a significant surge in 
knowledge related to salt reduction [276, 277]. Several studies have offered support for 
health education and communication as one of initial approaches and a compelling 
measure in salt reduction interventions [57, 259]. Varying approaches are recommended 
in terms of public advocacy, community mobilization, advertising, interpersonal 
communication and point-of-service promotion. That notwithstanding, limitations to 
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health education and communication needs to be identified to provide complementary 
methods better suited for constructs such as attitudes, perceptions and 
environmental/social support [257]. 
The WHO has introduced the ‘SHAKE’ package which is evidence-based resource and 
to assist WHO member states with the development, implementation and monitoring of 
salt reduction strategies, and to enable countries to achieve a reduction in population 
salt intake. The package outlines the policies and interventions which have proven to be 
effective, provides evidence of the efficacy of the recommended interventions, and 
includes a toolkit containing resources to assist member states to implement the 
interventions. 
Few countries have engaged with all the strategies outlined in the ‘SHAKE the salt Habit’ 
but cost-effectiveness of salt reduction programmes to reduce morbidity and mortality 
from NCDs may drive further uptake in the future [278]. 
1.8 Hypertension in Ghana 
Epidemiological studies on hypertension in Ghana over the past few decades have 
reported an increase in hypertension prevalence and an increased impact on disability 
and death [279, 280]. Hypertension was found to be a significant cause of renal and heart 
failure in Ghana [281] and remains consistently high in both urban and rural 
communities [282, 283].  Records obtained from the national hospital in Ghana between 
1994 and 1998 showed that 11 % of deaths in adults aged 20y and older were as a result 
of stroke, with hypertension being the underlying factor [284]. In 2005, hypertension was 
described as the second principal cause of outpatient morbidity in adults older than 45y 
in Ghana [285]. In the capital city of Accra, hypertension increased from fourth place to 
become second only to malaria as the leading cause of outpatient morbidity in 2007 [286]. 
The incidence of hypertension in outpatient public health facilities in the country 
increased more than ten-fold from 49,087 in 1988 to 505,180 in 2007 [287]. Consequently, 
hypertension became the major cause of hospital admissions and death, due primarily 
to its association with heart disease and renal failure [281]. A nationwide study 
conducted in 2008 (WHO’s Study on global AGEing and adult health (WHO SAGE) 
Ghana W1) which included 5,526 nationally representative participants reported a high 
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hypertension prevalence of 58.9% using the BP threshold of ≥ 140/90 mm Hg [62]. 
Despite rising hypertension levels, awareness, treatment and control of the condition 
remains low [62, 288], indicative of the poor state of the health system in Ghana. 
There is an urgent need for the health system in Ghana to improve its performance to 
adequately address the rising demands of hypertension and related CVDs. Issues 
concerning funding, uncoordinated care, shortage of qualified health workforce, low 
insurance coverage and inconsistent supply of medication remain the main setback to 
effective healthcare delivery in Ghana [289, 290]. Despite the rising burden of 
hypertension and its related CVDs, the allocated budget to NCD prevention and 
management was meagre; approximately 80% of the health budget goes to infectious 
diseases [291]. There is also the challenge of traditional and faith-based healers whose 
practices and approaches to the management of hypertension is questionable and often 
not regulated [292]. 
1.9 Summary of evidence and gaps in literature 
The narrative literature review has emphasized the rising trend of hypertension 
particularly in LMICs and highlighted the need for countries to develop strategies to 
better prevent and manage the occurrence. A modifiable risk factor for hypertension is 
diet, particularly salt consumption. However, population studies that assess relative 
hypertension and salt consumption are lacking in Ghana, a West African country that 
has a high burden of disease from hypertension. Gaps in the literature identified need 
for updated and valid data on population salt consumption levels, iodine intake levels, 
salt intake behaviours, and hypertension prevalence associated risk factors - to drive the 
salt reduction agenda through increased political will for policy formulation. This thesis 
will provide evidence to address some of the gaps. 
1.10 Hypotheses 
Hypertension prevalence has increased in Ghana particularly among older people and 
is associated with several modifiable risk factors. 
Salt consumption is high in Ghana, in terms of WHO recommendations, and is 
associated with hypertension. 
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1.11 Research Questions 
          1. What are the dietary sources of salt in the diets of populations in LMICs? 
       2. What are the salt use behaviors of Ghanaians and how do they compare with SA 
population that has had a relatively increased salt reduction messaging and a salt 
legislation? 
    3. How much Na and K is consumed by Ghanaians at the population level and what is 
the relationship between urinary Na, K, N:K ratio, and hypertension? 
    4. Did BP change in Ghana between 2007/8 and 2019 and what were the determinants  
thereof? 
                                        5. How do salt and iodine intakes in Ghanaians compare with those of South Africans? 
                                   6. What do stakeholders in Ghana perceive to be viable approaches to addressing high 
salt intake and hypertension in the country? 
1.12 Aims of the Study 
Study 1 – To identify and synthesize available evidence related to dietary sources of salt 
in LMICs through a systematic literature review. 
Study 2 – To examine salt knowledge, attitudes and practices of the Ghanaian population 
and compare it with a South African sample. 
Study 3 – To determine the current population salt consumption level and its relation to 
BP in Ghana.  
Study 4 – To identify any changes in BP levels between 2007 (WHO SAGE Ghana W1) 
and 2019 (WHO SAGE Ghana W3) and determinants thereof. 
Study 5 – To ascertain iodine levels in relation to salt intake in Ghana and compare that 
to SA, a country with salt reduction legislation and effective salt iodization 
programme. 
Study 6 – To conduct a high-level stakeholder meeting in Ghana, with the view of 
discussing the current hypertension situation in the country, salt 
consumption levels, and consolidate efforts at drawing the government’s 




1.13 Significance of the Study 
Hypertension and salt consumption are both rising among adults in LMICs. This thesis 
will primarily provide current knowledge relative to Ghana on salt intake and 
hypertension to drive policy, planning and further research. It will serve as a strong 
foundation of knowledge for other LMICs as it draws comparisons with SA. By 
emphasizing the sources of dietary salt in LMICs and evaluating salt behaviours among 
two countries in SSA, the thesis will provide direction for advocacy and support for salt 
reduction interventions. 
By evaluating the changes in BP overtime, this novel study will provide new knowledge 
about trends in BP, hypertension prevalence, awareness, treatment, control and the 
predictors of such in Ghana; which are critical in monitoring and policy formulation. 
The study will offer LMICs the opportunity to evaluate their salt iodization programmes 
alongside salt reduction strategies using Ghana as a case study, to ensure optimal iodine 
consumption while reducing salt intake. This study will create a road map for advocacy 
and support towards salt and hypertension reduction. 
1.14 Theoretical Framework 
The theoretical framework was inspired by ‘WHO’s SHAKE the Salt Habit’, which 
required identification of dietary sources of Na, determination of salt use behaviours 
and population salt intake, and development policy action to drive governmental efforts 
towards the reduction salt intake and hypertension [291]. The thesis followed the 




















                                       
Fig. 1.4 Theoretical framework for the thesis 
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2. 1 Introduction 
As discussed in Chapter 1, hypertension is a major public health concern and a risk factor 
for developing CVDs [1, 2]. Dietary sources with high amounts of Na and low levels of K 
have been established as contributory factors to raised BP [3, 4]. To place this study in 
perspective and to provide a context, a systematic review was conducted on dietary sources 
of salt (Chapter 3). Systematic reviews are important in providing a strong evidence by 
compiling and synthesizing findings from various studies [5]. Our review followed the 
evidenced protocols of the Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines with a checklist and a flow diagram to guarantee reliability 
and uniformity [6, 7]. It was registered with International Prospective Register of Systematic 
Reviews (PROSPERO CRD42016038173) and rated highly on the National Health and 
Medical Research Council (NHMRC) recommendations [8, 9]. 
2.2 WHO-SAGE Study Design 
Apart from the systematic literature review (Chapter 3), the entirety of this thesis was based 
on primary data collected during WHO-SAGE Ghana/SA Waves 1-3. Brief details of the 
study are provided within the published/submitted papers in chapters 4-8. Nonetheless, this 
chapter provides an in-depth description of the study design and scope, sample and 
sampling methods, instruments for data collection, validity of instruments, data collection 
techniques, ethical approval and data analysis for WHO-SAGE countries; Ghana and SA. 
Additionally, details of the nested sub study embedded with WHO-SAGE Ghana and SA 
W3 will be described. 
The WHO-SAGE longitudinal study was created by the WHO Evidence, Measurement and 
Analysis unit (formerly the Multi-Country Studies unit) as part of an existing program of 
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work to collect comprehensive longitudinal data on the health and well-being of adult 
populations and the ageing process for the purposes of planning, policy and research.   
A baseline cohort study created during the 2002–2004 World Health Survey (WHS) and 
implemented in about 70 countries formed the basis of WHO-SAGE study. The WHS study 
included six LMICs (i.e. China, Ghana, India, Mexico, Russia and SA), and data collected in 
these countries became what is known as WHO-SAGE W0 [10]. WHO-SAGE W1 was 
implemented from 2007 to 2010 as follow up to participants from W0. WHO-SAGE W2 
follow up was implemented by the end of 2015. The most recent WHO-SAGE W3 follow-up 
was completed in 2018/19 in China, Ghana, India, Mexico and SA. 
WHO-SAGE is a longitudinal cohort study that typically collects data on adults aged 18+y 
with about 70% of the participants being 50+y in a face-to-face interview that lasts 90-120 
minutes. Nationally representative samples are drawn from the six LMICs and were 
followed up in each wave with new households and participants included in the subsequent 
data collections to account for participant attrition [11]. 
In terms of its scope, WHO-SAGE broadly incorporates the collection of data on household 
and related characteristics, risk factors and preventive health behaviours, subjective well-
being and quality of life, as well as biomarkers among others. Participants also performed 
objective health tests such as grip strength, cognition tests and 4-metre timed walks. 
2.3 Geodata 
To assist in determining the sample, enumeration areas (EAs) were randomly selected using 
on Geo-coding/Global Positioning System (GPS) information based on the 2000 and 2001 
census in Ghana and SA respectively. Geo-reference data which included Geographical 
Information System (GIS) coordinates of latitude and longitude gave the physical location 
of EAs and households selected for WHO-SAGE. Geographical data served several 
purposes, first, the accurate recording of coordinates of sampled households was necessary 
to assist with locating potential participants for subsequent rounds of the WHO-SAGE 
longitudinal data collection. Second, the EA and household GIS coordinates were stored in 
the WHO-SAGE database to be used for further spatial analyses of health and illness data. 
60 
 
Finally, the data may be linked with other data sources to measure distance between 
selected households and health-care facilities [12, 13]. 
2.4 Population 
The total population was 24,658,823 in 2010 in Ghana, a figure representing an increase of 
30.4 percent over the 2000 census population of 18,912,079. Ghana has a youthful population 
consisting of a large proportion of children under 15 years, and a small proportion of elderly 
persons (65 years and older). The distribution of the population by sex indicates that women 
(51.2%) are more than men and there are more people living in urban areas (50.9%) than 
rural areas. Akans are the predominant ethnic group in Ghana (47.5%), followed by the Mole 
Dagbani (16.6%), the Ewe (13.9%) and Ga-Dangme (7.4%).  The Mande forms the smallest 
ethnic group (1.1%) in Ghana. Majority (74.1%) of the population 11 years and older is 
literate with variations in the levels of school attendance [14].   
In the case of SA, 44, 819, 778 and 51, 770, 560 people were counted in 2001 and 2011, 
respectively. Relative to Census 2011, 25.2 million (48.7%) males counted were compared to 
26.6 million (51.3%) females. Almost 29.6% of the population of SA is aged between 0-14 
years and a further 28.9% is aged between 15 – 34 years, SA has five racial groups (Black 
African, Coloured, Indian or Asian, White and other) with Black African forming the 
majority of the population (41, 000, 938) and ‘other’ forming the least (280, 454). 
Additionally, the population is differed along 13 main ethnic lines with ‘Africans’ forming 
the majority (6, 855, 082) [15, 16]. For the purposes of WHO-SAGE, the target population 
was adults aged 18y+. Study sample was drawn from nationally representative frames using 
general population parameters. 
2. 5 Sample and Sampling Techniques 
WHO-SAGE targets two adult populations: a large sample of persons aged 50y and older, 
and a smaller comparative sample of persons aged 18–49y; in line with the focus of the 
study. In all countries, households were used as primary sampling units and classified into 
one of these two mutually exclusive categories.: In the older households, all persons aged 
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50y and older, including spouses and siblings, were invited to participate. Proxy 
respondents were identified for participants who were unable to respond for themselves. A 
total of 250 and 396 EAs were randomly selected from Ghana and SA, respectively. Within 
each EA, 24 households were selected, comprising twenty 50+y households and four 18-49y 
households. The sample sizes varied over the three study waves based on feasibility and 
survey costs. Stratification for households was conducted according to region, provinces, 
population, and location (urban/rural) [12, 13]. For households that could not be accessed, a 
replacement was chosen. In Ghana, this was done by inviting all households within the EA 
that were originally not part of the study, but expressed willingness to participate, and 
randomly selecting those to participate. In SA, replacements for sample attrition used a 
systematic sampling approach to randomly select new households as previously described 
[17]. The sample sizes for Ghana and SA are given in Table 2.1:  
 
Table 2. 1 Sample sizes for Ghana and SA (WHO-SAGE W1-3) 
 SAGE W1 SAGE W2 SAGE W3 
Ghana 5,110 4,704 Pending 
SA 4,223 3,153 Pending 
WHO-SAGE Ghana, SA; sample sizes [18]. 
2.6 Nested Sub Study 
WHO-SAGE Waves 2 and 3 included the nested sub study undertaken in Ghana and SA 
only. For the sub study, approximately one-fifth of the total number of EAs in each country, 
were randomly selected with the aim to recruit about 1200 participants who in addition to 
the main WHO-SAGE survey, provided urine samples. The sampling process for these 
participants was the same as those employed in the main survey. Details of the urine 
collections, handling, transportation, storage and analysis of the electrolytes have been 
described accordingly. For the purposes of this thesis, only participants recruited in the sub 
study during the WHO-SAGE W3 study were included. In total, 2,310 participants (Ghana, 
1121; SA, 1189) provided urine samples.  
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2.7 Instruments for data collection 
The SAGE survey is a composite document made up of three different questionnaires. Each 
questionnaire consists of several sections focusing on distinct facets of health and well-being 
among populations: 1) household questionnaire 2) individual questionnaire and (3 proxy 
participant questionnaire (Appendix B). 
2.7.1 Household questionnaire 
This questionnaire collected information about the household members, housing 
characteristics, assets, income and money transfers between household members and those 
outside the household. This data provides background characteristics for analyzing health 
outcomes. The household informant agreed to be interviewed through understanding and 
signing of a household consent form [12, 13].  
2.7.2 Individual questionnaire  
This questionnaire sought information about the individual’s sociodemographic 
characteristics, work history and benefits, health state and descriptions, anthropometrics, 
performance tests and biomarkers, risk factors and preventive health behaviours, chronic 
conditions and health services coverage, health care utilization, social cohesion, subjective 
well-being and quality of life, and impact of caregiving. The survey required the collection 
of health measurements and conducting health tests. All participants including those of the 
nested sub study responded to this survey.  
2.7.2.1 Anthropometric measurement 
The stadiometer, weighing scale and a flexible measuring tape were used to measure 
participants’ height, weight and waist/hip circumference respectively. In using the 
stadiometer, a firm flat floor close to a wall was selected. Participants were barefoot, stepped 
onto the base of the stadiometer with feet together, knees straight, back and head against 
the wall, looking straight ahead, chin tucked slightly to the chest and eyes same level as 
ears. The top of stadiometer was stretched to topmost point on the head with enough force 
to compress the hair. To weigh participants, the calibrated weighing scale was placed on a 
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flat, firm surface. Participants removed their shoes and any heavy accessories and stood on 
the scale facing forward, arms placed at their side with palms facing inwards and not 
holding onto anything. In terms of waist measurement, the measuring tape was placed 
directly on the skin, or over no more than 1 layer of light clothing. The measurement was 
taken round the body and halfway between the lowest rib and the top of your hipbone; 
roughly in line with the belly button while the participant stood with feet together and arms 
to the side with palms facing inwards. The same procedure for waist measurement was 
applied to hip measurement, but with measuring tape going around the participants 
buttocks [19].  
2.7.2.2 BP measurement 
Wrist worn Omron BP devices with positional sensors (Omron R6, Kyoto, Japan) were used 
to measure BP. These devices satisfied the validation standards of the International Protocol 
for SBP and DBP [20, 21]. Following 5 minutes of seated rest, three BP readings were 
recorded on the left wrist (one-minute between each measurement) while the participant sat 
with legs uncrossed and the wrist positioned precisely at the level of the heart. An average 
of the second and third readings combined with self-reported use of hypertension 
medication was used in categorizing hypertension status. 
2.7.2.3 Urine collection 
Screw cap bottles, funnels, measuring cylinders and 5ml tubes were used to collect 24hr 
urine samples from nested sub study participants only. Fieldworkers handed a bag 
containing 1) a 5L capacity screw cap bottle to store urine, 2) a 1L container with a wide 
opening into which urine is voided with the use of a funnel, 3) 2L capacity screw cap bottle 
for temporal collections of urine made away from home, 4) funnel to be used during urine 
collection, kept inside a resealable plastic bag when not used, 5) plastic carrier bags for 
transporting the equipment away from home  and 6) an aide-memoire to help participants 
to remember to collect their urine [22],  selected participants for 24hr urine collection. 
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Fieldworkers explained urine collection requirements (both verbal and written) to 
participants and supervised the beginning and end of the collection periods. The 
instructions for the urine collection were that the participant should: 1) void the first urine 
of the in the morning of the start of the 24hr period, 2) record the time of the first urine 
collected, 3) collect all urine within the day and night into the 5L bottle including the first 
urine of the following morning, 3) only a participant’s urine should be collected into the 
bottles, 4) continue with urine collection if they missed a collection during the day, 5) take 
the 2L bottles out when they were leaving the house so all urine passed outside the house 
could be collected, 6) keep the urine bottles away from children, and at a cool place, 6) record 
time of the last collection, and 7) leave the urine bottles at a place that field workers can 
access to, after completion of urine collection [22].   
The bottles contained 1g thymol which has the property to preserve urinary creatinine, Na 
and K concentrations for a period up to 5 days [23]. The urine bottles were picked up after 
24hrs, the content thoroughly mixed up and volume measured. Volumes that were below 
300ml were discarded [2, 25] and the participant was rescheduled. The urine was then 
aliquoted into 5ml tubes and transported in cold boxes and stored at -20 0C at the Noguchi 
Memorial Institute of Medical Research, University of Ghana (NMIMR-UG) and Global 
Clinical and Viral Laboratories and North-West University Centre of Excellence for 
Nutrition in SA. Aliquoted samples were given codes that corresponded with the 
identification numbers of the participants so that samples could be linked to the survey data 
of the participants. 
2.7.3 Proxy Questionnaire 
This questionnaire collected characteristics of participants who were incapacitated at the 
time of the survey, by requesting close relatives or care givers of the participant to provide 
participant’s information (Appendix B). 
2.8 Data collection procedures and management 
Prior to data collection for each wave of the study, the WHO-SAGE team in Geneva, visited 
Ghana and SA conducted training sessions for all fieldworkers including nurses and 
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technicians using standardized training and survey materials [11]. This training lasted 10 
days on average, and taught fieldworkers the rudiments of survey, teamwork, general 
interviewer skills, ethics of research, how to use and complete WHO-SAGE survey, as well 
as collection and handling biological samples.  
Fieldworkers conducted face to face interviews with participants, either in the households 
or participant’s workplaces. Field teams worked in groups of 3-5 interviewers with a 
supervisor. Households or participants that could not be reached at the time of data 
collection were replaced. For the first two waves of the study where data were collected on 
paper questionnaires, whilst CAPI was used to collect data during W2 and W3. Interviews 
were conducted in the participants’ home language while incomplete interviews 
rescheduled. During data collection, supervisors checked the quality and consistency of 
data collected, and took custody of the survey (W1), and urine samples (W2 and W3). 
Tracking sheets were used to track day to day progress of activities on the field, to serve as 
reminders of incomplete interviews, correct errors and deal with missing information. 
Supervisors were silent observers of the interviews - a responsibility that was considered a 
marker of quality assurance. During W1, completed questionnaires and tracking sheets 
were collected and posted to the principal investigator’s office while in W3, collected data, 
were accumulated on a local server and later transferred onto a centralized server. Urine 
samples were sent directly to the laboratories with tracking sheets to monitor samples sent 
and those received (nested sub study).  
2.9 Study measures 
One question investigated knowledge about salt and health - “Do you think that a high salt 
diet could cause a serious health problem?”- with answer options “yes” or “no”. Another 
investigated attitudes about salt- “How much salt do you think you consume?”- with 
answer options of “far too much”, “too much”, “just the right amount”, “too little”, “far too 
little”, “don’t know”, and “refused”. Three questions assessed salt use behaviours: (1) “Do 
you add salt to food at the table?”; (2) “In the food you eat at home, salt is added in 
cooking?”; and (3) “Do you do anything on a regular basis to control your salt or Na 
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intake?”- with answer options “always”, “often”, “sometimes”, “rarely”, and “never” for 
items 1 and 2, and “yes”, “no”, “don’t know”, and “refused” for item 3. Likert type response 
scales were provided, but for analysis of responses to the salt use behaviour questions 
categories of “always” and “often” were combined to represent “frequent” use, whilst 
“rarely” and “sometimes” were combined to represent “infrequent” use.  
Regarding national health insurance status, ‘voluntary’ contributors were defined as those 
individuals who were not captured by the health insurance scheme as public or civil service 
workers, while ‘mandatory’ contributors were employees from the public, civil and private 
sectors. For questions on alcohol and working status, responses were reduced to categorical 
variables.    
Physical activity was measured using the International Physical Activity Questionnaire 
(IPAQ) through its long form questions. The level of physical activity was calculated based 
on type of activity, and number of days, hours and minutes participants engaged themselves 
in those activities per week. IPAQ has a high reliability and validity and has been used 
extensively in urban communities in both developed and developing countries [26]. BMI 
was calculated as the ratio of body weight in kilograms divided by the square of the height 
in metres.  
A BP measurement was determined valid if: Systolic (SBP) > Diastolic (DBP); and SBP was 
between 80-270 mm Hg; and DBP was between 40-180 mm Hg; and SBP minus DBP (Pulse 
Pressure, PP) > 13mm Hg. Hypertension classification was determined according to the 
European Society for Hypertension Guidelines (2018), that is, systolic ≥140 and/or diastolic 
≥90 mm Hg [27]. Hypertension status was classified as self-reported treatment or having a 
measured BP ≥ 140/90mm Hg, while hypertension awareness was based on self-reported 
previous diagnosis of hypertension in those with BP ≥ 140/90mm Hg. Hypertension 
treatment was determined as self-reported medication use for hypertension in at least two 
weeks prior to data collection. Hypertension control was assessed as those who self-
reported antihypertensive medication use within the last two weeks and had a BP 
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measurement of less than 140/90 mm Hg. PP was measured as difference between SBP and 
DBP, representing the force that the heart generates each time it contracts.  
Sodium and K concentrations were determined by indirect ion-specific electrodes, Cr 
concentration by using the Jaffe reaction colorimetric method iodine by Sandell-Kolthoff 
method with ammonium persulfate digestion and microplate [23]. Sodium (mmol/l) in the 
24 h urine sample was converted to salt (g/d) using the formula: Na mmol/l x 24 h volume 
(litres) x 23.1 (molecular weight of Na)/390 (390 mg Na per 1 g Nacl (salt). From this variable, 
participants were categorized as having low (<5 g/day), medium (5-9 g/day) or high (>9 
g/day) salt intake. K (mmol/l) in the 24 h urine sample was converted to K (mmol/d) using 
the formula: K (mmol/l) x 24 h volume (litres) [28]. 
2.10 Ethical considerations 
The study complied with the standards of the Helsinki Declaration [29] and approved by 
WHO Research Ethics Review Committee [RPC149] (appendix C). Country specific ethics 
approval was granted from the University of Ghana (MS-Et/M.03-P 3.1/2005-2006), 
(Appendix D), North-West University and University of Witwatersrand (SA). Only 
participants that reviewed and signed informed consent forms could participate in the study 
(Appendix B). 
2.11 Data analysis 
All statistical analyses are described in the respective chapters. 
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Dietary Sources of Salt in Low- and Middle-Income 
Countries: A Systematic Literature Review 
 
This chapter describes a systematic literature review conducted to ascertain the sources of 
food that contribute most salt to the diet in in LMICs. Urbanization and population growth 
coupled with the nutrition transition occurring in LMICs is transforming lifestyles and 
dietary patterns. As such, there has been a shift from the consumption of traditional staples 
to an increased reliance on energy dense foods that are high in salt. This chapter evaluates 
and synthesizes the evidence gathered from published literature and makes inferences.   
The most of this chapter is the substantive content of the published work:  
Menyanu, E., Russell, J. & Charlton, K. (2019). Dietary Sources of Salt in Low- and Middle-
Income Countries: A Systematic Literature Review. International Journal of Environmental 

















Rapid urbanization in low- and middle-income countries (LMICs) is transforming dietary 
patterns from reliance on traditional staples to increased consumption of energy-dense 
foods high in saturated fats, trans fats, sugars, and salt. A systematic literature review was 
conducted to determine major food sources of salt in LMICs that could be targeted in 
strategies to lower population salt intake. Articles were sourced using Medline, Web of 
Science, Scopus, and grey literature. Inclusion criteria were reported dietary intake of 
Na/salt using dietary assessment methods and food composition tables and/or laboratory 
analysis of salt content of specific foods in populations in countries defined as low or middle 
income (LMIC) according to World Bank criteria. Of the 3207 records retrieved, 15 studies 
conducted in 12 LMICs from diverse geographical regions met the eligibility criteria. The 
major sources of dietary salt were breads, meat and meat products, bakery products, instant 
noodles, salted preserved foods, milk and dairy products, and bouillon cubes. Identification 
of foods that contribute to salt intake in LMICs allows for development of multi-faceted 
approaches to salt reduction that include consumer education, accompanied by product 
reformulation. 
3.1 Introduction  
Cardiovascular diseases (CVDs) are the leading cause of death worldwide [1], with 
hypertension accounting for more than 50% of premature deaths [2]. Globally, the 
prevalence of hypertension has been rising from a figure of 25% reported in 2000 [3] to 40% 
reported by others in 2008[4]. Hypertension is the leading single risk factor contributing to 
overall Global Burden of Disease [2] through its association with cardiovascular disease. 
Low-and middle-income countries (LMICs) already share the highest prevalence of 
hypertension [5], with predictions that three quarters of the world’s hypertensive 
population will be found in these countries within the next 10y [3]. This may be in part due 
to the larger population sizes in LMICs compared to high-income countries, but also 
because of the inability of their health care systems to cope with the management of chronic 
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diseases. This results in large numbers of people with undiagnosed, untreated, and 
uncontrolled hypertension [6]. LMICs are currently facing an unprecedented hypertension 
burden [6]. The past four decades have seen a shift in the highest blood pressure (BP) levels 
from high-income countries to LMICs, particularly in some South Asian and sub-Saharan 
African countries [7] where more than a third of adults report being hypertensive [6]. 
Additionally, there is low awareness, treatment, and control measures for hypertension in 
LMICs [8], rendering current practices to reduce hypertension ineffective [9,10]. Ultimately, 
the worsening situation of hypertension together with increased prevalence of cancers, 
diabetes, and chronic respiratory diseases have culminated in nearly 80% of all deaths from 
NCDs occurring in LMICs [11]. The nutrition transition in many LMICs is occurring due to 
the rapid urbanization which has led to widespread availability of energy-dense foods that 
are high in saturated fats, trans fats, sugars, and salt. This has resulted in a shift in dietary 
patterns from a reliance on traditional staples such as maize and sorghum to more processed 
foods [12]. At the same time, food insecurity remains a challenge in LMICs [13]. Preserving 
food using traditional methods (e.g., salting) is important in ensuring food availability and 
addressing hunger in many communities [14,15]. Further, limited water supplies [16] have 
exposed populations to unhealthy water sources which often contain toxins or unacceptable 
levels of nutrients [17,18]. A mean Na concentration of about 700 mg/L (with extremes 
exceeding 1500 mg/L) was found in drinking water in coastal areas of Bangladesh [19] 
contributing to the overall daily Na consumption of people living along the coast. With this, 
the WHO’s recommended daily limit of 5 g salt [20] can easily be exceeded by just drinking 
2–3 L of water in some countries. There is compelling evidence from epidemiological, 
clinical, and experimental studies showing a positive and direct relationship between salt 
consumption and BP. It is widely accepted that high intakes of salt in food (beyond the 
WHO’s recommended level of 5 g salt or 2 g Na/day) and in water (>0.2 g Na/L) are major 
risk factors for hypertension [20,21], heart disease, and stroke [22]. Sodium is an important 
nutrient required by the body to ensure ion balance, maintenance of plasma volume, and 
transmission of nerve impulses [23]; however, when in excess, has been implicated in the 
development of kidney disease, gastric cancer, and hypertension [24,25]. Lower levels of Na 
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(<3 g/d) have also been identified to be associated with higher risk of death and 
cardiovascular events [26]. Several prospective cohort studies have indicated a U-shaped 
relationship between salt consumption and cardiovascular disease or mortality, with 
increased risk at both high- and low-intake extremes [27–30]. In comparison with a 
moderate consumption of salt, observational data demonstrate that very high intakes (>6 g 
Na/day, representing only 10% of the population studied) are associated with an excessive 
risk of cardiovascular events and death, but only in the case of those with hypertension. 
This study also reported associations between low salt intakes and increased risk of 
cardiovascular events and death in both hypertensives and normotensives [31]. While the 
optimal lowest intake of salt is still being debated, there is no question that in most countries, 
population-level estimates of salt far exceed the commendation of a maximum 5g/day, thus, 
necessitating salt reduction strategies [20]. In 2004, the WHO released its “Global Strategy 
on Diet, Physical Activity and Health” that was adopted by the World Health Assembly and 
which called upon all governments and stakeholders to work towards improving the 
healthfulness of diets [32]. More recently, WHO member states have agreed to work 
towards voluntary targets to reduce NCDs by 25% by 2025, with one of the nine global 
targets being a reduction in population salt intake by a relative 30% [22]. In order to develop 
national policies and strategies to lower population-level salt intake in LMICs, it is necessary 
to understand the main dietary sources of salt. This information is required to assist 
governments to enact policies and programs, and to concentrate on particular food items 
that are of relative importance to excessive salt consumption in LMICs. The aim of this 
systematic literature review is to identify the major food sources that contribute to salt 
consumption in populations in LMICs. 
3.2. Methods  
A literature search was conducted in March 2017 using the Medline, Web of Science, and 
Scopus databases. Hand searching of the reference lists was performed from articles 
retrieved from these databases. Grey literature was also searched by visiting institution and 
government websites and other sources. Data collected were synthesized according to the 
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Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [33] 
(Figure 3.1). The research question investigated was: “What are the dietary sources of salt 
in LMICs?” Search terms are listed in Table 3. 1. Outcome measures include dietary sources 
of Na/salt. Only articles reported in English were included. All countries in the LMIC 
bracket were listed among the search terms. Low-income economies were defined as those 
with a gross national income (GNI) per capita, calculated using the World Bank Atlas 
method, of $995 or less in 2017; lower middle-income economies were those with a GNI per 
capita between $996 and $3895; and upper middle-income economies were those with a GNI 
per capita between $3896 and $12,055 [34]. The search was restricted to articles published 





Table 3. 1 Search strategy 
 
Searches Search Terms 
Medline 





"source of salt" OR "dietary salt" OR "discretionary salt" OR "salt intake" OR "salt in food" OR "salt added at the table” OR  “dietary sources of sodium” AND “Algeria” OR 
“Angola” OR “Benin” OR “Botswana” OR “Burkina Faso” OR “Burundi” OR “Cameroon” OR “Cape Verde” OR “Central African Republic” OR “Chad” OR “Democratic 
Republic of Congo” OR “Republic of Congo” OR “Cote d'Ivoire” OR “Equatorial Guinea” OR “Ethiopia” OR “Gabon” OR “Gambia” OR “Ghana” OR “Guinea” OR “Guinea 
Bissau” OR “Kenya” OR “Lesotho” OR “Liberia” OR “Madagascar” OR “Malawi” OR “Mauritius” OR “Mozambique” OR “Namibia” OR “Nigeria” OR “Reunion” OR 
“Rwanda” OR “Sao Tome and Principe” OR “Senegal” OR “Seychelles” OR “Sierra Leone” OR “South Africa” OR “Swaziland” OR “Tanzania” OR “Togo” OR “Uganda” 
OR “Zambia” OR “Zimbabwe” OR “Afghanistan” OR “Albania” OR “American Samoa” OR “Armenia” OR “Azerbaijan” OR “Bangladesh” OR “Belarus” OR “Belize” OR 
“Bhutan” OR “Bolivia” OR “Bosnia and Herzegovina” OR “Brazil” OR “Bulgaria” OR “Cambodia” OR “China” OR “Colombia” OR “Comoros” OR “Costa Rica” OR 
“Cuba” OR “Macedonia” OR “Malaysia” OR “Maldives” OR “Marshall Islands” OR “Mexico” OR “Micronesia, Fed. Sts.” OR “Moldova” OR “Mongolia” OR “Montenegro” 
OR “Myanmar” OR “Nepal” OR “Nicaragua” OR “Pakistan” OR “Palau” OR “Panama” OR “Papua New Guinea” OR “Paraguay” OR “Peru” OR “Philippines” OR 
“Romania” OR “Rwanda” OR “Samoa” OR “Dominica” OR “Dominican Republic” OR “Ecuador “ OR “Serbia” OR  “El Salvador” OR “Solomo n Islands” OR  “Fiji” OR 
“Sri Lanka” OR “St. Lucia” OR “Georgia” OR  “St. Vincent and the Grenadines” OR “Grenada” OR “Suriname” OR  “Guatemala” OR “Syria” OR “Tajikistan” OR “Guyana” 
OR “Haiti” OR “Thailand” OR “Honduras” OR “Timor-Leste” OR “India” OR “Indonesia” OR “Tonga” OR “Iran” OR “Iraq” OR “Turkey” OR “Jamaica” OR  
“Turkmenistan” OR “Jordan” OR “Tuvalu” OR “Kazakhstan” OR  “Ukraine” OR “Kiribati” OR  “Uzbekistan” OR “Korea, Dem. People’s Rep.” OR “Vanuatu” OR “Kosovo” 






Figure 3. 1 Flow Diagram 
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Data extraction was completed by the lead author (EM) and reviewed by the second author 
(KC). Endnote X4 (Clarivate Analytics, Philadelphia, PA, USA) was used to manage the 
citations. Each article was ranked for level of evidence using the National Health and 
Medical Research Council (NHMRC) recommendations [35]. A narrative synthesis of the 
studies was completed because of the heterogeneity in reporting outcomes of the studies. In 
this literature review, Na and salt were used interchangeably. Studies were included if a 
study (a) reported actual quantities of Na/salt in foods (b) data were collected from food 
diaries, diet recalls, food frequency tables and (c) laboratory analysis of salt content in food. 
Data were extracted by first reviewing the title and selecting abstracts of those with relevant 
titles. If the abstract met the inclusion criteria, the full article was retrieved (Figure 3.1). 
Studies were summarized according to descriptive characteristics, including the region, 
country, data collection period, study emphasis, and the study design. Each paper was 
categorized also by the author, population, outcome measured, method of measurement, 
and the results. Quality rating was conducted using appraisal tools for cross-sectional 
studies for nine articles that utilized a human population [36] (Appendix A). This systematic 
review was registered with the International Prospective Register of Systematic Reviews 
(Prospero CRD42016038173). 
3.3 Result  
Our search of data bases and additional records yielded 3207 titles. One-hundred-and-
seventy-seven abstracts (23 hand-searched) were retrieved after duplicates and irrelevant 
papers were excluded, thereafter resulting in 34 full papers being assessed for eligibility and 
inclusion. Of these 34 articles, 15 were included in the final review. Reports from the country 
level WHO Stepwise Surveillance surveys were hand-searched but did not yield relevant 
information. Figure 3.1 shows the PRISMA flow diagram providing details of the search and 
included studies. Of the final included articles grouped according to WHO-defined 
geographical regions [37], the greatest number of articles (i.e., four each) were from Africa 
and the Western Pacific (though in the Western Pacific region, all the articles came from 
China), whereas the least number of the articles (i.e., one) came from European countries 
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(appendix K). Fifteen of the included studies were conducted in 12 countries and most of 
them had been published within the last two decades (1991–2016). Six of the articles did not 
report data collection periods. With the exception of one randomized controlled trial, all 
other studies were cross-sectional and descriptive in design and concentrated on dietary 
behavior and product reformulation. Analytical values for the salt content of bread were 
reported in five articles (Table 3.1). Zibaeenezhad et al. [38] included the highest number of 
samples of bread that were examined, whereas Ferrante et al. [39] recorded the greatest 
number of bakeries that were sampled within one study. For studies that included samples 
of bread from different suburbs and locations, salt content varied depending on the 
municipality and producer. The highest salt content found in bread was 1.80g/100g in 
Nigeria [40]. The average salt content in bread from all articles was more than the voluntary 
targets and recommended quantities in other countries (380–400 mg Na per 100 g bread) 
[41–43]. One study from Ferrante et al. [39] analyzed salt content in French bread, croissants, 
and cookies and crackers using dietary recall and additionally used biochemical analysis for 
French bread. Results from the two methods used for French bread indicated an 
underestimation of salt use with the dietary recall. Financial constraints did not permit 
chemical analysis of the other food items. There were three articles that reported salt content 
of additional foods other than bread, including preserved fish, cookies, crackers, as well as 
water (Table 3.2) and seven articles assessed total dietary salt intake (Table 3.3). Two of the 
included articles [44,45] investigated children’s’ dietary salt intake. Four of the articles that 
measured dietary intake also included biomarkers of participants’ 24hr urinary Na excretion 
[46–49]. The major sources of dietary salt were breads, meat and meat products, bakery 
products, noodles, salted preserved foods, milk and dairy products, and bouillon cubes. 
Additionally, some articles reported that a high amount of salt in the local diet came from 




Table 3. 2 Summary table of studies that reported salt content of bread by chemical analysis 





Silva et al., 2015 [43] All bakeries (n=17) situated in 
Maputo city that were listed 
in the Mozambican Yellow 
Pages were included.  
 
Na content in 
bread. 
Flame photometry. Mean Na content of bread was 
450 mg/100 g, ranging between 
255 mg/100g and 638 mg/100g, 
with no significant differences 
between bakeries and traditional 
markets. Most samples (88 %) did 
not meet the regulation for SA.  
Mean Na > a, b and c. 
 
Nwanguma & 
Okorie, 2013 [39] 
Retail samples of 100 brands 
of white bread made from 
wheat flour, representing the 
major brands were purchased 
from 10 standard retail 
outlets in Nsukka and Enugu 
towns, both in Enugu State in 
South-Eastern Nigeria.  
Na content in 
bread. 
Flame photometry. Na ranged from 396g to 
1332g/100g.Mean= 544mg/100g.  




Hussain & Takruri, 




68 samples of seven types of 
bread were collected from 13 















Mean Na content = 476 ± 
84g/100g ranging between 168 ± 
20g for White Arabic bread* to 
824 ± 76g/100g for Shrak bread*. 
Mean Na > a, b and c. 
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Zibaeenezhad et al., 
2010 [37] 
204 bakeries in districts of 
Shiraz city in Iran: 408 bread 
samples were collected 
representing from bakeries 
for measuring their salt 
content 6 different kinds of 
bread.  
 
Na content in 
bread. 
Laboratory testing of 
salt percentage in 
bread as outlined by 




Mean Na = 524g/100g ranging of 
0-1400g/100g bread. 







Vukić et al., 2013 [46] 12 samples of bread 
purchased in stores from the 
3 municipalities: Bijeljina, 
Zvornik and East Sarajevo in 
Bosnia. In each municipality 8 
samples were randomly 
selected.  




(AAS) using an 
instrument VARIAN 
SpectrAA-10. 
Mean Na = 405 ± 177mg/100 g, 489 
± 174mg/100g and 673 ± 
119mg/100g for East Sarajevo, 
Bijeljina and Zvornik respectively. 
Bread samples from East Sarajevo, 
mean Na > a and b 
Bread samples from East 
Bijeljina, mean Na > a, b and c. 
Bread samples from East 






                   White Arabic and shrak bread are bread types in Amman. 
a. > 380g/100g - maximum level of Na in bread established by the South African Government; effective June 2019 [40]. 
b. > 400mg/100g - maximum level of Na in bread recommended by the Government of Australia [41, 42]. 
c. > 450mg/100g - maximum level of Na in bread recommended by the National Heart Foundation of New Zealand [41]. 
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d. > 490mg/100g - Level of Na that is required by the Finish Government for the designation of ‘highly salty’ on a label [47]. 


















Table 3. 3 Summary table of studies that assessed consumption of salt from specific foods and water 
Reference Population Outcome measured  Method of measurement Results 
Kerry et al., 
2005 [51] 
12 villages (6 rural, 6 semi-urban 
were chosen in Ghana. Between 95 
and 250 subjects aged 40–75 years 
from each village, for a total = 1,896, 
selected by stratified random 
sampling from a census of all 
inhabitants of the village. 
Frequency of consumption of 




FFQ asked about the 
consumption of five salty 
foods: koobi, momoni, 
kako (all salted fish), salted 
pig’s feet and salted beef. 
Also questioned the use 
discretionary salt, stock 
cubes or monosodium 
glutamate (MSG). 
 
92% reported eating salted fish. While salted meat 
(pig’s feet and beef) was eaten more often by semi-
urban villagers, salted fish was eaten more often by 
rural villagers. Majority of the respondents (98%) 
frequently added salt to food in cooking.  
Ferrante et al., 
2011 [38] 
25 000 bakeries countrywide 
affiliated to Argentinean 
Federation of Bakeries. 
Na content in bakery 
products. 
Dietary recall and Flame 
photometry. 
Self-reported (using food composition table) mean 
Na contents: French bread = 1440mg ranging 800-
3200mg/100g, croissants and cookies  = 1440mg 
ranging 800-2800mg/100g, crackers = 2320mg 
ranging 1760-4000mg/100g, and flat rounded 
crackers = 1760mg ranging 960-2720mg/100g. 
Chemical analysis of French bread showed a mean 
Na concentration of 1600mg ranging from 1120-
2400mg/100g. 
 
Khan et al., 
2011 [52] 
343 pregnant Dacope women from 
Bangladesh recruited for a pilot 
phase of a larger study. 
Na intake from drinking 
water sources. 
Indirect estimates of 
individual salinity intake 
from groundwater and 
river water, determined 
using salinity data for 
1998-2000; Centre for 
Environment and 
Geographic Information 
System (CEGIS) in 
Bangladesh. 
 
Na from drinking water = 2064mg/day during the dry 
season (depending on the water source) and 
480mg/day during the monsoon season assuming a 
conservative water intake of 2 L/day/person. 
Note: 5g/d salt = 2000mg Na 
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                                        Table 3. 4 Summary table of studies that assessed total salt intake using dietary assessment methods 
Reference Population Outcome measured  Method of measurement Results 
Charlton et al., 2005 
[54] 
300 men and women from three 
different ethnic groups (black, 
mixed ancestry, and white), aged 
20 to 65 y, conveniently sampled 
from place of work, Cape Town 
City Council, SA. Equal numbers 
of hypertensive (BP ≥ 140/90 mm 
Hg and/or on antihypertensive 
medication) and normotensive 
(blood pressure < 140/90 mm 
Hg,) men and women were 
planned (n = 150/group, 50 from 
each ethnic group). 
 
Dietary intake of Na.  Interviewer-administered 
3-repeated  
24-h recalls. Standard 
household measuring 
utensils, rulers and food 
photographs of typical 
South African foods [57] 
used to quantify food 
portion sizes. The average 





based on Medical Research 
Council Food Composition 
Tables [58]. 
 
In all three subsamples, 
cereals were the main 
contributor to total 
reported dietary Na intake 
(45.9% to 48.6%), followed 
by meat and meat 
products (20.3% to 23.6%) 
and milk and dairy 
products (6.3% to 8.1%). In 
all groups, bread was the 
major source of dietary Na 
(25.2% to 40.5%). 
Liu et al., 2014 [53] 726 Chinese postmenopausal 
women who attended a 
screening visit for a randomized 
controlled trial testing the effect 
of soy products supplementation 
on BP were conveniently 
sampled. 
 
Dietary intake of food 
substances from which Na 
content was determined. 
3-day food records 
questionnaire was used to 
estimate dietary nutrients 
intake. Food items were 
those most frequently 
consumed based on 
previous local surveys [59, 
60]. Subjects received a 30-
min training on estimation 
of food amounts, portion 
and utensil sizes. Dietary 
Major sources of non-
discretionary salt include 
soup (21.6%), rice and 
noodles (13.5%), baked 
cereals (12.3%), salted/pre-
served foods (10.8%), 
Chinese dim sum (10.2%) 
and sea foods (10.1%) of 
the total salt intake. 
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Reference Population Outcome measured  Method of measurement Results 
nutrients were calculated 
based on the China Food 
Composition Table and  
local Na database [61, 62]. 
Total Na intake was 
calculated by summing the 
estimates from all 
contributory food items or 
groups. 
 
Zhao et al., 2015 [50] 903 families were conveniently 
sampled for the study. 2952 
participants were recruited from 
families in urban (Xicheng 
District) and suburban (Huairou 
District) Beijing. Study families 
were recruited through public 
primary and junior high schools. 
Eligible families were those with 
a child from the enrolled schools. 
Dietary salt intake and 
sources of salt in the diet. 
Questionnaire; a 
simplified “one-week salt 
estimation method” was 
designed to measure each 
family member’s daily salt 
intake and determine the 
sources of salt in the diet. 
This method estimates salt 
intake from three sources: 
household cooking, 
processed food, and 
cafeterias or restaurants. 
The methodology is 
previously published [63]. 
 
Soy sauce, vinegar, other 
sauces and MSG 
contributed 47%, 34%, 12% 
and 7% to total Na intake. 
The mean Na intake was 
5360 (SD 3320) mg/day. 
Adults consumed more Na 
6080(SD 3640) mg/day 
than children and 
adolescents 4400 (SD 2480) 
mg /day and senior 
citizens 4080 (SD 1920) 
mg/d. 
Health Promotion Board, 
Singapore, 2011 [64] 
National Nutrition Survey 2010 
comprised 739 subjects aged 18-
69 years conveniently sampled. 
 
Na content in selected 
foods. 
Face-to-face interviews 
were conducted where 
dietary practices and food 
frequency questionnaires 
were administered. 
Nutrients and various 
Fish balls, fish cakes, 
breads and noodles were 
estimated to contribute 
37% of the population’s 
salt intake. Daily salt 
intake was 3320mg/day. 
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Reference Population Outcome measured  Method of measurement Results 
food groups were assessed 
by comparing the levels of 
intake with dietary 




Most of the salt (60%) came 
from table salt and sauces. 
Du et al., 2014 [65] Secondary data from China 
Health and Nutrition Survey 
(1991-2009) comprising 16,869 




Na intake from foods and 
condiments 
Three consecutive 
24-h dietary recalls in 
combination with 
weighing methods. All 
foods and condiments 
recorded and measured. 
Na intake (ie, Na from all 
foods and condiments) 
were based on their 
compositions in the 
Chinese food-composition 
table. 
The major source of 
dietary Na was added salt, 
followed by soy sauce, 
processed foods, and MSG. 
The average soy sauce 
intake was 6.9 g/d, 
accounting for 8.5% of total 
Na intake. The average 
processed food intake was 
244.7 g/d, which 
represented 20.8% of all 
food consumed and 
accounted for 6.8% of total 
Na intake. The average 
MSG intake was 1.5 g/d, 
accounting for 3.4% of total 
Na intake. 
 
de Moura Souza, 2013 [49] Nationwide dietary survey. Food 
consumption of a representative 
sample of the Brazilian 
population 10 years of age or 
older (n = 34,003). 
 
Na content in foods and 
beverages. 
24hr dietary recall using 
the nutrition data system 
for Research software 
version 2008, the Brazilian 
Food Composition Table 
Foods with high Na 
densities (>600mg/100g) 
included salty preserved 
meats (997 mg/100 g), 
processed meats (974 
mg/100 g), cheeses (883 
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Reference Population Outcome measured  Method of measurement Results 
 [66], and Brazilian studies 
on regional foods [67]. 
mg/100 g), crackers (832 
mg/100 g), sandwiches 
(800 mg/100 g), pizza (729 
mg/100 g), and breads (646 
mg/100 g), as well as oils, 
spreads, sauces, and 
condiments (804 mg/100 
g). Altogether these food 
groups contributed 25% 
(811mg/100g) of the 
average daily Na intake. 
The mean Na intake was 
3190mg/day. 
 
Anderson et al., 2010 [55] Participants were 4,680 women 
and men aged 40 to 59 years, 
recruited by stratified random 
sampling from 17 diverse 
populations—community-based 
or workplace-based—in Japan 
(four samples), People's Republic 
of China (three rural samples), 
the United Kingdom (two 
samples), the United States (eight 
samples). 
 
Na intake was calculated 
by summing estimates 
from all contributory food 
sources, including foods 
and beverages, ingested at 
home or away from home. 
24-hour dietary recall. Na 
content of each food item 
was determined using the 
enhanced national food 
database for each country. 
For China, mean Na intake 
= 3, 990± 1943 
mg/person/day; Soy sauce 
= 256mg/person/ day, 
mustard, turnip greens, 
and cabbage = 
143mg/person/day, 
sodium bicarbonate and 
sodium carbonate 
(tenderizers) = 98mg/ 
person/day and noodles 
was 89mg/person/day. 
Japan, mean Na intake = 
4651 ±1279, United 
Kingdom mean Na intake 
= 3406±1162 and United 
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Reference Population Outcome measured  Method of measurement Results 
States mean Na = 
3660±1343. 
Note: 5g/d salt = 2000mg N
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3.4 Discussion  
To reduce population salt intake, the WHO “SHAKE the Salt” framework strongly 
emphasizes a need to identify major sources of salt in the diet and to embark on strategies 
that include product reformulation, taxation, nutrition labelling, and nutrition education 
[69]. The current review has identified bread as the major food source that provided the 
highest amounts of salt to the diets of populations in 12 LMICs. Meat and meat products, 
salted meat and fish, sauces, spreads, bouillon cubes, pizza, sandwiches, seafood, and 
ground or river water were also identified as major contributors to non-discretionary salt 
intake. Contribution of each of these foods differs by cuisine of the country, for example 
among Asian countries, sauces and MSG are prevalent [45,50,66], whereas in Africa and 
Latin America it is bakery, meat, and dairy products [40,44,49]. The average Na content for 
bread was above 400 mg per 100 g bread, which exceeded the generally accepted target for 
salt content of bread [41–43,70]. Similarly, in high-income countries such as Australia, some 
loaves provide more than 25% of the maximum daily recommended intake of salt in bread 
in just two slices [71], with bread and bread rolls contributing 25% of total salt provided by 
processed foods [72]. The consumption of bread has increased in LMICs [73] due to the 
decline in traditional staples such as maize, millet, and sorghum to the rise in wheat [74]. In 
India, the production of wheat increased from 75.81 million MT in 2007 to 94.88 million MT 
in 2012 [75], while Pakistan experienced a 3.2% increase between 2012 and 2013 [76]. Food 
preferences have changed, and this has altered the consumption of traditional staples. 
Relatively, there has been a global shift in dietary patterns from the reliance on traditional 
staples to processed foods due to the increased production of processed foods and changing 
lifestyles [20]. The Food and Agriculture Organization predicts that with the rise in income 
levels, preference for wheat products will increasingly overshadow traditional coarse grains 
[77]. In many LMICs, wheat is gradually replacing roots and tubers [78]. Furthermore, rapid 
urbanization in LMICs is changing diets such that “fast foods” (ready-to-eat), which 
typically contain excess salt, have replaced core staple plant-based foods, thereby increasing 
the demand for processed foods [79]. Other reasons for shifts to a greater reliance on 
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processed foods may be related to an increase in the number of women in the workforce, 
which has affected roles within the household related to food preparation [80]. The rising 
trend of eating away from home or eating prepared food away from home has contributed 
to the increased consumption of bakery products [81,82] in urban settings. Bread has 
virtually become a staple food [83], and which for many, forms the basis of breakfast, lunch, 
and dinner. For example, in some parts of the Democratic Republic Congo, bread has 
substituted cassava, the traditional starchy staple used in preparing “foufou” (dough made 
from boiled and ground plantain or cassava) [84]. Similarly, bread intake is higher than 
traditional staples in southern Mozambique [85,86] and is widely eaten as a snack or as a 
complete meal in Nigeria [87]. Bread is easily accessible from stores and vendors, and more 
convenient than traditional cereal and root staples, both of which require time and effort for 
preparation before consumption. In the Seychelles, there has been a decreased consumption 
of the traditional staple (fish) as a result of increased intake of meat, poultry, processed meat, 
and snacks [88]. There have been major increases in meat (i.e. beef, pork, and poultry) in 
LMICs [89, 90], including processed meat that is high in salt [91, 92]. Increased consumption 
of processed meat products has the potential risk of coronary heart disease, type-2 diabetes, 
and colorectal cancer [93, 94]. In Australia, processed meat contributed 10% of daily Na 
intake [95] and is a major contributor to salt intake in the United Kingdom [96]. Bacon for 
example, contains more than twenty times the quantity of salt compared to fresh pork of the 
same weight [97]. As countries are becoming more economically wealthy, there has been an 
increased demand for animal source products with livestock being one of the fastest 
growing agricultural subsectors in LMICs [98], and accompanying advancement in food 
technology in these countries resulting in increased availability of processed animal 
products. These processed animal products may be contributing to the increase in salt intake 
within LMIC populations. A potential strategy to reduce salt intake would be to reduce 
processed meat intake. This would have the additional benefit of reducing climate change 
issues such as high green-house gas emissions from cattle and diverting agricultural land 
use from human consumption to animal consumption [99,100]. Highly palatable, energy-
dense, low-cost, ultra-processed foods, snacks, and beverages are commonplace within the 
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food supply in LMICs [101,102]. This is evident in the growing number of supermarkets that 
are replacing open public markets in LMICs [12]. Consumers are attracted to these foods 
because of their affordability, ease of access, availability, and taste, which are often 
accompanied by intensive marketing by the food industry sector [103], particularly in 
poorer environments where alternatives are limited [104]. In most LMICs, food security is a 
major issue and food preservation using salt is commonplace. In these countries, food 
production is seasonal but in greater quantities during harvest, after which production 
dwindles significantly [14, 15]. Ghana, for example, experiences two rainy seasons a year 
(with the major one in June and the minor in October) and those are the times for crop 
production in most parts of the country [105]. The major fishing season shares the same 
timeframe [106,107], thus, the bulk of the country’s food supply is produced in one-half of 
the year, thereby warranting preservation, one of which is using salt [108] to ensure its 
availability and maintenance for off-season supply [14,15]. Often, an under-estimated 
source of dietary salt relates to the contribution from the water supply. Studies on river and 
underground shallow water salinity are lacking in the face of severe drought in LMICs [109–
111]. More challenging is the fact that there are no guidelines for safe salinity levels in 
drinking water [21]. During the dry season in Bangladesh, it is estimated that up to 5–16 g 
salt per day may be consumed from river and shallow underground drinking water [47]. 
There are many places in Africa and Asia where the sources of water are unsafe for human 
consumption [112–114] and the likelihood for excess salt provided by water bodies remain 
high as environmental and climatic conditions worsen [115]. This issue has been ignored in 
recommended global strategies [20] to reduce population-level salt intake. The shift in 
dietary patterns is also driven by the promotion of Western culture through media outlets, 
international trade, and other channels related to globalization [74]. Many supermarkets, 
hotels, restaurants, and fast food outlets in LMICs are multinational establishments that 
provide the same menu as their partners in higher income countries. These food outlets are 
a major driving force changing the food environment and dictating food preferences in 
LMICs [12]. Globalization of food systems in this way, undermines traditional dietary 
practices and creates an avenue for food and nutrient insecurity. Greater availability and 
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access to these cheap, imported, energy-dense, nutrient-poor foods have culminated in an 
increased prevalence of obesity and a myriad of NCDs plaguing many African countries 
(that are already burdened with infectious diseases) [116]. A challenge is for LMICs to 
consider agriculture within economic growth and development, to ensure that food 
insecurity is not exacerbated by increasing urbanization. A deliberative approach should be 
developed and geared towards the production, availability, accessibility, and consumption 
of a wide range of traditional staples in the face of rapid development. Countries in South 
East Asia provide exemplars as they have encouraged and improved the traditional cuisine 
to meet current developmental changes [117,118]. The United Nations’ Sustainable 
Development Goals provide a framework against which country progress towards 17 goals 
will be reported by governments [119]. Partnerships and global solidarity between countries 
should include commitments by major food companies to limit and standardize acceptable 
maximum limits of harmful components allowed in imported or branded foods sold across 
the globe and prevent dramatic differences currently seen in the salt content of similar 
products and fast food meals across countries. An urgent need to address food systems in 
LMICS is required in order to stem the pandemic of NCDs, as more than three-quarters of 
premature NCD deaths occur in these countries [20]. South Africa serves as an example 
where the government has mandated maximum salt levels permitted across a wide range 
of processed foods, in an effort to reduce the burden of hypertension [8, 120, 121] and its 
related morbidities [122]. Though the impact of this legislation is yet to be demonstrated 
[123], it is seen as a bold step towards saving lives and reducing health care costs [124, 125]. 
The WHO has emphasized that government policies and programs, collaboration with 
private sector organizations, and monitoring of population salt intake are key measures to 
population salt reduction [20]. Understanding salt use behaviors at the population level is 
required in order to determine best approaches to salt reduction in countries [126]. Many 
governments have focused on individual consumer behavior change [127], focusing on salt 
added at the table and during cooking. Though commendable, a multi-faceted approach 
which targets both discretionary and non-discretionally salt use is encouraged [20]. This 
review collated the available information on dietary sources of salt in LMICs in an effort to 
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identify the food sources that contribute to total salt intake. Many LMICs do not have 
reliable assessments of dietary salt intake nor do they have national targets and timelines 
towards ensuring a decline in salt consumption. This makes it challenging to assess progress 
towards achieving the WHO’s voluntary salt reduction target of a relative 30% by 2025 [20]. 
Advocacy by civil society groups, organizations, institutions, and professional health 
associations for salt reduction in foods is required to lobby governments whose health 
agenda does not include changes to the food supply. This approach has been demonstrated 
by the Australian Division of World Action on Salt and Health, whose efforts have resulted 
in voluntary salt targets for the food industry [71]. The legislative approach adopted by the 
South African government [41] may serve as blueprint for LMICs [128]. Limitations to the 
review relate to the selection criteria being based on the English language only. This may 
have limited the scope of the search and subsequent data retrieved for consideration. 
Nonetheless, studies included covered all WHO global regions. Many of the cited papers 
did not provide information on the actual dietary consumption patterns of the populations 
residing in the areas from where the food samples were obtained. This means that overall 
contribution of individual foods to total salt intake could not be determined. 
3.5 Conclusions 
Processed foods that have a high salt content are becoming common place in the diets of 
populations in LMICs. Major sources of salt are provided by bread, meat and meat products, 
salted meat and fish, sauces, spreads, bouillon cubes, pizza, and seafood. Differences exist 
between WHO regions regarding sources of food products that contribute to total salt 
intakes. Water sources in drought-affected areas also warrant further attention as sources of 
Na intake. Besides foods that contain high salt, discretionary salt use is widespread in 
LMICs. 
Supplementary Materials: The following are available online at 
http://www.mdpi.com/1660-4601/16/12/2082/s1, Table S1: Search strategy, Table S2: Risk of 
bias assessment, Table S3: Included articles and their regions of origin. Author  
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Salt use behaviours of Ghanaians and South Africans: A 
comparative study of knowledge, attitudes and practices 
 
This chapter describes a cross-sectional study of salt use behaviours among Ghanaians and 
South Africans during WHO-SAGE W2 study. In terms of advocacy and affirmative action 
for population salt reduction, salt knowledge, attitudes and practices are the targets of 
public health education. A comparison between the two SSA countries, with SA having 
implemented a salt reduction legislation, in addition to a massive salt reduction campaign, 
and Ghana without such, this novel study gives an insight into salt behaviours among these 
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Salt consumption is high in Africa and the continent also shares the greatest burden of 
hypertension. This study examines salt-related knowledge, attitude and self-reported 
behaviours (KAB) amongst adults from two African countries—Ghana and South Africa 
(SA)—which have distributed different public health messages related to salt. KAB was 
assessed in the multinational longitudinal World Health Organization (WHO) study on 
global AGEing and adult health (WHO-SAGE) Wave 2 (2014–2015). Respondents were 
randomly selected across both countries—Ghana (n = 6746; mean age 58y old; SD 17; 41% 
men; 31% hypertensive) and SA (n = 3776, mean age 54y old; SD 17; 32% men; 45% 
hypertensive). South Africans were more likely than Ghanaians to add salt to food at the 
table (OR 4.80, CI 4.071–5.611, p < 0.001) but less likely to add salt to food during cooking 
(OR 0.16, CI 0.130–0.197, p < 0.001). South Africans were also less likely to take action to 
control their salt intake (OR 0.436, CI 0.379–0.488, p < 0.001). Considering the various salt 
reduction initiatives of SA that have been largely absent in Ghana, this study supports 
additional efforts to raise consumer awareness on discretionary salt use and behaviour 
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The Global Burden of Disease study has demonstrated that diet contributes significantly to 
risk of non-communicable diseases (NCDs) such as cancer, cardiovascular diseases (CVDs) 
and diabetes [1]. Dietary risk factors include diets low in fruits, vegetables, whole grains, 
nuts and seeds, fibre, omega-3 oils, and polyunsaturated fatty acids and diets that are high 
in Na, red meat, processed meat, sweetened beverages, and trans fats [2,3,4,5,6]. The 
nutrition transition in many Sub-Saharan countries is resulting in a change in dietary 
patterns from traditional, plant-based diets to increasing intakes of processed foods that 
tend to be high in sugar and/or fat, known as energy dense, nutrient poor (EDNP) foods 
that are generally also high in salt [7]. Excess salt intake has been identified as one of the 
leading global health risks [8] and population level salt reduction is recognized as a cost-
effective means of reducing BP [9,10,11,12] and, in turn, reducing the risk of heart disease 
and stroke [13,14]. A 30% reduction in population level salt by 2020 is one of the voluntary 
global health targets identified by the WHO [7]. 
On a global scale, it has been estimated that 1.7 million lives could be saved annually if salt 
consumption levels were decreased to recommended levels of less than 5g per day [15]. 
Across high and low-middle income countries, interventions to reduce population salt 
intake are considered cost effective (less than $1USD per person per year) [16, 17]. 
Over 75% of cardiovascular deaths take place in low and middle-income countries [18] with 
the African region estimated to have around 20 million people with CVD [18]. As such, 
Africa shares the greatest burden of hypertension with almost half of adults aged 25 and 
older diagnosed and potentially more adults with undiagnosed, untreated and uncontrolled 
hypertension [19]. In Ghana, the prevalence of hypertension has continued to rise over the 
past 40y [20, 21, 22]. South Africa (SA) equally shares a large burden of hypertension [23, 
24]. The direct healthcare costs attributable to non-optimal BP in Sub-Saharan Africa (SSA) 
in 2001 were estimated to be two billion US dollars [25]. 
Despite the global targets to reduce the burden of NCDs, there are still limited examples of 
effective strategies to reduce population‐level dietary salt consumption globally, especially 
from African countries [26, 27]. In most African countries, salt is commonly added to food 
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at the table and during cooking, and is a major ingredient found in commonly used sauces 
and seasonings [28, 29]. Salted fish and meat are eaten frequently [30] while bread contains 
levels of salt that are generally higher than in countries in Europe and North America [31, 
32]. In SA, other sources of salt include cereals, meat and meat products, milk and dairy 
products, processed meats, meat pies and margarine. In that country, it is estimated that 
discretionary salt intake accounted for almost half of the total dietary intake in a sample of 
black urban dwelling people [33]. This represents a greater contribution as compared to 
many high-income countries, where 75–85% of dietary salt intake is estimated to come from 
processed foods [34]. The Ghana Demographic and Health Survey indicated that 84% of 
women surveyed reported that someone in their household had consumed processed foods 
containing salt within the past 24 hours, while more than a third had consumed salted dried 
fish, 21% reported having had canned fish, meat and legumes and 24% reported the use of 
other processed foods containing salt [35]. The report identified a high use of salty foods in 
both rural and urban areas. Similarly, the South African Demographic and Health Survey 
2003 indicated that more than 30% of survey respondents reported adding salt to food at 
the table and consuming salty snacks more than twice a week [36]. 
To reduce discretionary salt consumption in SA, there has been a concentrated focus on 
consumer education and awareness in recent years [37]. In addition, in June 2016, the SA 
government implemented mandatory legislation related to maximum levels of salt 
permitted in a wide range of processed food categories, including breads, meats, cereal 
products, fat spreads, snack foods and savoury products [38]. These foods have previously 
been shown to contribute significantly to overall non-discretionary salt intake in the South 
African population [33]. In contrast, in Ghana, there have been no concerted efforts by 
government or non-governmental organizations to implement salt reduction strategies. 
Instead, there has been a focus on the prevention of iodine deficiency through universal salt 
iodization programmes [39, 40, 41] with the message to consume iodized salt widely 
disseminated through the mass media [39]. Public health concerns related to the association 
between increased salt intake and cardiovascular risk in Ghana have received 
comparatively little attention despite promising proof of concept studies [42]. Iodization 
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programmes and salt reduction strategies are not mutually exclusive, as has been 
demonstrated [43]. However, for both programmes to successfully coexist, different sectors 
of government (nutrition and NCDs) need to work together, to effectively monitor the 
iodine status of populations as salt content in the food supply decreases. 
Given that the population in Ghana has been urged to consume iodized salt [39,40,44] 
combined with the generally increased accessibility of EDNP processed foods, it is timely to 
investigate knowledge, attitudes and behaviours (KAB) related to salt use in Ghana and to 
compare these against SA, an African country in which salt reduction has been strongly 
emphasized. Ghana and SA share similar socio-demographic characteristics, as well as a 
high hypertension burden. The findings will be important—particularly for low and 
middle-income countries—for informing approaches to reducing the health risks through a 
better understanding of salt intake behaviours. 
4.2. Methods 
The study methodology has been comprehensively described in Chapter two. Specific to 
this chapter, WHO-SAGE Ghana/SA W2 dataset was utilized. A total of 10,522 adults were 
recruited: n = 6746 in Ghana and n = 3776 in SA. In selecting the sample, all WHO-SAGE W1 
households were included for WHO-SAGE W2 data collection [45]. Field teams used an 11-
month period (September 2014 to June 2015) and a 5-month period (August to December 
2015) to complete data collection in Ghana and SA, respectively.  
4.2.1 Study Measures 
The main outcome of this analysis relates to reported salt KAB captured using a five-item 
questionnaire adapted from the WHO/PAHO protocol [46]. KAB is the usual term for such 
research and has been widely used in the context of salt behaviours [47, 48, 49, 50]. The 
congruence between attitudes and perceptions has been explored [50], but for the purposes 
of comparison with other studies we prefer to retain the terminology of “attitudes”. Age, 
sex, residential location (urban/rural), education, marital status, employment status, alcohol 
intake, smoking status, blood pressure (BP) and salt behaviour variables were recorded, as 
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shown in Table 4.1.  Approval for the study and informed consent statements from 
participants have been described in Chapter 2. 
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Table 4. 1 Sociodemographic characteristics and selected health characteristics of the study samples in Ghana and South 
Africa, Study on Global Ageing and Adult Health (SAGE) Wave 2.  
 
Characteristics 
Age Categories—Countries Combined 
Ghana  
n = 4753 
South 
Africa  




old (n = 2279) 
50+ years 




Age in years, median (IQR) 
50 plus years, n (%) 
   
n = 4743  
58 (19.0)  
3569 (75.2) 
n = 3396  




Sex male, n (%) 
n = 2277  
871 (38.3) 
 
n = 5857  
2171 (37.0) 
0.32 
n = 4753  
1954 (41.1) 
n = 3392  
1094 (32.3) 
<0.01 
Residence urban, n (%) 
n = 2110  
1176 (55.7) 
 
n = 5560  
2918 (52.5) 
0.01 
n = 4728  
1970 (41.6) 
n = 2924  
2124 (72.8) 
<0.01 
Education       
Ever attended school, n 
(%) 
n = 2108  
1839 (87.2) 
 
n = 5546  
3327 (60.0) 
<0.01 
n = 4734  
2764 (58.4) 
n = 2920  
2402 (82.3) 
<0.01 
Educational level high 
school or above, n (%) 
n = 2099  
1164 (55.5) 
 
n = 5493  
1646 (30) 
<0.01 
n = 4706  
678 (14.4) 




currently working, (%) 
n = 1473  
1124 (76.3) 
 
n = 4832  
2611 (54.0) 
<0.01 
n = 4537  
3169 (69.8) 






Age Categories—Countries Combined 
Ghana  
n = 4753 
South 
Africa  




old (n = 2279) 
50+ years 





married/cohabiting, n (%) 
n = 937  
231 (24.7) 
 
n = 1984  
684 (34.5) 
<0.01 
n = 4738  
2692 (56.8) 
n = 2921  
915 (31.3) 
<0.01 
Waist to height ratio <0.5, n 
(%) 
n = 1853  
693 (37.4) 
 
n = 4807  
1369 (28.5) 
<0.01 
n = 4347  
1553 (35.7) 
n = 2313  
509 (22.0) 
<0.01 
Body Mass Index (BMI), 
median (IQR) 
n = 1904  
25 (7.7) 
 
n = 4883  
24.2 (8.4) 
<0.01 
n = 4456  
22.9 (6.2) 
n = 2331  
28.6 (9.9) 
<0.01 
Alcohol intake       
Never n (%) 
n = 1597  
397 (24.0) 
 
n = 1625  
400 (24.6) 
0.87 
n = 1168  
786 (67.3) 
n = 2054  
1639 (80.0) 
<0.01 
Recently yes, n (%) 
n = 515  
351 (68.2) 
 
n = 1379  
912 (66.1) 
0.41 
n = 1379  
916 (66.4) 
n = 515  
347 (67.4) 
0.69 
Frequent, n (%) 
n = 508  
203 (40.0) 
 
n = 1371  
595 (43.4) 
<0.01 
n = 1369  
635 (46.4 ) 
n = 510  
163 (32.0 ) 
<0.01 
Smoking status, current use 
of tobacco, n (%) 
n = 1616  
137 (8.5) 




n = 1340  
208 (15.5) 
n = 2160  
403 (18.7) 
0.06 
Systolic blood pressure mm 
Hg, median (IQR) 
n = 2030  
119 (20.0) 
n = 5370  
131 (28.0) 
<0.01 
n = 4674  
124.67 
(28.0) 






Age Categories—Countries Combined 
Ghana  
n = 4753 
South 
Africa  




old (n = 2279) 
50+ years 




Diastolic blood pressure mm 
Hg, median (IQR) 
n = 2030  
75.7 (15.0) 
 
n = 5370  
79.3 (17.0) 
<0.01 
n = 4674  
77 (16.0) 
n = 2726  
80.67 (16.0) 
<0.01 
Hypertensive, n (%) 
n = 2079  
401 (19.3) 
n = 5455  
2320 (42.5) 
<0.01 
n = 4675  
1444 (30.9) 
n = 2859  
1277 (44.7) 
<0.01 
                                            Data recorded as median (inter quartile range) and frequencies (%). Smokers identified by self-report. Frequent alcohol use 
                                       defined as the consumption of one or more alcoholic drinks a day/week. Hypertensive categorized as BP ≥ 140/90 mm Hg  
                                       or previous diagnosis. Continuous variables were compared using the Independent Samples Mann Whitney U test;  
                                       categorical variables were compared using the Chi-Square test. 
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4.2.2 Statistical Analysis 
All data were collated and analysed using IBM SPSS Statistics for Windows, Version 20.0. 
(IBM Corp., Armonk, NY, USA). The normality of the data was checked by visual inspection 
and the Kolmogorov-Smirnov test. Descriptive statistics of frequencies, percentages and 
median (IQR) were used to describe respondents’ characteristics and responses to survey 
items. Country differences were evaluated using Chi-square and Independent Samples 
Mann Whitney U tests. The significance level was set at p < 0.05. Logistic regression was 
applied to compare the probability of various salt behaviours between Ghana and SA and 
odds ratios and 95% confidence intervals (95% CI) were computed. The model was adjusted 
for potential confounders which included age, sex, residential location, educational level 
and hypertension prevalence as demonstrated in other studies [51-53]. BMI was not 
included in the final regression model as it was not statistically significant. 
4.3 Results 
Approximately 30% of the recruited samples in both countries had data that could not be 
retrieved due to technical and data management issues during data collection and retrieval 
using the CAPI system. This loss of data was non-systematic and the sample size on which 
the current analysis is based is on a total samples size of n = 8145 (by sex). As such, in the 
sample for Ghana (41.1% (n = 1954) were male and 58.9% (n = 2799) were female, 75.2% (n = 
3569) aged 50+y old and 24.8% (n = 1174) aged 18–49 years old) and for SA (32.2% (n = 1094) 
were male and 67.8% (n = 2298) were female, 67.5% (n = 2291) aged 50+y old and 32.5% (n = 
1105) aged 18–49y old). The characteristics of the population are presented in Table 4.1. Due 
to non-responses for some questionnaire items, the number of responses (n) for each 
variable is included in the tables. Significant differences were recorded between the two 
countries, with more older people (Ghana 75.2%; SA 67.5%; p < 0.01) and more men (Ghana 
41.1%; SA 32.3%; p < 0.01) in Ghana than in SA, whereas SA had more urban residents 
(Ghana 41.6%; SA 72.8%), and more participants from SA had a higher educational status 
(Ghana 14.4%; SA 42.1%) and a higher level of hypertension prevalence (SA 44.7%; Ghana 




Approximately one-third (31.3%; n = 2190) of all respondents were not aware that a high salt 
diet could cause a serious health problem. This was consistently observed among older and 
younger adults, men and women and across both countries (Table 5.2). Significant 
associations were recorded between respondents’ knowledge and their ethnicity within the 
South African cohort. Those with a “coloured” ethnic background recorded the highest 





Table 4. 2 Association between salt knowledge, attitudes and behaviours (KAB) and demographic characteristics of 
Ghanaians (n = 6746) and South Africans (n = 3776); younger (n = 2279) and older (n = 5860); men (n = 3048) and women 










n = 2279 
50+ years 
old  




n = 3048 
Women  
n = 5097 
p 
Value 
n = 4753 n = 3392 
Do you think that a 
high salt diet could 
cause a serious 
health problem?  
Yes n (%) 
 
n = 1940  
1309 (67.5) 
n = 5061  
3502 (69.2) 
0.16 
n = 2602  
1756 (67.5) 




n = 4328  
2920 
(67.5) 








Just the right 
amount, n (%) 
 
n = 2047  
1613 (78.8) 
n = 5392  
3957 (73.4) 
<0.01 
n = 2804  
2176 (77.6) 




n = 4622  
3510 
(75.9) 




Do you add salt to 
food  
at the table?  
“Always” and 
“Often” n (%) 
 
n = 1453  
311 (21.4) 
n = 4026  
673 (16.7) 
<0.01 
n = 2024  
393 (19.4) 




n = 3552  
350 (9.9) 













n = 2279 
50+ years 
old  




n = 3048 
Women  
n = 5097 
p 
Value 
n = 4753 n = 3392 
In the food you eat 
at home,  
salt is added in 
cooking…?  
“Always” and 
“Often” n (%) 
 
n = 1822  
1689 (92.7) 
n = 4771  
4310 (90.3) 
0.03 
n = 2552  
2374 (93) 




n = 4459  
4294 
(96.3) 




Do you do 
anything on  
a regular basis to 
control  
your salt or sodium 
intake? Yes n (%) 
 
n = 1990  
688 (34.6) 
n = 5249  
2034 (38.8) 
0.01 
n = 2718  
970 (35.7) 




n = 4518  
1939 
(42.9) 
n = 2721  
783 (28.8) 
<0.01 






Three quarters (74.9%; n = 5570) of all respondents perceived that they consumed just the 
right amount of salt. The perception of consuming “just the right amount of salt” was more 
frequently observed in younger adults, men, and in Ghanaians compared to South Africans. 
4.3.3 Salt intake behaviours 
Among all respondents, 18% (n = 984) reported that they “always” and “often” (frequently) 
added salt to food at the table and the majority (n = 5999, 91%) reported that they frequently 
added salt to food at home during cooking. Almost two-thirds (62.4%) reported that they 
did not take any action to control their salt intake. The response to “taking actions to control 
salt intake on a regular basis” significantly differed according to knowledge about salt 
(knowledge and health, p < 0.001). For the two countries, fifty-two percent of respondents 
who did not think high salt could cause health problems reported that they never took 
actions on regular basis to reduce salt intake. Reported frequent alcohol intake was found 
to relate to less desirable salt intake behaviours. While 96.7% of respondents reporting 
frequent alcohol intake (n = 1971) also reported always or often adding salt to food while 
cooking, this behaviour was significantly lower (86.1%) in teetotallers (n = 756; p < 0.01). 
Additionally, significantly more teetotallers (51.0%) reported regularly attempting to 
control their salt intake when compared with frequent drinkers (33.7%; p < 0.01). Significant 
associations were recorded between respondents who frequently added salt to food at the 
table and their ethnicity within the South African cohort. Those with African/black ethnic 
background reported adding more salt to food at the table than any other group (36.5%, p < 
0.01). 
Younger adults more frequently added salt to food at the table, added salt to food eaten at 
home during cooking and did less on a regular basis to control their salt intake than did 
older adults (Table 4.2). More South Africans than Ghanaians reported that they frequently 
added salt at the table (SA 32.9%; Ghana 9.9%; p < 0.001) and did not take actions to control 
their salt intake (SA 28.8%; Ghana 42.9%). Significantly more Ghanaians than South Africans 
reported frequently adding salt to food during cooking (SA 79.9%; Ghana 96.3%; p < 0.01). 
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Multivariate analysis adjusted for sex, age, residence, educational level and hypertension 
prevalence showed that South Africans were more likely than Ghanaians to add salt to food 
at the table (OR 4.80, CI 4.071–5.611, p < 0.001) but less likely to add salt to food at home 
during cooking (OR 0.16, CI 0.130–0.197, p < 0.001) or to take action to control their salt 
intake regularly (OR 0.44, CI 0.379–0.488, p < 0.01); (Table 4.3). Men and younger adults 
were also significantly more likely to add salt to food and less likely to control salt intake. 
Those living in urban areas, educated to high school level or above, or those with 


















Table 4. 3 Associations between sociodemographic variables and salt behaviours of adults in Ghana (n = 6746) and 
South Africa (n = 3776) - comparing the odds ratio for sub-optimal salt behaviours, SAGE Wave 2.  
 
Variables 
Salt Frequently  
Added to Food  
at the Table 
Salt Frequently  
Added to Food  
during Cooking 
Takes Regular  
Action to Control  
of Salt Intake 





4.80 (4.071–5.611) * 
Ref  
0.16 (0.130–0.197) * 
Ref  





1.40 (1.182–1.605) * 
Ref  
1.36 (1.118–1.654) * 
Ref  


















1.41 (1.271–1.565) * 
Primary school and 
below  







1.12 (1.004–1.240) * 
Normotensive  
Hypertensives 





1.48 (1.328–1.649) * 
                                                          Note: Referent indicates reference category used for the comparison. Hypertension was categorized as  
                                                          BP ≥ 140/90 mm Hg or previous diagnosis, logistic regression was adjusted for sex, age category, residence,  





The finding that 80% or more of adults in Ghana and SA frequently add salt to their food 
during cooking indicates that discretionary salt use remains high in both countries. 
Significant differences were observed between the two countries for various behaviours, 
such as a third of South Africans reported adding salt to food at the table as compared to 
only a tenth of Ghanaians. Significant differences were also observed between younger and 
older adults and between the genders. The most potentially detrimental behaviours were 
identified in men and younger adults. The contribution of discretionary salt intake to total 
salt intake cannot be under-emphasized even in societies where most salt comes from 
processed foods. Health promotion activities are needed to decrease individual level salt 
intake [7] in order to decrease salt preferences over time and thus decrease discretionary salt 
use [7,36,54]. 
Knowledge related to the adverse effects of salt on health was poor. Almost one third (n = 
2190) of both Ghanaians and South Africans were not aware of the relationship between 
high salt intake and the possibility of a serious health problem. This could potentially 
explain practices of high discretionary salt use [51, 55, 56]. Conversely, individuals who 
know about the health effects of excess salt in the diet have been shown to be more likely to 
reduce their salt intake [47]. Knowledge of hypertension may influence both salt and self-
care behaviours [57]. Our results show that responses to salt knowledge, attitudes and 
behaviours are significantly related as shown by other authors [52]. 
Our data indicates participants’ high confidence in their perceived intake of the 
recommended levels of salt, since three-quarters of respondents reported that they 
consumed “just the right amount of salt.” A limitation of this study relates to potential 
under-reporting of salt use, as shown in other studies [47, 50, 58, 59] and responses to salt 
questions may not reflect actual intakes. Studies that measured 24 h urinary Na excretion in 
addition to self-reported discretionary salt use in the same respondents revealed an 
underestimation in reported salt intake [33, 60]. Hypertension levels were high in both 
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samples, but we did not investigate whether hypertensive individuals that were receiving 
treatment to control their BP had also received advice on salt intake. There is a possibility of 
misreporting, as those who have received information on salt use may feel that they 
consume the recommended amount. Furthermore, there might be some lack of knowledge 
relative to the amount of salt recommended for daily consumption, as was the case in other 
studies [52]. This discrepancy between perceived and actual salt consumption has the 
potential to result in higher than anticipated salt intakes [61]. 
Our data indicates a need to intensify consumer education on salt intake awareness in both 
countries, including discretionary salt use. Previous research contributing to South African 
policy change [33] suggests that further investigation into particular food items that 
contribute high amounts of salt to the diet is needed in Ghana. Consistent with other studies 
[52], more attention should be directed towards the younger population (18–49y old) and to 
men, who reported worse discretionary salt knowledge, attitudes and behaviours. Dietary 
salt education and awareness should also be integrated into school curricular and youth 
programmes, particularly as hypertension and associated morbidity and mortality typically 
occur at younger ages in Sub Saharan Africa (SSA) [62, 63]. 
Our finding that Ghanaians add more salt to food at home during cooking compared with 
their South African counterparts may not be surprising given investment in campaigns to 
increase consumption of iodized salt [64-66]. Within Ghana, any action related to salt 
reduction for addressing NCDs appears to have been overshadowed by the strong focus on 
the prevention of iodine deficiencies [39,40,41,66]. This situation appears in contrast to 
WHO guidelines [14], which suggest compatibility of polices on salt reduction and salt 
iodisation. The guidelines advise that regular monitoring of salt intake and iodine intake at 
country level is needed to adjust salt iodisation over time to ensure that individuals 
consume sufficient iodine while reducing overall intake of salt. If salt is sufficiently iodised, 
a reduction of salt intake to the recommended level of 5 g per day should still provide an 
adequate amount of iodine [43]. Ghana’s strong emphasis on the reduction of iodine 
deficiencies provides a unique and untapped opportunity for addressing discretionary salt 
use and behaviour change. Salt used in food processing is not included in the mandatory 
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Universal Salt Iodisation policies in either Ghana or SA, although there is some evidence 
from SA that indicates up to a third of margarines, bread, and savoury snack seasonings 
contain iodised salt [67]. 
We found that South Africans were almost 5 times more likely than Ghanaians to add salt 
to food at the table (controlling for sex, age, location, education level and hypertension 
prevalence). This finding was expected, as a greater proportion of the cohort in SA lived in 
urban areas compared with Ghana. Urbanization is one of the key drivers for excess salt 
consumption [15]. Further investigation regarding the effect of acculturation on addition of 
salt to food is of interest. The survey was conducted prior to salt legislation being introduced 
in SA, therefore it will be of importance to determine how the lowering of salt in processed 
foods impacts on both discretionary salt behaviours and actual salt intake levels in SA in the 
next wave of SAGE in 2017–2018. 
The present study shows that almost two-thirds of the population were not taking any 
action to control their salt intake, and this may be explained by the finding that a third of 
respondents did not have any knowledge regarding the links between high salt intake and 
health problems. Among the key broad strategies for salt reduction is individual 
responsibility and action [7], for example, limiting the consumption of salty snacks and 
reducing the amount of salt used in cooking. The Health Belief Model explains that 
perceived seriousness, perceived susceptibility, perceived benefits and perceived barriers 
are critical evaluations an individual undertakes prior to engaging in a health behaviour 
[68]. Our data suggests that strategies are required to firstly increase awareness within the 
Health Belief Model of health promotion as a means of supporting behaviour change. The 
other broad strategy is at a systemic level-including measures like those adopted in SA to 
work with food manufacturers to lower salt levels in processed foods. 
The findings of the present study were somewhat surprising because, despite the extensive 
public awareness campaign in SA to address population salt intake levels and influence salt 
related behaviour (Salt Watch) [37,69] and despite that population reporting greater salt 
knowledge, it was the Ghanaians who appeared to be more actively controlling their salt 
intake (Table 2). This highlights the point that knowledge alone is not sufficient to cause a 
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change in behaviour. Consistent with the present study, research from Newson et al. (2013) 
[58] showed that almost half of survey respondents were not interested in reducing their 
salt intake and had no intention of making any changes to their salt consumption in the 
immediate future. With a large hypertension burden [24], it is likely that some South 
Africans may not feel empowered to make dietary changes. Additionally, cultural beliefs 
and practices that encourage salt consumption are also of concern. Salt use for spiritual and 
religious purposes is commonplace in SA [37] and this would need to be considered in 
health messages.  
The finding that frequent alcohol intake was associated with less desirable salt intake 
behaviours has been reported by others [70]. Differences in reported alcohol intake between 
Ghanaian and South African study participants are similar to previous analyses of alcohol 
consumption from Wave 1 of SAGE which indicated that there were fewer “never” drinkers 
(lifetime abstainers) in Ghana than in SA, while the South African cohort had more “at risk” 
drinkers [71]. 
It is well established that reducing dietary salt to 3 g/day leads to a reduction in BP in both 
in hypertensives and normotensives [72]. Given the current estimated prevalence of 
hypertension in the African region, it is imperative that salt reduction messages are included 
in public health campaigns alongside various strategies to support behaviour change while 
also modifying salt levels in commonly consumed foods. Provision of practical skills and 
strategies to encourage change in salt intake behaviours is key in this regard. 
The present study had several strengths which included the use of large, nationally 
representative sample sizes in both SA and Ghana. A potential limitation relates to the use 
of questionnaire, which might be subject to recall bias and may lead to over reporting or 
under reporting. Additionally, oversampling of older people in keeping with the purpose 
of the SAGE may limit generalizability of the findings to the population younger than 50 in 
both countries.  Regardless, these are relatively large representations of the 50+ population, 






This study provided important insights into salt knowledge, attitudes and behaviours 
(KAB) in SSA. High discretionary salt use remains common practice in the region and needs 
urgent attention in the face of high and rising hypertension levels. Significant differences in 
salt KAB were evident between the two countries which suggests the use of different 
strategies and approaches for combatting high discretionary salt intake may be appropriate, 
although strategies particularly targeting men and younger adults may be beneficial for 
both countries. The findings suggest that SA requires investment into public health 
campaigns to address the practice of adding salt to foods at the table, while in Ghana a focus 
on changing behaviours related to the use of salt in cooking is required. Campaigns and 
consumer education strategies—based on the Health Belief Model—may be useful to raise 
awareness for salt reduction in SSA. 
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High salt and low potassium intake among adult 
Ghanaians: WHO-SAGE Ghana Wave 3 
 
This chapter highlights salt and K intake and their association with BP. The chapter also 
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Though Ghana has high hypertension prevalence, the country lacks current national salt 
consumption data required to build and enhance advocacy for salt reduction. We compared 
the characteristics of a nationally representative sample of the World Health Organization’s 
Study on global AGEing and adult health (WHO-SAGE), Ghana (n = 3053) and a randomly 
selected sub sample (n = 839). We also investigated the relationship between salt intake and 
BP among adult Ghanaians in the sub sample (median age = 60, cohort formed 27.5% of the 
WHO-SAGE Wave 3 Ghana study). BP was measured in triplicate and 24hr urine was 
collected for the determination of urinary Na, K, creatinine (Cr) and iodine levels. 
Hypertension prevalence was 44.3%. Median salt intake was 8.3g/day, higher in women 
compared to men (median 8.6, interquartile range (IQR) 7.5g/day vs 7.5, IQR 7.4g/day, p < 
0.01), younger participants (18-49 yrs) compared to older ones (50+ yrs) (median 9.7, IQR 
7.9g/day vs 8.1, IQR 7.1g/day, p < 0.01) and those with higher Body Mass Index (BMI) > 30 
compared to a healthy BMI (18.5-24.9) (median 10.04, IQR 5.1g/day vs 6.2, IQR 5.6 g/day, p 
< 0.01). More than three quarters (77%, n = 647) of participants had salt intakes above the 
WHO maximum recommendation of 5g/d, and nearly two thirds (65%, n = 548) had daily K 
intakes below the recommended level of 90mmol. Dietary Na: K ratios above 2mmol/mmol 
were positively associated with increasing BP with age. Population-based interventions to 
reduce salt intake and increase K consumption are needed. 










Cardiovascular diseases (CVDs) remain a major contributory factor for mortality and 
morbidity worldwide, accounting for 17.9 million deaths in 2016, and representing a third 
of all deaths globally [1]. While LMICs already share the greatest impact of CVD-related 
deaths, with rates of 300–600 deaths per 100,000 population, these are predicted to increase, 
causing premature, avoidable loss of lives [2]. Hypertension is a major risk factor for CVD 
and accounted for more than 50% of CVD-specific deaths in 2012 [3]. It has been estimated 
that the burden of hypertension will increase to approximately 1.56 billion people globally 
by 2025, with larger populations of hypertensives living in LMICs [3-5].  
Hypertension is a common condition in Ghana, where its prevalence has increased more 
than two-fold over just two decades (1988-2007) [6].  A recent nationally representative 
study among participants largely 50y and older, in Ghana, reported the prevalence of 
hypertension to be 58.9% in adults with about one-fifth of those with hypertension being 
aware of having the condition [7]. Reducing population-level prevalence of hypertension by 
30% by the year 2030 is identified by WHO as one of the nine voluntary global targets to 
reduce non communicable diseases (NCDs) [8]. Salt reduction has been identified by the 
WHO as one ‘best buys’ approach to reduce overall CVD risk through lowering of (BP) [9]. 
Increased consumption of salt (>2 grams Na/day, equivalent to 5 g salt/day) together with 
insufficient K intake (< 3.5 grams/day) are strongly associated with a number of NCDs 
including hypertension [10-14]. Several systematic literature reviews, meta-analyses and 
randomized-controlled trials have shown that reduced Na consumption results in a decline 
in BP in both hypertensives and normotensive adults [13-17], which saves lives [18]. In view 
of this, ‘WHO’s SHAKE the Salt Habit’ resource has emphasized the importance of 
measuring and monitoring population salt consumption patterns in order to inform 
stakeholders about strategies to reduce salt intake and evaluate the effect of any 
implemented salt reduction programmes [19]. Though Ghana is committed to the World 
Health Assembly’s target of 30% relative reduction in the population salt intake by 2025 
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[10], the country has made slow progress towards achieving the target due to other 
competing public health priorities and limited resources [20].  
Few studies have been conducted to assess salt intake in the Ghanaian population [21]. A 
lack of recent, nationally representative data on population salt consumption among adults 
has further been a disincentive for advocacy around salt reduction efforts [22]. The current 
study was undertaken to obtain a reliable estimate of population salt intake and salt use 
behaviour, and to assess the relationship between salt and K intake with BP in Ghanaian 
adults.  
5.2 Methods 
The study methodology has been described in Chapter two. Specific to this chapter, WHO-
SAGE Ghana W3 dataset was used. Data collection was completed over a period of one year 
(July 2018 - June 2019) with n = 1100 24hr urine samples collected nationwide. Out of 3053 
participants recruited for WHO - SAGE Ghana Wave 3, 102 (36.1%) were randomly selected 
to provide urine samples (nested sub study). Of these, 76.7% (n = 844) had successful (BP) 
data and 88.6% (n = 976) had complete urine samples. However, fewer participants (n = 839) 
had a complete urine collection, accompanied with survey, anthropometric and valid BP 






















 Figure 5. 1 Study flow chart. 
  
Main cohort 
N = 4449 participants interviewed 
Nested cohort 
N = 1121 urine samples collected 
Deleted: 
 15 duplicated barcodes 
 2 triplicated barcodes 
N = 1102 samples 
N = 957 common subjects (main & nested) 
N = 865 with valid urine measurement 
(cut-off: Volume≥300ml) 
N= 16 urine samples replaced with 
validation data 
Deleted: 
 164 urine data only 
 477 no age recorded 
 32 low volumes 
 56 invalid Na figures 
  
 
N = 3053 main cohort 
N = 839 nested cohort 
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The 24hr urine was collected, thoroughly mixed, volumes recorded, 3 aliquots of 5ml were 
generated, and samples kept in cold boxes and transported to NMIMR-UG for Na, K and 
Cr analyses.  Additionally, iodine was assessed for analysis because Ghana had a universal 
iodine programme in place. 
Creatinine excretion in this population was much lower than that reported for many other 
populations, from which Cr cut-off values have been determined to indicate completeness 
of 24hr urine collection [23]. Because of this, only urine volume was used to indicate whether 
urine samples were considered to represent completeness. This approach has been used in 
other multi-country studies including the International Population Study on 
Macronutrients and Blood Pressure [INTERMAP] and the International Study of Sodium, 
Potassium, and Blood Pressure [INTERSALT] [24]. In the first enumerator areas (EAs) 
sampled within the Accra region, some calculated salt values were unfeasibly high (> 40g/d, 
n = 40,) due to unacceptable storage conditions [25]. A follow-up validation study conducted 
in n = 67 participants included the collection of repeated 24hr urine samples from the same 
participants in one EA (Alajo; n = 19), while an additional two non-urine EAs from the larger 
survey sample were visited as a comparator (Mataheko; n = 24 and Nima; n = 24). A second 
laboratory (Liberty Medical Laboratory, Accra) also performed duplicate analyses in the 
validation study. Values for Dosise EA (n = 23) were excluded after the validation study 
because they were confirmed as being unfeasible, and the validation study values replaced 
original measures for the case of Alajo (n = 16; 3 barcodes of urine samples in validation 
study were excluded because they could not be matched with those of the original study) 
(Supplementary Table 5.1).  
The ratio Na (mmol/L) to K (mmol/L) was created (Na:K) and categorised as low (<2), 
medium (2-5) or high (>5). Mean Arterial Pressure (MAP) is the average arterial pressure 
throughout one cardiac cycle, systole, and diastole. MAP was calculated using the formulae: 
MAP = SBP + 2 (DBP)/3 [26]. Hypertension status was measured as self-reported treatment 
or having a measured BP ≥ 140/90mm Hg. Hypertension prevalence, awareness, treatment 
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and control were measured. Individuals with no current medication use and a measured BP 
<140/90 mm Hg were categorized as non-hypertensive.  
5.2.2 Statistical Analysis 
Data were analysed using Stata Statistical Software: Release 15 (Stata Corp LLC, 2017; 
College Station, USA). Data distribution was checked visually and with the Shapiro Wilks 
test for normality. Descriptive statistics of frequencies, percentages and median 
(interquartile range, IQR) were used to describe participants’ characteristics. Categorical 
variables were evaluated using frequencies, Pearson’s Chi-Square and Fisher’s Exact tests. 
Comparison between groups for non-parametric data was examined using Mann-Whitney 
U and Kruskal-Wallis tests and Spearman’s Rho was used to test for correlations. Linear 
regressions were used to evaluate the associations between variables. To test regression 
slopes for equality between the three salt level groups and between the three Na:K ratio 
groups, the interaction terms of groups with age was added into the models. To test if a 
difference in the group’s coefficients (i.e. slope) was present, the F test was applied. If 
significant, post-estimation was pursued to identify which group differed from the others. 
5.3 Results  
Table 5.1 compares sociodemographic characteristics of the nested sub study sample with 














Table 5. 1 Demographic profile of SAGE GHA W3 survey participants and subsample 
with valid urine data (urine data considered valid if volume ≥ 300ml) 
 
Characteristics Main SAGE 
cohort 
(n=3053) 




Age   
   Years 60 (20) 60 (19) 0.3294 
   18-49y , n (%) 717 (23.5) 174 (20.7) 0.0100 
   50+y, n (%) 2336 (76.5) 665 (79.3) 0.4494 
Sex, n (%)    0.001 
   Men 1183 (38.8) 371 (32.3)  
   Women  1870 (61.2) 568 (67.7)  
Ethnicity, n (%)   <0.0001 
   Akan 1544 (50.6) 497 (59.2)  
   Ewe 216 (7.1) 58 (6.9)  
   Ga-Adangbe 224 (7.3) 45 (5.4)  
   Gruma 30 (1.0) 6 (0.7)  
   Grusi 76 (2.5) 12 (1.4)  
   Guan 38 (1.2) 16 (1.9)  
   Mande-Busanga 63 (2.1) 3 (0.4)  
   Mole-Dagbon 174 (5.7) 24 (2.9)  
   Other 612 (20.0) 174 (20.7)  
Residence, n (%)    <0.0001 
   Urban 1301 (42.6) 457 (54.5)  
   Rural 1752 (57.4) 382 (45.5)  
Marital status, n (%)   0.002 
   Never married 208 (6.8) 39 (4.6)  
   Married/cohabiting 1760 (57.7) 470 (56.0)  
   Separate/divorced 369 (12.1) 87 (10.4)  
   Widowed 715 (23.4) 243 (29.0)  
Never been to school, n (%) 1119 (36.7) 240 (28.6) <0.0001 
Education (Years) 10 (5) 10 (5) 0.0139 
Body Mass Index (BMI, kg/m2) 24.2 (6.8) 25.4 (7.4) <0.01 
Waist to height ratio 0.54 (0.11) 0.56 (0.13) <0.01 
Never used alcohol, n (%) 1865 (61.3) 483 (57.6) 0.052 
Never used tobacco, n (%) 2739 (90.0) 759 (90.5) 0.68 
Systolic BP (mm Hg) 124 (26.5) 126.5 (29) <0.01 
Diastolic BP (mm Hg) 76 (17) 76.5 (17) 0.83 
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Characteristics Main SAGE 
cohort 
(n=3053) 




Mean Arterial Pressure (Map) 
mm Hg 
92.5 (19.2) 93.2 (20.7) 0.24 
Hypertension, n(%) 1132 (37.6) 370 (44.3) <0.01 
Diabetes, n(%) 157 (5.2) 67 (8.0) 0.01 
Portions of fruit, n(%)   0.05 
Met WHO’s recommendation of 
at least 5 servings of friuts and 
vegetables 
1591 (57.4) 442 (54.5) 0.14 
Frequently add salt to food at 
table, n(%) 
642 (21.1) 107 (12.7) <0.01 
Frequently add salt to food 
during cooking, n(%) 
2527 (83.0) 672 (80.1) 0.05 
Believe they consume too much 
salt, n(%) 
265 (8.8) 92 (11.0) 0.05 
Believe a high salt diet is bad for 
health, n(%) 
2247 (75.9) 651 (80.0) 0.02 
Regularly control of salt intake, 
n(%) 
1243 (42.1) 394 (48.5) <0.01 
Nested sub sample: all respondent with CAPI data and valid urine, sex and age recorded. Some 
variables may contain missing data. Data are presented as median (IRQ) unless otherwise indicated. 
Hypertensive by measured BP≥140 and/or 90 mm Hg or previous diagnosis (self-reported). 
Ethnicity, marital status, education, alcohol/tobacco use and diabetes prevalence by self-report. 
Mann-Whitney Test used to compare medians, Pearson Chi-Square test and Fisher’s Exact Test used 
to compare proportional data. 
 
Hypertension prevalence in the nested sub study was 44.3% (n = 370) with 41.4% and 46.1% 
for men and women respectively. Of those with hypertension, 59.7% were aware of their 
condition (n = 222) of which 69.1% (n = 154) were receiving prescribed antihypertensive 
medication. Of those being treated for hypertension, 51% (n = 77) had controlled BP (ie BP 
≤ 140/90).  
Among participants with both urine, survey data and BP data (n = 839), median intake of 
salt was equivalent to 8.3g/day (IQR 7.5) (mean = 10.2g ± 7.2). Salt intake was higher in: (1) 
women compared to men; median 8.6 (7.5)g/day vs 7.5 (7.4)g/day, p < 0.01; (2) younger 
participants (18-49 yrs) compared to older ones (50+ yrs); median 9.7 (7.9)g/day vs 8.1 
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(7.1)g/day, p < 0.01; and (3) those with higher BMI (30+) compared to a desirable BMI (18.5-
24.9); median 10.04 (5.1)g/day vs 6.2 (5.6)g/day, p < 0.01. There was no significant difference 
in salt consumption between rural and urban dwellers. Overall, 77.7% (n = 647) of 
participants had salt intakes above the WHO maximum recommendation of 5g/d, with 
38.9% consuming more than twice this level (> 10g/d, n = 321) and 16.3% consuming more 
than three times the recommended level (> 15g/d, n = 137).  More men than women (27.1% 
(n = 73) vs 19.9% (n = 122); p = 0.02) and older participants than younger ones (24.8% (n = 
164) vs 12.1% (n = 21); p <0.01) achieved the WHO’ salt recommendation of ≤ 5g salt/day 
(Supplementary Tables 5.2 and 5.3). 
According to groupings by salt intake (low, < 5g/d; medium, 5-9g/d; high, > 9g/d), those 
with higher salt intakes were significantly younger, had higher BMI, a higher urinary K 
excretion, a higher urinary Na: K and lower urinary iodine concentrations. However, BP 
and hypertension status did not differ between the groups (Table 5.2).  
Table 5. 2 Nested cohort by salt excretion levels, low, medium and high salt 
groups, WHO – SAGE Ghana Wave 3 (2019) 
Characteristics Low salt  
<5g/d 




(n = 269) 
High salt  
>9g/d  
(n = 378) 
p 
value 
Age yrs 64 (20)  60 (17) 58 (18) < 0.01 
Sex male n (%) n = 185 
73 (39.5) 
n = 269 
90 (33.5) 
n = 378 
105 (27.8) 
0.02 
Ethnicity (%) n = 184 n = 268 n = 376 0.03 
  Akan 122 
(66.3) 
168 (62.7) 203 (54.0)  
  Ga 7 (3.8) 11 (4.1) 27 (7.2)  
  Ewe 14 (7.6) 18 (6.7) 24 (6.4)  
  Mole-dagbon 5 (2.7) 6 (2.2) 13 (3.5)  
  Mole-busanga 1 (0.5) 0 (0.0) 2 (0.5)  
  Grusi 3 (1.6) 3 (1.1) 6 (1.6)  
  Guan 0 (0.0%) 11 (4.1%) 5 (1.3)  
  Gruma 1 (0.5) 3 (1.1) 2 (0.5)  
  Other 31 (16.8) 48 (17.9) 94 (25.0)  
Urban (%) n = 185 n = 269 n = 378 0.79 
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Characteristics Low salt  
<5g/d 




(n = 269) 
High salt  
>9g/d  





149 (55.4) 200 (52.9) 
 
Education (yrs) n = 118 
10 (5) 
n = 179 
10 (3) 
n = 250 
10 (5) 
0.07 
BMI, kg/m2 n = 179 
23.8 
(6.5)a 
n = 258 
25.5 (7.8) 
n = 356 
26.2 (7.5)a 
<0.01 
Salt intake g/d n = 186 
3.6 (1.5)ab 
n = 269 
6.7 (2.0)ac 
n = 371 
13.4 (8.9)bc 
< 0.01 
K intake, mmol/d n = 186 
32.0 
(25.8)ab 
n = 269 
54.9 
(43.8)ac 




Na: K n = 186 
1.7 (1.2)ab 
n = 269 
2.0 (1.4)ac 
n = 378 
2.3 (1.9)bc 
< 0.01 
Urinary iodine excretion, 
mmol/day 
n = 150 
166.2 
(168.5)b 
n = 211 
148.2 
(131.4)a 




Systolic BP, mm Hg n = 186 
129 
(31.0) 
n = 266 
126 (31.0) 




Diastolic BP, mm Hg n = 188 
76 (18.0) 
n = 270 
75.5 (17) 




Pulse pressure, mm Hg n = 186 
50.5 
(16.7) 
n = 266 
49.5 (17.6) 
n = 375 
49.5 (16) 
0.20 
Mean Arterial Pressure 
(MAP), mm Hg 




n = 266 
110 (41.0) 
n = 376 
93.5 (19.4) 
0.85 
Hypertension      
  Prevalence, n (%) 
n = 186 
94 (50.5) 
 
n = 268 
110 (41.0) 
n = 378 
166 (44.3) 
0.13 
  Hypertension      
  awareness, n (% of   
  hypertension  
  prevalence) 
n = 94 
51 (54.8) 
n = 110 
62 (55.4) 
n = 166 
108 (65.1) 
0.16 
  Hypertension   
  medication,   
n = 51 
31 (60.8) 
n = 62 
47 (75.8) 





Characteristics Low salt  
<5g/d 




(n = 269) 
High salt  
>9g/d  
(n = 378) 
p 
value 
  current use n    
  (% of hypertension    
  awareness)  
  Hypertension  
  control, n (% of  
  Hypertension  
   medication) 
n = 31 
16 (51.6) 
n = 47  
22 (46.8) 




Stroke, n (%) 
 
n = 185 
6 (3.2) 
 
n = 269 
6 (2.2) 
 




Diabetes, n (%) n = 185 
10 (5.4) 
 
n = 269 
24 (8.9) 
n = 378 
32 (8.5) 
0.37 
Tobacco use, n (%) n = 182 
25 (13.7) 
 
n = 269 
25 (9.3) 
n = 378 
29 (7.7) 
0.72 
Alcohol use, n (%) n = 182 
80 (44.0) 
 
n = 269 
115 (42.8) 
n = 378 
156 (41.3) 
0.82 
Fruits and Veg., met 
recommendation n (%) 
n = 186 
97 (52.2) 
 
n = 269 
152 (56.5) 
n = 378 
193 (51.1) 
0.38 
Frequently adds salt to food 
at the table, n (%) 
n = 158 
24 (13) 
 
n = 269  
35 (13) 
n = 279 
(12.4) 
0.65 
Frequently adds salt to 
cooking at home, n (%) 




n = 296 
225 (83.6) 
n = 378 
291 (77) 
0.05 
Believe that they are eating 
just the right amount of salt 
n (%) 




n = 267 
169 (63.3) 
n = 376 
228 (60.6) 
0.18 
Believe a high salt diet can 
cause a serious health 
problem, n (%) 




n = 259 
207 (79.9) 
n = 368 
296 (80.4) 
0.99 
Does something to control 
salt consumption, n (%) 
n = 183 
82 (44.8) 
n = 260 
126 (48.5) 





Data are presented as median (IQR, interquartile range) unless otherwise stated. BMI, body; 
hypertension prevalence, BP ≥ 140/90 or previous diagnosis; Current use of hypertension 
medication represents current use in the last two weeks; BMI, body mass index; tobacco use 
by self-report; alcohol use by self-report; met fruits and vegetable recommendation indicates 
consumed five or more servings of fruits and vegetables a day; salt behaviour responses, 
frequently indicates ‘always’ and ‘often’; continuous variables compared using Independent 
Kruskal-Wallis Test and categorical variables compared using Pearson Chi-Square Test and 
Fisher’s Exact Test. a, b, c; sig at p < 0.05. 
In response to the salt behaviour questions (Supplementary Table 5.4), 12.8% (n = 107) of 
participants reported that they frequently (always and often) added salt to food at the table 
with significantly greater numbers of younger (27.3%, n = 28, p = 0.02) and rural (61%, n = 
61, <0.01) dwellers responding affirmatively to this question. More than three quarters 
(80.1%, n = 671) of the surveyed population reported that they frequently added salt to food 
at home during cooking while 60.9% (n = 508) perceived themselves to consume the right 
amount of salt. While 19.9% (n = 126) did not know that a high salt diet could cause a serious 
health problem, 48.5%, (n = 394) of the participants reported actively doing something on a 
regular basis to control their salt intake. Of those who knew a high salt diet could cause a 
serious health problem, 58.9% (n = 378) did something on a regular basis to control their salt 
intake. 
Almost two-thirds (65%, n = 548) of participants did not meet the daily K recommendation 
of ≥ 90mmol [27], with those in the lowest salt intake group having the lowest urinary 
concentrations. While 42.6% (n = 141) of urban participants met the guidelines for K intake, 
this was the case for only 28.6% (n = 101) of participants residing in rural areas (p < 0.01). 
Only 7.6% (n = 63) achieved the recommended Na: K ratio of ≤ 1mmol [27].   There was a 
strong positive correlation between 24hr urinary Na and K concentrations (Spearman’s rho 
= 0.71, p < 0.01). Linear regression indicated that urinary Na excretion accounted for more 
146 
 
than half the variability in urinary K excretion (R2 = 0.51, F (1, 832) = 861, p = <0.01). Urinary 
K excretion increased by 0.71mmol/day for each mmol/day increase in urinary Na such that 
Na: K ratio was significantly higher in the high salt group compared to the low salt group 
(median 2.3 (1.9) g/day vs 1.7 (1.9) g/day, respectively, p < 0.01). 
The high Na: K group had a significantly higher BMI than those in the lowest Na: K group 
(median 28.1, IQR 8.2 vs 24.8, IQR 7.0, p = 0.01) and had higher number of participants who 
reported doing something on regular basis to control their salt intake than those in the 
lowest Na: K group (61.5%, n = 15 vs 42.7%, n = 166, p < 0.01) (Table 5.3).  
Table 5. 3 Nested cohort by urinary sodium to potassium (Na:K) ratio, low, medium 
and high  groups,  WHO – SAGE Ghana Wave 3 (2019). 
Characteristics Low Na: K (< 2) 
n = 399 
Medium 
Na: K (2 – 5) 
n = 389 
High Na: K ( >5) 
n = 41 
p value 
Age yrs 60 (18) 61 (19) 58 (22) 0.44 
Sex male n (%) n = 399 
139 (34.8) 
n = 389 
116 (29.8) 
n = 41 
12 (29.3) 
0.29 
Ethnicity (%) n = 397 n = 387 n = 41 < 0.01 
  Akan 229 (57.7) 246 (63.6) 17 (41.5)  
  Ga 5 (1.3) 29 (7.5) 10 (24.4)  
  Ewe 31 (7.8) 23 (5.9) 1 (2.4)  
  Mole-dagbon 13 (3.3) 11 (2.8) 0 (0.0)  
  Mole-busanga 2 (0.5 ) 1 (0.3) 0 (0.0)  
  Grusi 7 (3.0) 5 (1.3) 0 (0.0)  
  Guan 12 (3.0) 4 (1.0) 0 (0.0)  
  Gruma 3 (0.8) 3 (0.8) 0 (0.0)  
  Other 95 (23.9) 65 (16.8) 173 (21)  
Urban (%) n = 398 
183 (46.0) 
n = 389 
240 (61.7) 
n = 41 
26 (63.4) 
< 0.01 
Education n = 253 
10 (4) 
n = 267 
10 (5) 
n = 26 
10 (6) 
0.51 
BMI n = 387 
24.8 (7.0) 
n = 364 
25.7 (7.4) 
n = 39 
28.1 (8.2) 
0.04 
Salt intake g/d n = 398 
7.5 (7.4)ab 
n = 384 
8.6 (6.6)ac 
n = 40 
13.9 (11.9)bc 
< 0.01 
K intake, mmol/d n = 399  n =389  n = 41 < 0.01 
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Characteristics Low Na: K (< 2) 
n = 399 
Medium 
Na: K (2 – 5) 
n = 389 
High Na: K ( >5) 
n = 41 
p value 
93.4 (97.8)ab 49.5 (38.7)b 38.2 (38.4)a 
Na: K n = 399 
1.4 (0.6)ab 
n = 389 
3.0 (1.3)ac 





n = 383 
129.7 (116.0)a 
n = 370 
153.9 
(164.4) 
n = 40 
146.9 (193.9)a 
< 0.01 
Systolic BP, mm Hg n = 398 
126 (26) 
n = 385 
126 (32.0) 
n = 40 
125 (34.0) 
0.03 
Diastolic BP, mm Hg n = 398 
77 (17.0) 
n = 385 
75 (17.0) 
n = 40 
77 (18.0) 
0.25 
Pulse pressure, mm 
Hg 
n = 398  
48 (16.6) 
n = 385 
51 (17.0) 




Pressure (MAP), mm 
Hg 
n = 399 
93.7 (18.8) 
n = 387 
92.5 (21.2) 
n = 41 
91.7 (25.3) 
0.61 
Hypertension   
  Prevalence, n (%) 
n = 398 
170 (42.7) 
n = 387 
178 (46.0) 




  Hypertension  
  awareness, n (% of  
  hypertension  
  prevalence) 
n = 170 
102 (60.0) 
n = 178 
106 (59.6) 
n = 18  
11 (61.1) 
0.10 
  AHT, current use n  
  (% of hypertension  
  awareness)  
n = 102 
65 (63.7) 
n = 106 
79 (74.8) 
n = 11 
7 (63.6) 
0.22 
  Hypertension  
  control, n (% of  
  AHT) 
n = 63 
33 (52.5) 
n = 78 
40 (51.3) 
n = 7 
3 (42.9) 
0.89 
Stroke, n (%) n = 399 
11 (2.8) 
n = 389 
7 (1.8) 




Diabetes, n (%) n = 399 
34 (8.5) 
n = 389 
30 (7.7) 
n = 41 
2 (4.9) 
0.69 
Tobacco use, n (%) n = 399 
45 (11.3) 
n = 389 
34 (8.7) 
n = 41 
0 (0.0) 
0.05 
Alcohol use, n (%) n = 399 
160 (40.1) 
n = 389 
172 (44.2) 
n = 41 
19 (46.3) 
0.44 
Fruits and Veg., met 
recommendation n 
(%) 
n = 399 
212 (53.1) 
n = 389 
203 (52.2) 
n = 41 
24 (58.5) 
0.74 
Frequently add salt to 
food at the table, n (%) 
n = 399 
52 (13) 
n = 389 
48 (12.3) 
n = 41 
6 (14.6) 
0.88 
Frequently add salt to 
cooking at home,  
n (%) 
n = 399 
320 (80.0) 
n = 389 
311 (79.9) 





Characteristics Low Na: K (< 2) 
n = 399 
Medium 
Na: K (2 – 5) 
n = 389 
High Na: K ( >5) 
n = 41 
p value 
Believes that they are 
eating just the right 
amount of salt n (%) 
n = 397 
247 (62.2) 
n = 387 
231 (59.7) 
n = 41 
24 (58.5) 
0.48 
Believes a high salt 
diet can cause a 
serious health 
problem, n (%) 
n = 389 
304 (78.1) 
n = 375 
311 (82.9) 




Does something to 
control salt 
consumption, n (%) 
n = 389 
166 (42.7) 
n = 375 
209 (55.7) 
n = 39 
15 (61.5) 
<0.01 
Data are presented as median (IQR, interquartile range) unless otherwise stated. BMI, body; hypertension 
prevalence, BP ≥ 140/90 or previous diagnosis; AHT, antihypertensive medication use in the last two weeks; 
BMI, body mass index; tobacco use by self-report; alcohol use by self-report; met fruits and vegetable 
recommendation indicates consumed five or more servings of fruits and vegetables a day; salt behaviour 
responses, frequently indicates ‘always’ and ‘often’; continuous variables compared using Independent Kruskal-
Wallis Test and categorical variables compared using Pearson Chi-Square Test and Fisher’s Exact Test. a, b, c; 
sig at p < 0.05. 
 
Excluding all participants on treatment for hypertension (n = 154), a Spearman’s rank order 
correlation showed no association between Na excretion, K excretion or Na: K ratio and SBP, 
DBP or PP. We also found no significant difference between the regression slopes of SBP, 
DBP or PP with age in low (<5g/d, n = 154, medium (5-9g/d, n = 220 and high (> 9g/d, n = 
302) salt groups (Figure 2). However, there was an association between BP and the age 
regression slope according to urinary Na: K ratio. Compared with low Na: K ratio (<2) and 
medium Na: K (2-5) ratios, the high Na: K group (> 5) had a significantly steeper slope with 
age for both SBP and DBP (p = 0.01 and p < 0.01 respectively). No significant differences for 
the slopes in all three Na: K groups was found for PP (Figure 3). Among the high salt group 
(> 9g/d), univariate analysis showed a significant relationship between age, father’s 
education, diabetes, K and physical activity with SBP while sex, age and father’s education 








Figure 5.2 Slope of systolic, diastolic, pulse pressure and MAP with age in low (< 5 g/day, n = 154), medium (5–9 g/day, n = 220) and 3 




Figure 5.2 Slope of systolic, diastolic and pulse pressure with age in low (< 2 mmol/mmol, n = 334), medium (2–5 mmol/mmol, n = 308) 





In a nationally representative sample of adult Ghanaians (50y and older), we report that 
24hr urinary Na excretion equated to a median salt intake of 8.3g/day, with more than three-
quarters of participants having salt intakes more than the WHO recommendation of 
<5g/day. This is considerably higher than median salt consumption values of 6.8g - 7.2g/day 
reported by recent studies from SA [28, 29], a country that has adopted mandatory salt 
reduction policies. Our data provides much-needed information required to inform 
strategies to meet the WHO global voluntary target for NCD prevention of 30% reduction 
in mean population intake of salt, with the aim of achieving a target of less than 5 grams per 
day by 2025 [8]. The only other available information on 24hr urinary Na excretion in Ghana 
was collected over a decade ago when salt intake was estimated to be 6.0g/day [30]. Over 
this time, the Ghanaian food environment has changed dramatically [31, 32] with the 
emergence of energy dense, nutrient poor, processed convenience foods such as instant 
noodles, salty snacks (e.g. potato, corn, and tortilla chips), visible fat (e.g. butter, margarine, 
oils, dressings and gravies), ready-made baked foods (e.g.  cookies, cakes, pies and pastries), 
desserts such as puddings and cheesecake, and sweetened products (e.g. sugar, syrup, ice 
cream, candy, and carbonated and noncarbonated sweetened drinks).   Additionally, 
frequent consumption of highly salted foods, such as fish and meat, remains part of the 
traditional Ghanaian cuisine, and salt use in cooking, remains high [30, 33]. 
 It is noteworthy that more than three quarters of participants in the current study reported 
adding salt to food during cooking. Poor salt use behavior is widespread in the Ghanaian 
population; a previous study involving 12 villages in Ghana in 2006 reported that 98% of 
participants added salt to food during cooking, while about half (52%) added salt to food at 
the table [21]. In comparison to South Africans, Ghanaians reported adding salt to food 
during cooking more frequently [33], presumably because mass media public health 
campaigns to lower salt use, such as Salt Watch in SA have not yet occurred in Ghana [34]. 
Further, Ghana’s national salt iodization programme, along with accompanying major 
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public health campaigns on iodine consumption [35-38] may partially be responsible for an 
increase in discretionary salt intake. However, lack of information on sources of salt 
provided from discretionary and non-discretionary sources, as in processed foods, prevents 
further hypothesis in this regard.  
Despite the current study not including a dietary assessment component, a recent systematic 
review of dietary sources of salt in LMICs identified that bread, meat and meat products, 
bakery products, instant noodles, salted preserved foods, milk and dairy products, and 
bouillon cubes were major sources thereof [39]. In some LMICs, bread alone may contain as 
much as 1.36g salt per 100g bread [40]. For many African countries, bread has become a 
staple food, such as in some regions of Democratic Republic of Congo, where bread has 
replaced cassava [41]. The nutrition transition taking place in Sub Saharan Africa and its 
transformation of dietary patterns from a reliance on traditional staples to an increased 
intake of energy dense, nutrient poor foods (and often Na rich) foods may partly be 
responsible for the observed high salt intake reported by this study. In support of this, the 
Ghana Demographic and Health Survey 2014 reported that more than a third (36%) of 
participants consumed salted dried fish [42], while in the Ghana National Iodine Survey 
Report 2015, consumption of bouillon cubes was frequent and widespread with nearly half 
(48.8%) of the participants having consumed this item at least 6 times a week [43]. 
Awareness of excessive salt intake was low in the current study. Sixty one percent of 
participants believed that they were meeting the salt recommendation guidelines, but only 
22.3% achieved this. Estimations of dietary salt intake using dietary recall methods usually 
indicates a reduced daily intake compared to 24hr urinary collections [44-46]. The tendency 
to under-estimate salt consumption is high as many people are unaware of the 
recommendation for salt consumption, unable to determine the salt content of everyday 
foods such as bread and cereals, or that of composite meals [47-49]. In Ghana, there are no 
salt reduction strategies in place such as: mandatory or voluntary levels of salt permitted in 
processed foods; regulations for food labelling to indicate salt content in products, or front-
of-pack signposting for high salt warnings. In addition, the Ghanaian food composition 
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tables are outdated and incomplete in the case of Na [50], making it difficult to assess food 
contributors to total salt intake.  In view of this, regular monitoring and evaluation of the 
food environment and food consumption patterns are warranted. 
Potassium excretion, although low (median 63.8mmol /day, IQR 74.8, 65% did not meet 
recommended daily intake of K), was higher than that reported by other studies in the 
region [28, 29]. The K content of the food items obtained from the 2010-2011 Ghana Food 
Balance Sheet indicated that K supply per capita per day was about 9,086mg/day 
(233mmol/day), approximately 2.6-fold larger than the WHO recommended level (> 
90mmol/day) with yams, cassava and plantains constituting the bulk of K supply [51, 52]. 
However, it is well known that food balance sheets represent apparent, rather than actual, 
food consumption. 
Hypertension prevalence in the current study was high (50 +yrs, 52.6%; 18-48yrs, 14.5%), 
with less than two thirds (60%) of participants classified as hypertensives being aware of 
the condition (i.e. diagnosed), of which 69.1 % were being treated with antihypertensive 
medication, half of which had BP levels considered to be controlled (< 140/90mm Hg). 
Surprisingly, we found no association between urinary Na, K or N:K ratio with BP in 
contrasts to findings from other comparable studies [53-55] but in agreement with others 
[28, 56]. A possible reason may be the day-to-day variability in salt intake, which results in 
a high intra-individual variability in urinary Na excretion. Furthermore, salt sentivity and 
obesity have also been identified to cause variations in BP levels to dietary salt intake, 
among African populations [57-60]. Though 24hr Na excretion is the gold standard method 
for determination of population Na intake, repeated 24hr collections over periods provide 
more accurate estimating an individual’s habitual salt intake [61, 62]. However, this 
approach is typically impractical for large population studies such as the one reported here. 
Similarly, no difference was found between the slopes of SBP, DBP or PP with age according 
to three categories of salt intake, namely low (5g/day), medium (5-9g/day) and high 
(>9g/day). However, high and medium urinary Na: K had steeper slopes of BP with age as 
compared with those in the low Na: K category. A national survey (WHO-SAGE Wave 2, 
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SA) conducted in 2015 reported similar findings [28]. This association was first explored in 
the INTERSALT study, the largest multinational study on 24hr urinary excretion and BP 
with 10,079 adults across 48 centres worldwide [54]. This implies that a simultaneous 
increase in K and a decrease in Na will be beneficial in reducing BP with age and ultimately 
hypertension incidence [27, 54]. As such, strategies such as taxes on high-salt products, 
labelling and effective communication, voluntary salt commitments by food industries and 
legislations for Na reduction are warranted.  Similarly, to increase K intake, nutrition 
promotion of K rich fruits and vegetables may be needed, along with policies that make 
these foods more accessible and affordable. 
A strength of the study is the use of a large nationally representative sample of participants 
aged 50+ years, in keeping with the aim of WHO-SAGE studies.  This design on the other 
hand, may limit generalization to the entire population. Another potential limitation is the 
recruitment strategy which resulted in more women than men. Women are known to be 
more likely to volunteer to participate in surveys than men [63] and this has been observed 
in other 24hr urine collection studies [28, 29]. Akan, the largest ethnic group in Ghana is 
well distributed over the entire country [42] which is why this group was proportionally 
larger than other ethnic groups in the sample. Additionally, the cross-sectional analysis 
limits the ability to evaluate the influence of dietary Na and K intake on BP over time. The 
choice of urine volumes as a sole determinant of completeness of 24 h urine collections 
require explanation. Presently, there is no universally accepted standard for determining 
completeness of 24 h urine collections. The International Consortium for Quality Research 
on Dietary Sodium/Salt (TRUE), recommends the use of para-aminobenzoic acid (PABA) as 
being the preferred method [64] but experiences using PABA in African communities is 
limited and experiences from South Africa [65] suggest that participants may forget or 
choose not to take their PABA tablets during the urine collection period, thus rendering this 
method impractical. 
 
The TRUE consortium recognized a need to establish further additional measures of 
assessing 24 h urinary completeness beyond PABA. A systemic review found that no single 
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exclusion criteria (24 h urinary creatinine excretion, creatinine index < 0.7, total urinary 
volume, a combination of creatinine excretion and total urine volume or self-report of 
missing urine) appeared more accurate in identifying incomplete 24-h urine collections than 
any others [66]. Importantly, the authors point out that the use of a combination of methods 
such as creatinine excretion together with urinary volume may lead to the unnecessary 
exclusion of participants with complete urine samples. The reference values used as a cut-
off for inadequate urinary collection based on creatinine values has largely been based on 
those recommended by Stolarz-Skrzypek et al., namely urinary volume < 300 ml, or 
creatinine excretion < 4 mmol or > 25 mmol for women and < 6 mmol and > 30 mmol for men 
[28]. The applicability of these creatinine excretion reference values across different ethnic 
groups has recently been questioned [66]. While the TRUE authors concluded that a 
creatinine index < 0.7 may best increase the sensitivity of eliminating incomplete urine 
sampling, they go on to promote the use of similar methodologies used by the INTERSALT 
and INTERMAP studies as the preferred method to determine 24 h urinary completeness in 
population-based studies [27, 67]. These were as follows: samples that fell outside of the 
collection time of 22–26 h; participants’ indication that the collection was incomplete and 
that they had spilled ‘more than a few drops’ of urine; or if total urinary volume was 
< 250 ml. Given that creatinine is generally variable and largely dependent on muscle mass 
and protein intake [62], and the reference cut-off values in African populations have not 
been widely validated, we opted to use 24 h urinary volumes ≤300 ml as the measure for 
incomplete collections. The generally low creatinine excretion values found across the entire 
cohort suggest a possible low dietary protein intake, but a lack of dietary data precludes 
further consideration in this regard. 
5.5 Conclusions 
This nationwide study of Ghanaians, using 24hr urinary collections, reported a high intake 
of salt, accompanied by a low K intake. Increasing urinary Na: K ratio was associated with 
increasing BP with age. Given the high prevalence of hypertension in the study, our findings 
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identify a need for population-wide strategies to reduce dietary salt intake whilst, at the 
same time, increase K intake in Ghana. 
5.6 References 
1. Cardiovascular diseases (CVDs). https://www.who.int/newsroom/-
factsheets/detail/cardiovasculardiseases(cvds). Accessed 12/07/2019. 
2. WHO: Global status report on noncommunicable diseases 2010. Geneva: WHO; 2011. 
3. Erratum: A comparative risk assessment of burden of disease and injury attributable to 
67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for 
the Global Burden of Disease Study 2010. The Lancet 2013; 381(9874):1276. 
4. Kearney PM, Whelton M, Reynolds K, et al.: Global burden of hypertension: Analysis 
of worldwide data. Lancet 2005; 365(9455):217-223. 
5. Hypertension. https://www.who.int/newsroom/factsheets/detail/-hypertension. 
Accessed 07/082019. 
6. Centre for Health Information Management: Outpatient morbidity in health facilities, 
Ghana. Accra: Ghana Health Service; 2008. 
7. Sanuade OA, Awuah RB, Kushitor M. Hypertension awareness, treatment and control 
in Ghana: a cross-sectional study. Ethnicity and Health 2018; 1-15. 
8. WHO: About 9 voluntary global targets. Global Monitoring Framework for NCDs. 
https://www.who.int/nmh/ncd-tools/definition-targets/en/. Accesed 22 Feb 2020. 
9. WHO and World Economic Forum: From Burden to "Best Buys": Reducing the 
Economic Impact of Non-Communicable Diseases in Low- and Middle-Income 
Countries. Geneva: World Economic Forum; 2011. 
10. Salt Reduction. https://www.who.int/newsroom/factsheets/detail/-saltreduction. 
Accessed 06/08 2019. 
11. Institute of Medicine (US). Panel on Dietary Reference Intakes for Electrolytes and 
Water. DRI, dietary reference intakes for water, potassium, sodium, chloride, and 
sulfate. Washington, DC: National Academies Press; 2005. 
12. He FJ. How far should salt intake be reduced? Hypertension 2003; 42(6):1093-1099. 
157 
 
13. He FJ, Li J, Macgregor GA. Effect of longer-term modest salt reduction on blood 
pressure. Cochrane Database of Systematic Reviews 2013, (4) DOI: 
10.1002/14651858.CD004937.pub2. 
14. Strazzullo P, D'Elia L, Kandala NB, Cappuccio FP. Salt intake, stroke, and 
cardiovascular disease: Meta-analysis of prospective studies. BMJ (Online) 2009; 
339(7733):1296. 
15. Graudal NA, Hubeck-Graudal T, Jurgens G. Effects of low sodium diet versus high 
sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and 
triglyceride. Cochrane Database of Systematic Reviews 2017; 2017(4). 
16. Dickinson HO, Mason JM, Nicolson DJ, et al. Lifestyle interventions to reduce raised 
blood pressure: A systematic review of randomized controlled trials. Journal of 
Hypertension 2006; 24(2):215-223. 
17. Dietary Guidelines Advisory Committee. Adults and sodium: what is the relationship 
between sodium and blood pressure in adults aged 19 years and older? Washington, 
D.C., Department of Health and Human Services and Department of Agriculture; 2010. 
18. Cobb LK, Anderson CAM, Elliott P, et al..: Methodological issues in cohort studies that 
relate sodium intake to cardiovascular disease outcomes: A science advisory from the 
american heart association. Circulation 2014; 129(10):1173-1186. 
19. WHO: 'SHAKE' the salt habit. Geneva: WHO; 2016. 
20. Sookram C, Phori PM, Varenne et al.: WHO’s supported interventions on salt intake 
reduction in the sub-Saharan Africa region. Cardiovasc Diagn Ther 2015; 5(3):186-190. 
21. Cappuccio FP, Kerry SM, Micah FB, et al.: A community programme to reduce salt 
intake and blood pressure in Ghana [ISRCTN88789643]. BMC Public Health 2006; 6. 
22. Chockalingam A, Balaguer-Vintro I, Achutti A, et al.: The world heart federation's white 
book: Impending global pandemic of cardiovascular diseases: Challenges and 
opportunities for the prevention and control of cardiovascular diseases in developing 




23. Stolarz-Skrzypek K, Kuznetsova T, Thijs L, et al.: Fatal and nonfatal outcomes, 
incidence of hypertension, and blood pressure changes in relation to urinary sodium 
excretion. Journal of the American Medical Association 2011; 305(17):1777-1785. 
24. Elliott P. Sodium intakes around the world. Background document prepared for the 
Forum and Technical meeting on Reducing Salt Intake in Populations (Paris 5-7th 
October 2006). Geneva: WHO.; 2007. 
25. RibeiroI KCB, Nolasco EL, VanelliI CP, et al.: Urine storage under refrigeration 
preserves the sample in chemical, cellularity and bacteriuria analysis of ACS. J Bras 
Patol Med Lab 2013; 49(6). 
26. Selvarag S, Elbez Y, Sorbets E, et al.: Pulse pressure and risk for cardiovascular events 
in patients with atherothrombosis: From the REACH Registry. J Am Coll Cardiol 2016; 
67(4):392-403. 
27. Guideline: Potassium intake for adults and children. 2012. 
http://apps.who.int/iris/bitstream/10665/77986/1/9789241504829_eng.pdf?ua=1&ua=1 
Accessed 21 Aug 2019.  
28.  Ware LJ, Charlton K, Schutte AE, et al.: Associations between dietary salt, potassium 
and blood pressure in South African adults: WHO SAGE Wave 2 Salt & Tobacco. 
Nutrition, Metabolism, And Cardiovascular Diseases 2017; 27(9):784-791. 
29. Swanepoel B, Schutte AE, Cockeran M, et al.: Sodium and potassium intake in South 
Africa: an evaluation of 24-hour urine collections in a white, black, and Indian 
population. Journal of the American Society of Hypertension 2016; 10(11):829-837. 
30. Kerry SM, Emmett L, Micah FB, et al. Rural and semi-urban differences in salt intake, 
and its dietary sources, in Ashanti, West Africa. Ethnicity and Disease 2005; 15(1):33-39. 
31.   Monteiro CA, Moubarac JC, Cannon G, et al.: Ultra-processed products are becoming 
dominant in the global food system. Obesity Reviews 2013, 14(S2):21-28. 
32. Andam KS, Tschirley D, Asante SB, et al.: The transformation of urban food systems in 
Ghana: Findings from inventories of processed products. Outlook on Agriculture 2018. 
159 
 
33.    Menyanu E, Charlton KE, Ware LJ, et al.: Salt use behaviours of ghanaians and south 
africans: A comparative study of knowledge, attitudes and practices. Nutrients 2017, 
9(9). 
34. Wentzel-Viljoen E, Steyn K, Lombard C, et al.: Evaluation of a mass-media campaign to 
increase the awareness of the need to reduce discretionary salt use in the South African 
population. Nutrients 2017; 9(11). 
35. Ghana: Stakeholder Campaign On the Use of Iodated Salt. http://allafrica.com/-
stories/201110060238.html. Accessed 05/05/2020. 
36.  Intensify Universal Salt Iodization Campaign—Official. http://www.ghananews-
agency.org/print/36. Accessed 04/04/2020. 
37. ICCIDD: Progress of Household Consumption of Iodated Salt in Some African 
Countries. Iodine Deficiency Disorders Newsletter 2008, 31:71-78. 
38. Combatting IDD in Ghana. http://www.ign.org/newsletter/idd_nl_-may06_ghana.pdf. 
Accessed 04/04/2020. 
39.    Menyanu E, Charlton KE, Ware LJ, et al.: Salt use behaviours of ghanaians and south 
africans: A comparative study of knowledge, attitudes and practices. Nutrients 2017, 
9(9). 
40.   Nwanguma BC, Okorie CH: Salt (sodium chloride) content of retail samples of Nigerian 
white bread: Implications for the daily salt intake of normotensive and hypertensive 
adults. Journal of Human Nutrition and Dietetics 2013, 26(5):488-493 
41.  Will Cassava Remain a Staple Food in the Congo? Available online: 
http://www.fao.org/docrep/U3550t/ Accessed on 8/03/2020.  
42. Ghana Demographic and Health Survey. http://www.statsghana.gov.gh/docfiles/-
publications/2014%20GDHS%20%20Report.pdf. Accessed 10/03/2020  
43. National Iodine Survey Report 2015.https://www.ghanahealth-
service.org/downloads/Iodine_Survey_Report.pdf Accessed 28/03/2020. 
44.   Keogh JB, Lange K, Hogarth R, et al.: Foods contributing to sodium intake and urinary 




45. Villani AM, Clifton PM, Keogh JB: Sodium intake and excretion in individuals with type 
2 diabetes mellitus: A cross-sectional analysis of overweight and obese males and 
females in Australia. Journal of Human Nutrition and Dietetics 2012, 25(2):129-139. 
46. Margerison C, Riddell LJ, Wattanapenpaiboon N, et al.: Dietary sources and meal 
distribution of sodium and potassium in a sample of Australian adults. Nutrition and 
Dietetics 2013, 70(4):294-299. 
47. Charlton K, Yeatman H, Houweling F, et al.: Urinary sodium excretion, dietary sources 
of sodium intake and knowledge and practices around salt use in a group of healthy 
Australian women. Australian and New Zealand Journal of Public Health 2010, 
34(4):356-363. 
48. Sarmugam R, Worsley A, Flood V: Development and validation of a salt knowledge 
questionnaire. Public Health Nutrition 2014, 17(5):1061-1068. 
49. Consensus Action on Salt and Health Salt and Your Health-TNS Public Opinion Survey 
Summary report. http://www.actiononsalt.org.-uk/Docs/39307.pdf accessed 07/03/2020. 
50. Stadlmayr B, Charrondière UR, Burlingame B: Development of a regional food 
composition table for West Africa. Food Chemistry 2013, 140(3):443-446. 
51.  Food and Agriculture Organization. Food balance sheets: a handbook, Economic and 
Social Development Department, Food and Agriculture Organization of the United 
Nations, Rome ,Italy.; 2012. 
52. Yawson DO, Adu MO, Ason B, et al., Quansah R: Ghanaians might be at risk of excess 
dietary ntake of potassium based on food supply data. Journal of Nutrition and 
Metabolism 2018, 2018. 
53. Intersalt: An international study of electrolyte excretion and blood pressure. Results for 
24 hour urinary sodium and potassium excretion. British Medical Journal 1988, 
297(6644):319-328. 
54. Aburto NJ, Ziolkovska A, Hooper L, et al.: Effect of lower sodium intake on health: 
Systematic review and meta-analyses. BMJ (Online) 2013, 346(7903). 
161 
 
55. Stamler J, Chan Q, Daviglus ML, et al.: Relation of dietary sodium (Salt) to blood 
pressure and its possible modulation by other dietary factors the intermap study. 
Hypertension 2018, 71(4):631-637. 
56. Charlton KE, Steyn K, Levitt NS, et al.: Diet and blood pressure in South Africa: Intake 
of foods containing sodium, potassium, calcium, and magnesium in three ethnic 
groups. Nutrition 2005, 21(1):39-50. 
57. Olde Engberink RHG, Van Den Hoek TC, Van Noordenne ND, et al.: Use of a single 
baseline versus multiyear 24-ho ur urine collection for estimation of long-term sodium 
intake and associated cardiovascular and renal risk. Circulation 2017, 136(10):917-926. 
58. Weinberger MH, Miller JZ, Luft FC, et al. Definitions and characteristics of sodium 
sensitivity and blood pressure resistance. Hypertension. 1986;8(suppl 2):II127–II134. 
59. Balafa O, Kalaitzidis RG. Salt sensitivity and hypertension. J Hum Hypertens (2020). 
https://doi.org/10.1038/s41371-020-00407-1 
60.  Kanbay M , Chen Y , Solak Y , et al. Mechanisms and consequences of salt sensitivity 
and dietary salt intake. Curr Opin Nephrol Hypertens 2011, 20:37–43. 
61.   Sougawa, Y., Miyai, N., Morioka, I. et al. The combination of obesity and high salt intake 
are associated with blood pressure elevation among healthy Japanese adolescents. J 
Hum Hypertens 2020, 34: 117–124. 
62. Lerchl K, Rakova N, Dahlmann A, et al.: Agreement between 24-hour salt ingestion and 
sodium excretion in a controlled environment. Hypertension 2015, 66(4):850-857. 
63. Markanday S, Brennan SL, Gould H, et al.: Sex-differences in reasons for non-
participation at recruitment: Geelong Osteoporosis Study. BMC Research Notes 2013, 
6(1). 
64. Campbell NRC, He FJ, Tan M, Cappuccio FP, Neal B, Woodward M, et al. The 
International Consortium for Quality Research on Dietary Sodium/Salt (TRUE) position 
statement on the use of 24-hour, spot, and short duration (&lt;24 hours) timed urine 
collections to assess dietary sodium intake. J Clin Hypertens. 2019;21(6):700–9. 
162 
 
65. Charlton KE, Steyn K, Levitt NS, Peer N, Jonathan D, Gogela T, et al. A food-based 
dietary strategy lowers blood pressure in a low socio-economic setting: a randomised 
study in South Africa. Public Health Nutr. 2008;11(12):1397–406. 
66. John KA, Cogswell ME, Campbell NR, Nowson CA, Legetic B, Hennis AJM, et al. 
Accuracy and usefulness of select methods for assessing complete collection of 24-hour 
urine: a systematic review. J Clin Hypertens. 2016;18(5):456–67. 
67. Stamler J, Elliott P, Dennis B, Dyer AR, Kesteloot H, Liu K, et al. INTERMAP: 






Determinants of change in blood pressure in Ghana: WHO-
SAGE Ghana Waves 1 – 3 
 
This chapter highlights the change in BP, hypertension awareness, treatment and control 
over a period of 11-12y among the same participants. It also identifies the predictors of 
change in DBP and hypertension awareness. 
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The prevalence of hypertension is increasing in low- and middle-income countries (LMICs), 
however statistics are generally derived from cross sectional surveys that utilize different 
methodologies and population samples. We investigated BP changes over 11-12years in a 
nationally representative cohort of adults aged 50 years and older (n = 820) included in the 
World Health Organization’s Study on global AGEing and adult health (WHO-SAGE 
Ghana) Wave 1 (2007/8) with follow up in Wave 3 (2019). Participants’ BP were measured 
in triplicate and a survey completed at both time points. Survey instruments collected 
information on sociodemographic characteristics, lifestyle, health behaviors and chronic 
conditions. While no significant difference was found in systolic BP between Waves 1 and 
3, diastolic BP decreased by 9.7mm Hg (mean = 88.6, 15.4 to 78.9, 13.6 respectively) and pulse 
pressure (PP) increased by 9.5mm Hg (44.8, 13.7 to 54.3, 14.1). Awareness of hypertension 
increased by 37%, from (20% to 57%), but no differences were found for the proportion of 
hypertensives receiving treatment nor those that had controlled BP. Mixed effects modelling 
showed a decrease in DBP was associated with increasing age, living in rural areas and 
having health insurance. Factors associated with an increased awareness of hypertension 
were residing in urban areas, having health insurance and increasing body mass index 
(BMI). While diagnosis of hypertension has improved over time in Ghana, there is an 
ongoing need to improve its treatment in older adults.  
Keywords 








An urgent need to reduce population level BP is recognized globally by health agencies and 
governments to minimize the associated outcomes of stroke, myocardial infarction, cardiac 
failure, dementia, renal failure, blindness and premature death [1-9]. A 25% relative 
reduction in the prevalence of raised BP by 2025 is one of the voluntary global targets of the 
World Health Organization (WHO) for prevention of NCDs, and resources have been 
developed to assist countries to achieve this target [9, 10]. However, progress towards this 
target has been slow, with hypertension remaining a major health challenge in many 
countries [9, 11-14].  
Worldwide, population level BP has been declining particularly for high and middle-
income regions while it has remained stable or has increased among low-income countries. 
In an extensive analysis of 1479 national, subnational and community studies conducted 
between 1975 and 2015 in 19·1 million participants, significant reductions in mean SBP and 
DBP over time were demonstrated (15). In a worldwide study, SBP decreased by 0.8mm Hg 
and 1 mm Hg per decade for males and females, respectively, between 1980 and 2008 with 
substantial reductions reported in Australia, Western Europe and North America [16].  
However, increased SBP has been recorded in the Oceania, east Africa, and south and 
southeast Asia for both sexes, and in West Africa for women, ranging from an increase of 
0·8-1·6 mm Hg in men and 1·0-2·7 mm Hg in women per decade [16]. Furthermore, studies 
examining BP across the life-course indicate that, while SBP typically increases continuously 
until age 70 or 80years, DBP typically rises less steeply than SBP and remains constant or 
even declines after the fifth to sixth decade of life [17-21]. Consequently, an increased pulse 
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pressure (PP) poses a major cardiovascular risk [19, 22-24]. However, it remains unclear how 
changes with age in older adults in regions such as Sub-Saharan Africa (SSA) where 
population level BP is not declining. With high hypertension rates and low levels of 
awareness, treatment and control in the African region [25-29], understanding changes over 
time in older adults is essential in order to reduce associated morbidity and mortality. 
To better understand the trajectory of hypertension and predictors of change in BP over 
time, we aimed to identify changes in population level BP in a nationally representative 
longitudinal cohort of Ghanaians over an 11-12year period. 
6.2 Methods 
Details of the methodology has been described in chapter two. For the purpose of this 
analysis, data from participants included in WHO-SAGE W1 (2007/2008) were compared 
with those followed up in a preliminary analysis of data from W3 (2019). We followed up 
820 participants with valid BP and self-reported hypertension status data from W1 to W3. 
The flow diagram (Fig. 1) demonstrates the selection procedure. We compared the 820 
subjects (50+ y olds) included in this work with both the 3,904 (=4,724-820, aged 18+) 
participants excluded (i.e. not followed-up and not valid BP data) and the 79 (=899-820, aged 
50+) subjects followed-up but with no valid BP data. Supplementary tables 2 and 3 
(Appendix E) show the distribution of selected socio-demographic and health variables; all 
the frequencies were not weighted. The main study outcome for this analysis was BP. 















Fig. 6.1 Flow Diagram 
Data were analyzed using Stata Statistical Software: Release 16 (Stata Corp LLC, 2019; 
College Station, USA). Due to non-responses for some survey items, the number of 
responses (n) for each variable are included in the tables. The WHO-SAGE Ghana 
participants are allocated a unique 10-digit identifier code that facilitates linking of 
participant’s information over the two waves of the study. Categorical variables were 
compared using Chi square test while the Wilcoxon Signed Ranked Test was used to 
compare continuous variables in the cohort over time. Change in BP was calculated by 
subtracting the BP measurement obtained in WHO-SAGE W1 from that in WHO-SAGE W3. 
Nonparametric kernel-density plots were constructed with the kdensity command and the 
default Epanechnikov kernel function utilized. A kernel density plot is a smoothed 
representation of a histogram with the area under the curve representing the proportion of 
values compared to all values and sums to 1. Kernel density shows the probability density 
Aged 50+ 
n = 4,724 
Aged 50+ 
n = 3,067 
Follow-up subjects (Both w1 and w3) n = 
899 
Valid BP measurements 
and valid SR-hypertension 
n = 820 
Wave 1 
n = 5,573 
Wave 3 
n = 4,449 
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estimates of the distribution. Mixed model effects regression modelling was used to assess 
potential predictors of the longitudinal changes in SBP and DBP between W1 and W3. This 
statistical method for repeated measurements accounts for correlations among 
measurements within an individual and variations across participants [30, 31]. Logistic 
regression was used to access factors associated with change in hypertension awareness. 
6.3.1 Results 
Out of the total W1 sample (n = 5,573), 899 participants were aged 50y+ and were followed-
up in W3. Of these, 820 respondents had complete data on BP and self-reported 
hypertension diagnosis.  
Table 6. 1 Characteristics of participants in WHO-SAGE, Ghana W1 and W3 (n = 820) 
Characteristic Wave 1 Wave 3 P 
 
Age in years 









School attendance    
Ever schooled, n (%)  n = 817 
419 (51.3) 
n = 820 
477 (58.2) 
< 0.001 
Years educated for those who have 
‘ever schooled’ 
 
n = 390 
10 (4) 




Marital status: married/ cohabiting, 
n (%) 
n = 820 
489 (59.9) 




Waist to height ratio (WtHR) n = 815 
0.51 (0.1) 




BMI n = 815 
22.2 (5.9) 




Current alcohol use (%)  
   Never 
   Current use 
   Yes, but not current 
 
 














Overall Physical Activity, n  
  (%) 
 
n = 812 
701 (86.3) 
 









































All data are presented as median (Interquartile range, IQR) unless otherwise indicated. Whereas walking/cycling 
refers to such activities completed in a typical week, overall physical activity represents all activities including 
vigorous, moderate, walking/cycling, vigorous fitness and moderate fitness completed in a typical week. 
Hypertension prevalence refers to BP ≥140/90 or self-reported treatment while hypertension awareness refers 
self-reported diagnosis. Hypertension treatment denotes blood pressure medication use (within the last 2 weeks) 
prior to the survey and hypertension control represents medication use with a measured BP less than 140/90 mm 
Hg. Continuous variables were compared using Wilcoxon signed-rank test; categorical variables were compared 
using the Chi-Square test. 
 
Out of the W1 sample (n = 5,110), 820 participants aged 50yrs+, had complete BP data at both 
W1 (median age, 59years) and W3 (median age, 71years) and were included in the analysis. 
The sample comprising 433 (52.8%) men and 387 women (47.2%), with 364 (44.4%) and 456 
(56.6%) living in urban and rural areas, respectively. We further examined 
sociodemographic and cardiovascular related risk factors and found several changes. There 
Diabetes, n (%)  n = 820 
17 (2.1) 




Depression, n (%) n = 820 
13 (1.6) 




Health Insurance, Yes n (%) n = 820 n = 820 < 0.001 
   307 (37.4) 706 (86.1)  
      
   2   
      
 
SBP, mm Hg 
 
n = 820 
131.0 (30.0) 
 





DBP, mm Hg n = 820 
88.6 (20.5) 




PP, mm Hg n = 820 
43.0 (16) 
n = 820 
52.5 (17) 
< 0.001 
Hypertension, n (%) n = 820 n = 820 < 0.001 
   Prevalence  
 
   Hypertension awareness (% of  
   hypertension prevalence) 
 
   Hypertension treatment (% of  
   hypertension awareness) 
 
   Hypertension control (% of  































was an increase in the proportion of participants reporting ever attended school which may 
reflect participation in adult learning literacy programmes in Ghana [32]. WtHR, BMI, 
diagnosis of diabetes and having voluntary health insurance increased in the cohort while 
current alcohol intake and overall physical activity levels decreased significantly between 
W1 and W3 (Table 6.1). 
6.3.2 Blood pressure changes within the population 
There was no difference in SBP between W1 and W3, however, a significant reduction of 
9.7mm Hg W1, mean (SD) = 88.6 (15.4); W3, 78.9 (13.6) in DBP was observed over the 11-12 
year follow up period. PP significantly increased by 9.4mm Hg (95% CI, W1 = 43.9-45.8; W3 
= 53.3-55.2). Figures 6.1 and 6.2 graphically demonstrate that the distributions of SBP and 
DBP in both waves. While the curves are almost overlapping for SBP, the W3 distribution 
for DBP is clearly shifted to the left compared to W1. 
 





Figure 6. 3 Non-parametric kernel-density estimates for the distribution of DBP (W1, W3 n = 820) 
Hypertension prevalence decreased significantly by 3.2% over the period (W1, 52.0%, CI = 
0.48-0.55; W3, 48.8%, CI = 0.45-0.52). Hypertension awareness increased by 37.0% (p < 0.01) 
over time with no differences observed for hypertension treatment nor the proportion of 
treated hypertensive participants that had controlled BP (Table 6.1). Fig 6.3 illustrates the 
distribution of hypertension prevalence, awareness, treatment and control in both waves by 
sex and age. There were significantly more women than men with hypertension in both 
waves. Hypertension prevalence was highest among the 50-59year group in W1 (51.9%), 








Figure 6. 4 Top left; hypertension prevalence (W1 n = 426, W3 n = 400), top right; hypertension 
awareness (W1 n = 95, W3 n = 245), bottom left; hypertension treatment (W1 n = 66, W3 n = 187), 
and bottom right; hypertension control (W1 n = 18, W3 n = 99).
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6.3.3 Predictors of decrease in DBP and increase in awareness of hypertension 
A mixed regression model that included change in DBP as the dependent variable found 
that the observed DBP decrease from W1 to W3 was associated with increasing age, living 
in rural areas, physical activity and having health insurance (Table 6.2).  Predictors of 
change in prevalence of hypertension were increasing BMI and residing in rural areas 
(Supplementary Table 6.1). Female gender, ageing residing in rural areas, increasing BMI 
and having health insurance and diabetes predicted an increase in hypertension awareness 






















Table 6. 2 Multivariate analysis showing thepredictors of decrease in DBP (WHO-SAGE 
Ghana Waves 1 and 3), n = 794 
 
Table 6. 2 Multivariate analysis showing the predictors of decrease in DBP (WHO-SAGE Ghana 
Waves 1 and 3), n = 794 
               DBP mm Hg 
Characteristics Estimate p-value 95% CI  
Sex    
  Male  Ref    
  Female  
 
-0.0.02 0.990 -3.415 – 3.19 
Age -0.19 < 0.001 -0.30 - (-0.07) 
Location    
  Urban  Ref    
  Rural -3.98 < 0.002 -5.97 - (-1.10) 
Marital Status    
  Married Ref    
  Not married -2.36 0.933 -2.68 - 2.92 
 
Own education (yrs)  -0.30 0.04 -0.58 - (-0.01) 
Mothers education    
  Less than secondary  
  school completed 
Ref    
  Secondary and above  
  Completed 
-8.06 0.059 -16.41 - 0.29 
Fathers Education    
  Less than secondary  
  school completed 
Ref    
Secondary sch. and 
above completed 
-1.20 0.477 -24.11 - 4.52 
Health Insurance    
  No Ref    
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               DBP mm Hg 
Characteristics Estimate p-value 95% CI  
   Yes -2.60 0.037 -5.03 - 40.16 
      
     
BMI 0.03 0.359 -0.03 - 0.094 
Ever used alcohol    
  No  Ref    
  Yes  0.81 0.34 -0.34 - 2.49 
Diabetes    
  No Ref    
  Yes  0.31 0.878 -3.63 - 4.24 
Ever used tobacco    
  No  Ref    
  Yes  0.88 0.548 -1.99 - 3.76 
Overall physical activity -2.65 0.030 -5.03 -0.25 
Note: Ref represents reference category used for the comparison. Voluntary refers to 
contributors to health insurance who were not captured by the insurance scheme as public 
or civil service workers, while mandatory refers to contributors who were employees within 
the public, civil and private sectors. Overall physical activity represents all activities 
including vigorous, moderate, walking/cycling, vigorous fitness and moderate fitness 
completed in a typical week. Multivariate regression was adjusted for age, sex, marital status, 
years of education, mother’s education, father’s education, health insurance, diabetes and 















Table 6. 3 Odds Ratio showing the predictors of change in hypertension awareness 
(WHO-SAGE Ghana Waves 1 and 3), n = 369 
 





95 % CI 
Sex     
  Male  Ref    
  Female  1.98 
 
0.021 1.10 -3 4.450 
Age  1.05 <0.01 0.96 - 1.06 
Location    
  Urban  Ref    
  Rural 0.58 0.017 0.37 - 0.91 
Marital status    
  Married  Ref    
  Not married 0.92 0.753 0.54 - 1.56 
Years of education  0.01  0.589 0.96 - 1.10 
Mothers education    
  Less than  
  secondary/high 
school  
  completed 
Ref    
  Secondary/high 
school  
  and above completed 
3.654 0.053 0.98 - 13.54 
Fathers education    
  Less than  
  secondary/high 
school   
  completed 
Ref    
  Secondary/high 
school  
  and above completed 
0.60 
 
0.644 0.63 - 4.32 
Health Insurance    
  No Ref   
   Yes 1.99 0.008 119. - 3.33 
      
    
   
   
BMI 1.05 0.002 1.02 - 1.09 
Diabetes    
  No Ref    
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95 % CI 
  Yes  74.29 <0.01 3.18 - 16.65 
Overall physical 
activity 
1.44 0.109 0.92 - 2.25 
Note: Ref represents reference category used for the comparison. Voluntary refers to contributors 
to health insurance who were not captured by the insurance scheme as public or civil service 
workers, while mandatory refers to contributors who were employees within the public, civil and 
private sectors. Overall physical activity represents all activities including vigorous, moderate, 
walking/cycling, vigorous fitness and moderate fitness completed in a typical week. Logistic 
regression was adjusted for age, sex, marital status, years of education, mother’s education, father’s 
education, health insurance, diabetes and overall physical activity. 
 
6.4 Discussion 
The main finding from this 12 year follow of older Ghanaians is an observed reduction in 
DBP accompanied by a reduction in hypertension prevalence. While no differences were 
recorded in SBP, there was a significant decrease DBP, accompanied by an increase in PP. 
DBP decreased for every age decile, with those aged 60-69years at baseline having the 
greatest reduction over the period. A rise in hypertension awareness over the time was 
expected since older people are generally higher users of health services. Over the past 
decade, there has been an increased focus on hypertension screening activities [33] as well 
as heightened efforts from the health care system in Ghana to implement strategies to 
address NCDS [34-36]. It was not surprising that hypertension was higher among women 
than men due to the age of the cohort (50y+). 
A lack of change in SBP between the two time periods is in contrast with many other studies 
that have reported a rise (18, 20, 21).  This may however be explained by the age of the cohort 
in W3 (median, 71years), and life expectancy in Ghana (64years) [37]. Due to the median age 
of the cohort, survival bias could not be ruled out, however further investigation in this 
regard could not be conducted due to lack of access to information on cause and time of 
death. The observed decline in DBP with advancing age in this older cohort agrees with 
findings from other studies. A review on the epidemiology of hypertension indicated that 
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in most populations, DBP remained stable or reduced after age 50-60yrs [21]. Similarly, data 
from the Framingham Heart Study, which followed participants for three decades, showed 
that DBP varied with ageing, increasing until the fifth decade and gradually declining from 
age 60yrs onwards [20]. These age-related phenomena are explained by physiological 
changes in arterial structure and function. Aging is associated with an increased thickness 
of the arterial wall, nearly 3-fold between the ages of 20y and 90y, even in the absence of 
atherosclerotic plaques [38, 39]. An increase in the thickness of the arterial wall is 
accompanied by an increase in arterial stiffness [40] which in turn induces a decline in DBP 
[41,42-44]. The mechanism behind this decline is unclear, however, structural and molecular 
changes in the arteries (i.e. decreased elastin content, increased collagen I deposition and 
calcification) have been implicated [41-44]. Due to the fall in DBP and without any change 
in SBP in the current study, a reduction in hypertension prevalence was observed. However, 
this reduction should not be misconstrued to indicate a reduction in cardiovascular risk 
among the cohort. A longitudinal study that evaluated the risk of cardiovascular mortality 
emphasized that participants whose DBP decreased with unchanged SBP had a higher 
cardiovascular mortality compared to those whose SBP and DBP remained constant over 
time [45]. Similarly, Witteman et al. reported that, among females, a decline in DBP during 
a nine-year follow-up was associated with an enhancement of atherosclerotic lesions of the 
aorta, suggesting that a decline in DBP was a marker for atherosclerosis progression [46], 
reflecting prevailing compromise of the coronary circulation [42]. Hypertension is a known 
risk factor for atherosclerosis [47, 48]. Additionally, PP increased significantly due to the 
declining DBP in the current study, a situation that has the tendency to cause extensive 
damage to essential organs such as the brain and kidneys [41]. A large PP is associated with 
a greater risk for myocardial infarction, increased coronary disease and stroke even after 
effective BP control [23, 42, 49]. PP remains the most powerful independent predictor of 
cardiovascular risk in the elderly [18, 50]. 
The observed rise in hypertension awareness may reflect the older age of the participants 
who have experienced more engagement with health services over time, including routine 
measurement of BP at clinic visits. Other studies that included largely older participants 
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from Ghana, China, India and Mexico reported relatively higher hypertension awareness 
figures [25], compared to whole-of-population studies [51]. Despite the influence of 
advancing age, increasing hypertension awareness in the Ghanaian population could also 
be attributed to several health interventions and programmes that have been implemented 
by the Ghana Health Service (GHS) over the past 15-20 years. The government’s broader 
development plan was focused on Ghana achieving middle income country status by the 
year 2015, through various policies, such as the Ghana Poverty Reduction Strategies (2003–
2005; 2006–2009); as well as those driven by the United Nations’ Millennium Development 
Goals, including the Ghana Shared Growth and Development Agenda, 2010–2013 [, 52-54].]. 
Concurrent policies with varied mandates were also operationalized such as provision of 
community-based health planning and services (CHPs), which provided health information 
services preventive and curative care for chronic health conditions [55] and increased access 
to primary health care for particularly hard-to-reach communities [56]. In addition, the roll 
out of the national health insurance scheme in 2003 provided a major boost for services 
offered by CHPs and increased access to healthcare services in general, as clients were no 
longer required to provide out of pocket payments for some rendered healthcare services 
[34]. It is noteworthy that the current study reports of a dramatic increase in voluntary 
health insurance between W1 and W3. 
Along with CHPs, the Ministry of Health, in 2005, introduced the regenerative health and 
nutrition programme (RHNP) as part of its effort to curb the rising trend of NCDs [57] while 
in 2014, the ministry collaborated with Novartis Foundation to launch the community-based 
hypertension improvement program (ComHIP), which to date, conducts community-based 
BP screening and BP monitoring in many parts of the country [33]. 
The finding that more women were hypertensive than men was expected due to the 
biological changes that take place in women after menopause. Estrogen has been cited to 
cause endothelial vasodilation, inhibit sympathetic and renin-angiotensin system (RAS) 
activity, enhance the production of endothelin, reduce oxidative stress, increase antioxidant 
production and reduce inflammation - all of which regulate BP [58-60]. After menopause, 
estrogen levels fall causing an increase in hypertension [61-63].  
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The current study found that increasing age, residing in rural areas, increasing physical 
activity and having health insurance were associated with a reduction in DBP between W1 
and W3. The assertion that BP increases with age has been established [ 64, 65], however 
age-related BP may differ according to individual circumstances. Our finding that living in 
a rural setting was associated with a decline in DBP is consistent with other studies 
conducted in Ghana. Data from the Ghana Demographic and Health Survey 2014 which 
surveyed 13,265 participants nationwide reported lower BP levels in rural compared to 
urban areas [66]. Similarly, sub-population studies conducted in Ghana have reported lower 
BP in rural residents compared to their urban counterparts [67, 68]. However, contrasting 
findings have been reported in other recent African-based comparison studies, indicating a 
rising BP in rural settings [69-71]. The finding that increasing physical activity is associated 
with BP reduction is well known (72, 73). In terms of dose-relationship, engagement in more 
regular and frequent physical activity results in greater reductions in BP irrespective of age, 
sex or ethnicity [74, 75]. Increased awareness of hypertension was associated with ageing, 
female gender, higher BMI, diabetes and having health insurance in the current study. 
Women were about 2 times more likely than men to be aware of their hypertensive status 
in the current study. This may be expected as women are known to generally have more 
interaction with clinics and hospitals through maternal and child health programmes and 
are known to place more importance on healthcare than men [76]. Furthermore, the 
sociocultural context (where men who sought healthcare were seen as feminine, vulnerable 
or weak) [77, 78] may be a disincentive for health-seeking behaviours in men. Increasing 
BMI predicted hypertension awareness. This association can be attributed to the higher 
incidence of hypertension among obese individuals compared to those with ‘healthy 
weight’ [79, 80]. Increasing body weight is a growing concern in Ghana [ 81] and a major 
modifiable cardiovascular risk factor [27]. Those having diabetes were about 7 times more 
likely to be aware of their hypertensive status than non-diabetics in the current study. 
Similarly, odds of hypertension awareness among diabetics have been reported (27, 82). 
Hypertension is a known risk factor for diabetes (90) and the two conditions mostly coexist 
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(83). As such, Ghana has introduced clinics in open food markets specifically for diabetes 
(84) and which simultaneously offers opportunity for BP monitoring. 
It was not surprising that having health insurance was associated with a decrease in DBP 
and an increase in hypertension awareness in the current study. The National Health 
Insurance Scheme (NHIS) which provides universal access to health care, has over the years 
improved in its efficiency and increased the range of healthcare services it covers, 
particularly among those of the lowest socioeconomic status and those most vulnerable 
groups in the population [85]. The number of outpatient visits increased sharply and health-
seeking behaviour was enhanced as a result of the NHIS roll out [86, 87]. As of 2014, the 
NHIS had 40% coverage of Ghana’s population, an increment of 6.3% from 2010 [88, 89]. 
The NHIS’s widened access to most healthcare facilities in Ghana may have been an 
enabling factor in increase in hypertension awareness.  
A major strength of the current study was the prospective design that allowed follow up of 
the same participants in two large nationally representative studies of persons aged 50 years 
and older using the same study design and methodology. Validity of data was achieved 
using extensively trained teams of interviewers that used standard protocol and 
instruments and inherent quality control measures. Limitations were the high rate of loss to 
follow up and the inability to generalize the findings over the entire population because of 
the higher age of the cohort.  
6.5 Conclusions 
Despite a reduction in DBP recorded between WHO-SAGE Ghana W1 and W3 (2007-2019), 
hypertension prevalence in W3 remained high. An increase in awareness of hypertension 
over this time period suggests improved health services for BP monitoring, but this was not 
accompanied by an increase in the proportion of hypertensive participants who were 
receiving treatment for the condition, nor improved BP control. Factors associated with a 
reduction in DBP included increasing age, residing in a rural area and having health 
insurance, while predictors of hypertension awareness included higher BMI and having 
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voluntary health insurance. This data suggests that existing health programmes should be 
intensified to improve the management of hypertension in Ghana. 
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Salt reduction strategies may compromise salt iodisation 
programmes: Learnings from South Africa and Ghana 
 
This chapter discusses salt reduction in relation to its impact on iodine intake. The chapter 
emphasizes the importance of population salt reduction but, at the same evaluates its effect 
on dietary iodine in Ghana and SA - these countries have adopted and effectively 
implemented the universal salt iodization (USI) programme. With SA having successfully 
implemented a salt reduction legislation, and Ghana without, the chapter compares iodine 
intakes across salt categories in Ghana and SA. 
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Universal salt iodization (USI) has been adopted by many countries to address iodine 
deficiency. More recently, salt reduction strategies have been widely implemented to meet 
global salt intake targets of <5g salt/day. Compatibility of the two policies has yet to be 
demonstrated. This study compares urinary iodine excretion (UIE) according to 24hr 
urinary Na excretion, between SA and Ghana, both with implemented USI, but Ghana 
without salt reduction legislation. Participants from World Health Organization’s (WHO) 
Study on global AGEing and adult health Wave 3 (2019), with survey and valid 24-hour 
urinary data (Ghana, n = 495; SA, n = 707) comprised the sample. Median 24-hour UIE was 
compared across salt intake categories <5, 5–9 and >9g/day. In Ghana, median Na excretion 
indicated a salt intake of 10.7g/day (IQR 7.6), while median UIE was 182.4 µg/l (IQR 162.5). 
In SA, salt and iodine values were lower (median salt 5.6g/day (IQR 5.0); median UIE 100.2 
µg/l (IQR 129.6)). UIE differed significantly across salt intake categories (p<0.001) in both 
countries but in opposite directions. In Ghana, a weak correlation (r = 0.1501, p < 0.0011) was 
observed, compared to a moderate, positive association in SA (r = 0.4050, p < 0.0001). 
Participants with salt intakes <5g/day in SA did not meet WHO’s recommended iodine 
intake of 150µg/day, but this was not the case in Ghana. Monitoring and surveillance of 
iodine status is recommended in countries that have introduced salt reduction strategies in 
order to prevent re-emergence of iodine deficiency. 
Key words: iodized salt, salt intake, legislation, sodium, Ghana, South Africa 
7.1 Introduction 
Iodine deficiency disorders remain a major global health issue affecting nearly 2 billion 
people worldwide, placing them at risk of irreversible brain damage and cognitive 
impairment. Iodine deficiency causes thyroid dysfunction and is implicated in psychomotor 
and developmental problems in its mild forms, and cretinism in its most severe form [1]. 
Populations residing in areas affected by severe ID may exhibit learning difficulties, 
particularly in children born to women who were iodine deficient whilst pregnant [2].  
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The World Health Organization (WHO) in 1991, attempted to address ID as a public health 
concern by recommending universal salt iodization (USI). As such, many countries have 
made excellent progress towards achieving the targets of IDD elimination [3].  
Ghana launched its USI in 1995 in response to a nationwide survey conducted in 1994, which 
reported that IDD was endemic in almost half of the 110 districts of the country [4]. 
Following the adoption of USI, household access to iodized salt fluctuated in the 20years 
that followed [4-6]. Recent studies among Ghanaian school aged children (6-12yrs) and 
pregnant women have reported a median urinary iodine concentration (UIC) of 202μg/L 
and 155μg/L respectively, indicating adequate iodine intake [7, 8].  
Similarly, in SA, low access to iodized salt by much of the population [9] led to 
implementation of a mandatory salt iodisation programme in 1995 [10].  Following an 
intensive mass education and health promotion programme related to iodine intake, 
improved coverage and usage of iodized salt was recorded in the 2005 national survey with 
a 15% increase in number of households using iodized salt and a median UIC of 215 µg/L 
and 177 µg/L for school children and adult women, respectively. However, since that time, 
no further national surveys have been conducted to assess iodine status in SA [11]. South 
Africa’s mandatory salt legislation introduced in 2016, in response to WHO’s voluntary 
target of < 5g salt per day, may have implications for the adequacy of iodine intake because 
of reductions in iodized salt used in processed foods and changes in salt use behaviours [12-
14], but this is yet to be investigated.  
Given that both Ghana and SA have national salt iodization programmes, but only SA has 
implemented mandatory salt legislation, a comparison of salt and iodine intake between 
these two countries provides an opportunity to investigate the impact of the salt legislation 
on iodine intakes in South Africans, using Ghana as a comparator country. It will provide 
an updated evaluation of the effectiveness of the salt iodization programmes in both 
countries. The aim of is study was to compare urinary iodine excretion across urinary Na 




Details of the methodology have been described in chapter two. Specific to this chapter, a 
total of 6,973 participants were recruited for the main WHO-SAGE cohort (Ghana; n = 4,449, 
SA; n = 2,2524) out of which 5,756 that had valid data (Ghana, n = 3,548; SA, n = 2,208) were 
selected using the criteria of urine volume ≥300ml/day and creatinine concentration of 
≥3mmol/day [15] and if corresponding survey data were available. Figure 7.1 provides 
details of the main sample and the nested sub study for both countries. 
Sodium (mmol/l) in the 24 h urine sample was converted to salt intake (g/day) and 
categorised according to ow (<5 g/day), medium (5-9 g/day) or high (>9 g/day) salt intakes, 
and iodine metrics investigated between these categories. To convert urinary excretion 
values to estimated daily iodine intake (μg/day), urinary iodine excretion (UIE; μg/24h) was 
divided by 0.92, based on the assumption that approximately 92% of dietary iodine is 



































Ghana main cohort 
N=4449 respondents 
interviewed 
Ghana nested cohort 
N= 1121 24hr urine 
samples collected 
N=957 common subjects 
(main+nested) 
N=586 with valid urine 
measurement (cut-off: 




 164 urine data only 
 477 no age recorded 
 439 invalid urine 
N = 3053 main cohort 
N = 495 main + nested cohort 




SA nested cohort 
N= 1189 24hr 
urine samples 
collected 
N=876 common subjects 
(main+nested) 
N=887 with valid urine 
measurement (cut-off: 




 313 urine data only 
 148 no age recorded 
 169 invalid urine 
N = 1501 main cohort 
N = 707 main + nested cohort 
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Estimated iodine intake values and UIE analyses were compared across three categories of 
24-hour urinary Na values, equivalent to salt intakes of <5g/day, 5–9g/day and >9g/day. 
Normality of data was checked by visual inspection of histograms and the Shapiro-Wilk 
test. Categorical variables were evaluated using absolute numbers (percentages), Chi square 
and Fisher’s Exact tests while the Mann Whiney U and Kruskal-Wallis tests explored 
differences between groups for non-parametric data. Spearman’s ranked order correlations 
was used to ascertain the relationship between iodine concentrations and estimated salt 
intake, body mass index (BMI) and weight.  Pearson correlation coefficient was calculated 
between log-transformed UIE and estimated salt intake. Data were analyzed using Stata 
Statistical Software: Release 16 (Stata Corp LLC, 2019; College Station, USA). 
7.3 Results 
Out of 2,310 participants who provided urine samples, 52% (n = 1202) who had both valid 
urine and survey data and were included in the sample. The sociodemographic 
characteristics of the subsample is compared with the main survey sample. Whereas the SA 
subsample had significantly older participants than in its remaining main survey, the Ghana 
subsample had a significantly higher proportion of younger participants than in its 
remaining main survey. Waist to height ratio and diabetes were significantly higher in the 
subsamples than in the main surveys in both countries. In Ghana, median UIE was 182.4 
µg/ day (IQR 162.5), equivalent to median UIC of 137.3µg/l, while median salt intake was 
10.7g/day (IQR 7.6). In the SA subsample, median UIE was much lower at 100.2 µg/day (IQR 
129.6), equivalent to median UIC of 90.2µg/l, and accompanied by a lower median salt 
intake of 5.6g/day (IQR 5.0). There were no significant differences in UIE according to sex 
or age category (50+ yrs and 18-49yrs) in both countries. In the lowest salt category of 
<5g/day, UIE indicated suboptimal iodine intake among the SA subsample (72.4µg/l, IQR 
75.6) but in Ghana, this was adequate (UIE 135.2µg/l, IQR 102.7) (Tables 1 and 2). A trend 
was observed for a decrease in UIE associated with increasing salt intake in the Ghana while 
in contrast, UIE significantly increased with increasing salt intake in the SA. (Fig 7.2). Weak 
correlations were found between UIE and salt intake in the Ghana subsample (r = 0.1501, p 
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Table 7. 1 Urinary iodine, estimated iodine intake and sodium excretion values by salt intake equivalent 





Salt 5-9 g/day 
(n=233) 
 Salt >9 g/day 
(n=161) 
P value 
Sodium (mg/day) 2171.4 (1958.9) 1270.5 (646.8) 2564.1 (716.1)  4550.7 (1570.8) 0.0001 
Salt (g/day) 5.6 (5.0) 3.3 (1.7) 6.6 (1.8)  11.7 (4.0) 0.0001 
UIC (μg/L) 90.2 (107.2) 79.3 (96.8) 95.3 (100.7) 112.5 (126.6) 0.0001  
UIC < 50 μg/L, n(%) 165 (23.7) 93 (30.3) 40 (17.4) 32 (20.0) 0.001  
24-hour UIE (µg/day) 100.2 (129.6) 72.4 (75.6) 117.3 (124.2)  170.8 (200.7) 0.0001 
Estimated iodine intake (µg/day)* 108.9 (140.8) 78.7 (82.1) 127.5 (135.0)  185.7 (218.1) 0.0001 
% with daily iodine intake below EAR 
for iodine (95 µg/day), n (%) 
302 (43.3) 186 (60.6) 79 (34.4)  37 (23.1) <0.0001 
Frequently add salt to food at table, n(%) 108 (15.3) 46 (14.7) 39 (16.7)  23 (14.3) 0.745 
Frequently add salt to food during cooking, 
n(%) 
460 (65.1) 199 (63.6) 158 (67.8)  103 (64.0) 0.559 
Believe they consume too much salt, n(%) 59 (8.6) 30 (9.9) 19 (8.4)  10 (6.3) 0.417 
Believe a high salt diet is bad for health, 
n(%) 
506 (81.6) 230 (81.9) 165 (80.5)  111 (82.8) 0.853 
Regularly control of salt intake, n(%) 
 
 
255 (42.7) 114 (42.9) 83 (42.6)  58 (42.7) 0.998 
Data are presented as median (interquartile range; IRQ) unless otherwise indicated. Continuous variables compared using independent samples 
Kruskal-Wallis test. *Daily iodine intake assumed as 24-hour UIE (µg/day)/0/92 to account for biovariability. UIC: Urinary Iodine Concentration; 
UIE: Urinary Iodine Excretion; EAR: Estimated Average Requirement.
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Table 7. 2 Urinary iodine, estimated iodine intake and sodium excretion values by salt intake equivalent 





Salt 5-9 g/day 
(n=140) 
Salt >9 g/day 
(n=307) 
P 
Sodium (mg/day) 4163.5 (2980.8) 1573.1 (435.9) 2777.4 (747.6) 5447.7 (3646.6) 0.0001 
Salt (g/day) 10.7 (7.6) 4.0 (1.1) 7.1 (1.9) 14.0 (9.3) 0.0001 
UIC (μg/L) 137.3 (136.9) 184.9 (204.6) 164.5 (131.4) 118.9 (130.3) 0.0001 
UIC < 50 μg/L, n(%) 42 (8.9) 0 3 (2.2) 39 (13.2) <0.0001 
24-hour UIE (µg/day) 182.4 (162.5) 135.2 (102.7) 172.5 (187.4) 200.6 (180.4) 0.0002 
Estimated iodine intake (µg/day)* 198.3 (176.6) 146.9 (111.6) 187.4 (155.7) 218.1 (196.1) 0.0002 
% with daily iodine intake below EAR for 
iodine (95 µg/day), n (%) 
55 (11.6) 9 (21.4) 20 (14.9) 26 (8.8) 0.025 
Frequently add salt to food at table, n(%) 58 (11.7) 4 (8.9) 13 (9.3) 41 (13.4) 0.381 
Frequently add salt to food during cooking, 
n(%) 
399 (80.6) 40 (88.9) 119 (85.0) 237 (77.2) 0.051 
Believe they consume too much salt, n(%) 48 (9.7) 7 (15.6) 8 (5.7) 33 (10.8) 0.096 
Believe a high salt diet is bad for health, n(%) 378 (78.3) 34 (77.3) 107 (79.3) 236 (78.4) 0.958 
Regularly control of salt intake, n(%) 235 (48.9) 15 (33.3) 75 (55.1) 143 (48.1) 0.038 
Data are presented as median (interquartile range;IQR) unless otherwise indicated. Continuous variables compared using independent samples 
Kruskal-Wallis test. *Daily iodine intake assumed as 24-hour UIE (µg/day)/0/92 to account for biovariability. Urinary Iodine Concentration; UIE: 






        Figure 7. 1 Correlation between urinary iodine concentration and estimated salt intake 
7.4. Discussion 
Our study found that in a sample of SA adults surveyed after introduction of a salt reduction 
policy, those with low salt intakes (<5g salt/day) had inadequate iodine intakes but however 
this was not observed in the sample of Ghanaian adults, using 24hr UIE as a biomarker of 
intake. Conversely, South Africans with high salt intakes (> 9g/day) had optimal iodine 
intakes, but Ghanaians with high salt intakes had suboptimal iodine intakes. This data 
suggests that, in Ghana, people who are consuming high amounts of salt may be using non 
iodized salt or salt that is not adequately iodized [17], whereas in SA, the strategies being 
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used for salt reduction, including the mandatory salt targets for processed food may be 
resulting in inadequate consumption. 
Table 7. 3 Spearman’s rank-ordered and partial correlations between 24-hour urinary 
iodine concentration, estimated salt intake and body size, WHO-SAGE W3, SA. 






Correlation with 24-hour urinary 
iodine concentration (µg/day)/;’ 
    
   Salt intake (g/day) r 0.4050 0.4166 0.3999 
 p <0.0001 <0.0001 <0.0001 
   BMI (Kg/m2) r 0.0210 0.1227 -0.0081 
 p 0.5944 0.0859 0.8641 
   Weight (Kg) r 0.0425 0.1684 0.0103 
 p 0.2736 0.0161 0.8263 
   Waist circumference (cm)  r 0.0460 0.0156 0.0561 
 p 0.2481 0.8304 0.2416 
   Hip circumference (cm) r -0.0319 -0.0008 -0.0439 
 p 0.4429 0.9914 0.3882 
                    Correlations between iodine and body size controlled for salt intake. 
 
Table 7. 4 Spearman’s rank-ordered and partial correlations between 24-hour urinary 
iodine concentration, estimated salt intake and body size, SAGE Ghana W3. 






Correlation with 24-hour urinary 
iodine concentration (µg/day) 
    
   Salt intake (g/day) R 0.1501 0.1494 0.1460 
 P 0.0011 0.0678 0.0102 
   BMI (Kg/m2) R 0.1051 -0.0266 0.1768 
 P 0.0254 0.7421 0.0023 
   Weight (Kg) R 0.1191 0.0136 0.1704 
 P 0.0107 0.8655 0.0030 
   Waist circumference (cm)  R 0.1595 0.1353 0.1873 
 P 0.0006 0.0922 0.0012 
   Hip circumference (cm) R 0.1466 0.0709 0.2030 
 P 0.0019 0.3790 0.0005 
           Correlations between iodine and body size controlled for salt intake 
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Data from a sub study of WHO-SAGE SA Wave 2 [14] that were collected immediately prior 
to implementation of the salt legislation in 2016; by which time some manufacturers may 
have already reformulated their products [18], supports the current finding. The impact of 
the SA salt legislation on consumption of iodine has not been thoroughly investigated to 
date [19], and with more stringent salt restrictions that came into effect in June 2019 [20], 
adverse consequences on iodine intake of the population needs to be carefully monitored. 
Fortification levels of iodine in salt may need to be revised accordingly. Based on the current 
policy that mandates iodization of table salt, the results could be interpreted that, those in 
the highest category of salt intake may have been using more table salt (iodised) thus 
contributing to higher iodine intakes but lack of dietary data limits further interpretation. It 
has previously been reported that despite manufacturers not being required by law to use 
iodized salt in processed foods (only table salt falls under the legislation), commercial use 
of iodized salt in processed food production is common. Significant amounts of iodine were 
detected in a third of foods surveyed, and these were common brands of bread, margarine 
and salty snack flavourings [21].  If food manufacturers have previously used iodized salt 
in food processing, then salt reduction legislation may inadvertently reduce population salt 
iodine [19]. 
In relation to Ghana, the finding that, participants who had high salt intakes also had low 
iodine intakes, might be explained considering salt use behaviours. Previous studies have 
reported that salt intake in Ghana is high, and that only a third of households nationwide 
had access to sufficiently iodized cooking or table salt [, 17, 22,]. The 2014 Ghana 
Demographic and Health Survey also indicated that 36.6% of women and children live in 
environments with no iodized salt [23], and only 4 in 10 households consumed salt with 
adequate iodine [24]. Additionally, traditional eateries (i.e. informal eating places outside 
the home called ‘chop bars’) are popular in Ghana [25], however, a good number of these 
tend not to use iodized salt in their meal preparation [26]. The potential widespread use of 
non-iodized salt in Ghana is a practice that requires monitoring as it poses a major setback 
to effectiveness of the USI programme. Our data supports findings from surveys that have 
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reported widespread availability non-iodized salt in Ghana, that is related, in part, to 
relative affordability of iodized salt and consumer low education on the importance of using 
iodized salt [19, 27-29]. Findings from the Ghana Iodine Survey (GIS) indicated that half of 
all households in the south-salt-producing areas and approximately half of households in 
the mid region of Ghana were accessing salt with no added iodine, thus violating the Public 
Health Amendment Law 2012 Act 851 [17, 30].  Only 8.6% of the national sample of 
households were using salt with iodine levels in the WHO recommended range of 15-40ppm 
for household salt, suggesting that production methods for salt iodisation, may have been 
compromised [17, 31]. Chemical analysis of the iodine content in 11 most popular brands of 
iodized salt in Ghana indicated that, only 3 brands met recommended 50ppm of iodine at 
retail [32]. Both household and market surveys also reported that low availability and high 
cost of adequately iodized salt were deterrents to accessing the commodity [29]. In the 
current study, despite known inadequacies in the salt iodisation programme in Ghana, 
median UIE was considerably higher than in SA. Other sources of iodine warrants 
consideration.  
Our study found that median salt intake was considerably lower in the SA sample compared 
to the Ghana sample as expected because of salt legislation for maximum salt levels 
permitted in processed foods [19] and other national health promotion programmes to 
reduce discretionary salt intake, such as Salt Watch [33]. The high morbidity and mortality 
associated with noncommunicable diseases [34], has resulted in many countries embarking 
on salt reduction interventions to reduce hypertension and cardiovascular disease [35], 
however such strategies do not exist in Ghana. The current analysis is supported by data 
from both WHO-SAGE SA Wave 2 [14] that raised concern that salt reduction strategies may 
adversely affect iodine consumption.  However, other studies provide conflicting results 
[36, 37]. A previous study in South African adults in 2004, reported no difference in median 
urinary UIC across salt intakes categories [13]. Reasons are unclear but at that time, it was 
assumed that the predominant use of non-iodized salt in the production of processed food 
products resulted in lack of a difference in iodine across a range of salt intakes. Additionally, 
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national data collected in 2002 showed that 37.3% of households in SA used non-iodized 
salt at home [38]. 
Our findings highlight a need for health authorities in Ghana and SA to continually monitor 
both salt and iodine intakes in order to adjust salt iodization levels as required, to ensure 
the compatibility of salt iodisation and salt reduction strategies [39]. Monitoring of salt 
iodization at any point along the food supply chain (i.e. production, packaging, storage, 
retail outlets and homes) is key in ensuring efficacy of salt iodisation. Greater advocacy 
efforts are required to result in implementation of healthy food environment polices geared 
towards the prevention of nutrition related-noncommunicable disease (NCDs) in Ghana. 
An analysis of 41 food environment policies investigated in the country rated 75% of all 
good practice indicators as ‘low’ [40]. 
It is also timely for SA to reconsider iodine levels in table salt [41, 42] to meet the needs of 
those with lowest salt intakes while at the same time avoiding excessive iodine supply to 
areas where salt intake is high. In both countries, coordination and collaboration between 
government agencies and sectors are needed to harmonize food policies to enhance their 
effectiveness.  A multi-sectoral approach backed by a strong political or social interest from 
government will be most appropriate.  
Strengths of the study include: 1) the comparison of salt and iodine intake in two low to 
middle income countries, both with mandatory salt iodisation programmes but only one 
with a mandatory salt reduction policy; 2) large nationally representative sample of 
participants aged 50+ years and; 3) the use of the gold standard method (24-hour urine 
collection) for measuring salt intake. Limitations include loss of sample size due to 
incomplete survey or urine collections, and gender disparity with more women than men 
likely to provide urine samples in both countries. Data collection procedures may have 
created a selection bias for greater participation by those who were home or had flexible 
employment requirements. . A lack of dietary intake data limits the ability to identify which 
sources of food contributed to total salt or iodine intake in both countries. Additionally, this 
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study excluded pregnant women and children therefore further study is warranted among 
those iodine-sensitive groups. 
7.4 Conclusions 
While SA’s salt legislation may influence its population iodine intake, salt iodisation 
programmes in Ghana require effective regulation. Our findings highlight an urgent need 
to continually monitor the effectiveness of salt iodisation programmes especially in 
countries where salt reduction efforts are being undertaken to meet WHO’s global voluntary 
target of population intake of less than 5g salt/day.  
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Towards Population Salt Reduction to Control High Blood 
Pressure in Ghana: A Policy Direction 
 
This chapter completes the study by discussing actions that were taken, after the initial 
chapters have provided substantial evidence of sources of dietary salt, level of salt intake, 
salt use behaviours, hypertension prevalence and the determinants thereof, in Ghana. The 
chapter details a high-level stakeholder engagement conference that was attended by 
government agencies, academics, research institutions, non-governmental organizations 
and international bodies in Ghana, to evaluate the evidence provided and discuss 
population salt reduction strategies to curb hypertension in the country. This chapter 
demonstrates roles that government, various agencies, groups and individuals must play to 
build advocacy and support for salt reduction. The chapter highlights recommendations 
and action plans that were discussed by stakeholders, and which were to be considered in 
by the Health Ministry of Ghana. 
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Although population salt reduction is considered a „best buy‟ in addressing hypertension 
and cardiovascular disease, Ghana shares a high hypertension burden with a seemingly 
high salt consumption. This paper discusses best practices in reducing population salt intake 
and preliminary data on salt and K intake, and the process to develop a road map and 
identification of actions needed to support the development of a strategic national 
document towards salt reduction in Ghana. In February 2019, a two-day stakeholder 
meeting was held with government agencies, researchers, non-governmental organizations, 
civil society organizations and international partners to deliberate on salt reduction 
strategies and interventions needed in the face of rising hypertension and other 
noncommunicable diseases (NCDs) in Ghana. Recommendations were developed from the 
stakeholder meeting and are being considered for inclusion in the revision of Ghana’s 
national NCD policy.  
8.1 Introduction  
Hypertension was highlighted as the leading risk factor for disability and mortality in 2017 
Global Burden of Disease Study accounting for 10.4 million deaths and 218 million disability 
adjusted life lost years [1]. One-third of the global hypertension burden is experienced in 
LMICs where on average one in three adults are hypertensive [2]. Irrespective of age, the 
risk of dying from high hypertension in LMICs is more than twice that in high-income 
countries (HICs). While HICs experienced 7% mortality due to hypertension, LMICs such 
as those from the African region recorded figures as high as 25% for all persons less than 60 
years [3].  The sub-Saharan African region had the greatest burden of hypertension globally 
as of 2015 [4] and this is projected to increase in the coming decades [5].  
Ghana is a country in West Africa with a population of 25,758,108 [6], and that is 
experiencing rapid economic growth, along with an increase in health expenditure [7, 8]. 
Over the past two decades, the country has increased its public healthcare spending by 11% 
[9], however this has not translated into an expected improvement in human resources (as 
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there is a decline in the number of healthcare personnel) [10] nor enhancement of existing 
healthcare equipment and facilities [9, 11]. There has been a reported increase in Non-
Communicable Disease (NCDs) in Ghana claiming an estimated 86, 200 lives each year [12]. 
The severity of hypertension was demonstrated by Addo et al., where nearly half of people 
identified with hypertension in Ghana in 2008 had evidence of target end organ damage 
[13]. In 2014, health facility-based records indicated that hypertension was the leading cause 
of disability among adults in Ghana [14]. More recent estimates of hypertension prevalence 
in Ghanaian adults using cohort data of largely 50 years and older, reported a figure of 
58.9%, of which 19% aware of their hypertension status. Of those aware of their 
hypertension status, 67.6% were receiving treatment but only 11.6% of those being treated 
had controlled BP [15]. Whilst families, communities and economies continue to be 
impacted by this burden,  
current health systems are unable to adequately manage the large numbers of persons with 
hypertension [16].  
Preventive strategies are urgently required in Ghana to reduce the hypertension burden. 
There are two approaches that could be adopted. Reduction in the prevalence of raised BP 
could be achieved through a shift in the entire distribution of BP to the left, or through a 
targeted approach to condense the high-blood-pressure tail by implementing intensive 
clinical interventions to control BP in the hypertensive population [17]. The latter approach 
depends on well-resourced health services, while the former requires a public health 
approach. A pooled analysis of 88.6 million participants demonstrated that a change in 
mean BP of the population is the main driver of the worldwide change in the prevalence of 
raised BP [17], providing evidence for the effectiveness of a population-wide strategy.  
Habitual consumption of excess salt is well-known major risk factor for raised BP, and 
contributes to cardiovascular-related disability and premature deaths globally [18] with one 
in ten deaths from cardiovascular disease (CVD) being attributed to excessive salt intake 
[19]. Reducing population salt intake has been identified as a voluntary global target to 
reducing salt intake by 30% by 2025 and a World Health Organization’s (WHO) “best buy 
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“strategy to reduce long-term risk of stroke, coronary heart disease and premature mortality 
from NCDs  
[20, 21] Considering this target, international best practice policies, guidelines and 
interventions have been developed to reduce excessive salt intake at the population level as 
part of efforts to prevent and control high BP levels. Currently, populations around the 
world are consuming an average of 9-12 grams of salt a day or around twice the maximum 
recommendation of the WHO (ie. 5g/day) [22].  
It has been estimated that 2.5 million deaths could be prevented each year if global salt 
consumption was reduced to less than 5g a day [22]. Despite considerable progress towards 
achieving this goal in many countries [23] low-middle-income countries in Africa have been 
slow to adopt salt reduction strategies within their public health priorities. Much of the 
attention in the past has been on infectious diseases [24] though morbidity and mortality 
from NCDs are projected to overtake infectious diseases by 2030 [25, 26]. With the exception 
of SA and Mauritius, mandatory legislation to regulate salt content in the food supply has 
not been adopted on the African continent [23].   
In Ghana, most of the population consume processed foods that are high in salt [14] 
and*report a high use of discretionary salt added to foods at the table and in food 
preparation [27]. Rapid urbanization, population growth and changing lifestyles have 
resulted in a rapid nutrition transition in the country and that has resulted in an increased 
intake of processed foods [28].  However, a community-based intervention study has 
demonstrated that BP could be lowered through behavior change related to salt reduction 
strategies [29]. As well as salt intake, other lifestyle related risk factors for CVD include lack 
of physical inactivity, smoking, excessive intake of alcohol and low intake of fruit and 
vegetables [30].   
To address this gap in policy around the need for public health interventions to address the 
rising prevalence of hypertension and other NCDs in Ghana, an international conference on 
NCDs was held at the Noguchi Memorial Institute for Medical Research, University of 
Ghana from the 15th-16th of February, 2019. The conference was organized by the NCDs 
Support Centre for Africa at the University of Ghana, in collaboration with the University 
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of Wollongong, Australia, through a grant provided by CDC Foundation with financial 
support provided by Bloomberg Philanthropies as part of the WHO-SAGE salt sub-study. 
Additional funding support was received from the Ghana National Petroleum Corporation.  
Sixty-seven participants attended the conference, including representatives from 
government agencies, academia, Non-Governmental Organizations (NGOs), Civil Society 
Organizations (CSOs) and international partners.  The conference allowed for plenary and 
small group discussions to discuss implementation strategies relevant to Ghana, and to plan 
the way forward for Ghana to adopt a strategy to reduce population level BP through salt 
reduction policies. Specific objectives of the conference included:   
1. To provide a platform for academics, policy makers, CSO/NGOs and state actors to be 
informed and share experiences/lessons in relation to high BP control using salt 
reduction strategies.  
2. To support participants to understand and make use of the evidence on the best practice 
interventions to reduce excessive salt intake in foods.  
3. To provide a road map and identify necessary actions to support the development of a 
strategic national document towards salt reduction in Ghana.  
4. Identify opportunities for collaboration, capacity building and advocacy to ensure the 
development of a legislative instrument on salt reduction in foods. 
8.2 Meeting Outcomes   
Professor Michael Wilson, Director of the NCD Support Centre for Africa, opened the 
conference and expressed his appreciation and gratitude for such a gathering of people with 
an intense interest for NCDs in Ghana. Professor Karen Charlton, University of 
Wollongong, provided a global overview of progress on salt reduction. While highlighting 
the global NCD targets, she reminded participants of governments‟ commitment and 
responsibility to salt reduction and ultimately hypertension [22]. Professor Charlton 
explained that food reformulation strategies, either through mandatory or voluntary salt 
targets have been successful in reducing population salt intakes in the United Kingdom and 
Australia [31].  
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Multifaceted approaches that include industry salt reduction in foods, food labelling, and 
consumer education have been successful in various countries. While stressing the 
feasibility of WHO‟s less than 5g salt per day recommendation, she highlighted the need to 
also monitor population iodine levels in countries with universal salt iodization [32], 
particularly for children and lactating mothers who are vulnerable to iodine deficiency 
disorders [33]. Population salt reduction has implication for iodine consumption, as salt is 
used as the vehicle for iodine fortification. If salt is adequately iodized, a reduction of salt 
to the recommended level should still provide enough iodine [34]. She demonstrated how 
WHO’s ‘SHAKE the salt’ package would assist WHO member states with the development, 
implementation and monitoring of salt reduction strategies to enable them to achieve a 
reduction in population salt intake [35].   
8.3 Local Situation  
Dr Dennis Laryea, the NCDs program manager of the Ghana Health Service (GHS) 
identified a need for more research, to generate local evidence on NCDs to inform policy. 
He stressed importance of addressing high salt consumption since hypertension is one of 
the top five NCDs, with regards costs to the Ghana National Health Insurance Scheme. The 
composition of salt in traditional Ghanaian foods, such as salted fish, is not well 
documented. The conference was timely in that the NCD unit of the Ghana Health Service 
was in the process of revising its national policy on NCDs and developing strategic plans 
for its implementation and thus, relevant insights from the conference will inform its 
development.   
Dr Sandra Boatemaa, a postdoctoral researcher, provided new (unpublished) data on food 
sources that contributed the most salt to the Ghanaian diet. These included bread, bouillon 
cubes, salted fish or meat, instant noodles and pizza with rural populations and 
communities living in the northern region of Ghana consuming more salty foods than those 
in urban areas, or those in other regions of the country [14]. The emergence of energy dense, 
nutrient poor, processed convenience foods such as salty snacks, ready-made baked, 
desserts and sweetened products has dramatically changed the Ghanaian food environment 
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[36]. While more than a third (36%) of participants during the 2014 Ghana Demographic and 
Health Survey reported having consumed salted dried fish on a daily basis [14] the Ghana 
National Iodine Survey Report 2015 reported frequent and widespread use of bouillon 
cubes with nearly half (48.8%) of the participants reporting consumption of more than 5 
times a week [37]. The importance of salt in the Ghanaian cuisine was highlighted by 
conference delegates as a challenge to changing consumer preferences and food preparation 
behavior.   
Despite the large body of evidence that supports the association between high salt intake 
and hypertension, very little attention has been given in Ghana in terms of salt reduction 
policies. Further, only limited small-scale community studies on salt reduction strategies 
have been conducted [29]. WHO-SAGE biostatistician, Dr Nadia Minicuci, presented data 
that indicated that much of the NCD burden is preventable or modifiable but stressed that 
ongoing surveillance is needed to inform policy and to make changes to health systems.   
8.4 Interventions to Date  
Professor Ama de-Graft Aikins, a social psychologist reported that most of the interventions 
to address NCDs in Ghana have focused on strengthening three of the six health system 
building blocks, namely: information systems; health workforce; and service delivery [38]. 
She recommended the scaling up of interventions that work, making use of cost-effective 
interventions, addressing NCDs as a developmental issue and empowering communities to 
be more aware of the risk factors for NCD development. While identifying NCDs 
interventions, Dr Leonard Baatiema, a postdoctoral researcher, drew the attention to the fact 
that, despite the increasing burden of NCDs in Ghana, there has not been any systematic 
effort to profile existing initiatives and interventions in the country to either prevent or 
control NCDs. Interventions to date that have targeted hypertension, diabetes, stroke and 





8.5 New Data on Salt Intake in Ghana  
The paucity of salt intake data in Ghana has been a setback to the initiation of population  
level salt reduction strategies, as evidence is required to drive political commitment and the 
public health agenda [32]. Professor Richard Biritwum, the principal investigator of WHO - 
SAGE, Ghana, provided an overview of the six-country cohort study, with special reference 
to WHO-SAGE (Ghana) Wave 3 that has incorporated a nested salt sub-study [44]. This sub 
study is the first attempt to measure national population salt consumption and assess its 
association with hypertension and co-morbidities in Ghana.  
Professor Charlton provided preliminary urinary salt results from WHO-SAGE (Ghana)  
Wave 3 for one region (Ashanti) out of ten sampled regions. With a mean salt consumption 
of 8.54±5.23g/day for men and 10.33±7.91g/day for women (n = 277), the younger 
participants, 18-49yrs (n = 56) consumed more salt (10.91±7.37 g/day) than older adults aged 
50+ yrs (n = 221) (9.43±7.00 g/day).  It was also noted that, while 73.2% and 79.9% of men 
and women, respectively, had intakes above the WHO‟s < 5g/day salt recommendation, 
65.8% and 67% fell short of WHO‟s K recommendations of 90mmol//day [45].  
Though preliminary, this data obtained from one of the most populated regions of Ghana 
suggests that salt intake is excessively high in both men and women, and among both young 
and old. Comparatively, salt intakes seem to be higher in Ghana compared to SA [46] while 
K intake appears relatively higher in Ghana. In agreement with Professor Charlton’s 
finding, Elias Menyanu, a PhD candidate, presented data on salt use behavior from WHO-
SAGE Ghana Wave 2 data. Compared to South Africans, Ghanaians added more salt to food 
during cooking, but had much lower levels of obesity and smaller waist  
circumference measures. As would be expected from major differences in obesity, the South 
African sample had a higher age-standardised prevalence of hypertension than Ghana [47]. 
Differences in determinants of awareness, treatment and control of hypertension were also 
evident between the countries, at least for women. Such differences would need to be 
considered in policy development. It is clear that salt reduction strategies in Ghana would 
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need to focus both on salt reduction in the food supply, as well as efforts to raise consumer 
awareness on discretionary salt use in cooking and added to foods at the table [27].   
8.6 Discussion  
Throughout the conference and in break-out sessions, participants highlighted the essential 
role of the Food and Drugs Authority of Ghana (FDA) in the monitoring and surveillance 
of the food supply, in relation to NCD risk. It was acknowledged that the standards of the 
FDA do not include how much Na is permissible in various food products. Additionally, 
Ghana does not have food labelling standards nor does it have adequate laboratory facilities 
to analyze the Na content of foodstuffs. Representatives from the FDA explained the 
difficulties and constraints experienced by the directorate from food industry if such 
regulations were to be adopted and enforced.   
Another issue that arose from the lively discussion was the fact that the structure of the basic 
school level curriculum did not sufficiently inform children with life skills about healthy 
eating habits, including salt consumption. It was agreed that the Ministry of Health (MOH), 
in collaboration with the Ministry of Education, should make it mandatory to reduce salt in 
foods served in schools (particularly schools where the government is implementing the 
National School Feeding Programme) [48] as well as in other environments, such as 
workplaces and healthcare institutions.  
Despite the existence of a national NCD policy in Ghana [12], a need was identified for more 
advocacy for NCD prevention, as well as for participants with expert knowledge on NCDs 
to make themselves available for media communication. There was also a call for 
stakeholders and researchers to better utilize social media opportunities to ensure 
dissemination of information on NCDs.  
Break out group discussions addressed the following issues, according to the ‘SHAKE the 
salt’ framework: (1) institutional nutrition standards (2) industry salt reduction targets (3) 
front of pack labels for packaged food (4) reduction of salt in foods prepared outside the 
home and (5) behavior change communication to reduce salt use.   
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8.6.1 Institutional standards  
The main issues raised included the implementation of the policy on NCDs which will 
ensure the targeting of foods containing hidden salts (such as processed and restaurant 
foods) through legislation and education. Participants discussed a need for the MOH to 
liaise with other ministries and agencies such as the Ministry of Food and Agriculture 
[MOFA] and Ministry of Tourism, as well as key institutions to provide a consistent message 
around salt reduction. The Ghana National Communication Authority (NCA) was 
identified as a relevant stakeholder in this regard according to its mandate to advocate for 
consumer education and protection rights. Stricter control of food advertising of unhealthy 
foods was identified as a priority.  
8.6.2 Industry salt reduction targets  
There was discussion regarding a need for updated analytical data on food composition in 
Ghana. Dietary surveys are required to identify foods that are major contributors to total 
salt intake. Voluntary targets for the food industry regarding maximum salt targets 
permitted in processed foods were identified as a crucial and the roles of NCA, FDA, NGOs 
and CSOs as partners in this process was emphasized.   
8.6.3 Front of pack labelling for packaged food  
The FDA representatives reported that nutrition information panels will soon become 
mandatory for some categories of food products. Food labels are required to be legible and 
in bright colors to make them easily identifiable. Discussants argued that the FDA should 
develop guidelines for salt content in food items and identify those products with high salt 
using consumer signposting warnings, as has occurred in Chile [49]. Similarly, there was 
support for restaurants and food outlets to display the salt content of their products. The 
FDA was urged to improve its education and advocacy programs to promote healthy diets, 
particularly aiming to reach vulnerable and hard-to-reach communities. In addition, 
regulation of advertising on food products needs attention by the FDA.  
8.6.4 Reduction of salt in foods prepared outside the home  
All stakeholders were in agreement of a need to develop a multi-sectoral approach to 
addressing excess salt in foods consumed outside of the home, including consumer 
sensitization and education on salt use; removal of salt and bouillon cubes from eating 
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tables; limiting the consumption of salty snacks; education and training of food vendors; 
and enforcement of food regulations by the FDA.  
8.6.5 Behaviour change communication to reduce salt use  
The socio-cultural context was identified as being essential in considering the development 
of health promotion messages on salt reduction. Discussants suggested using sketches and 
drama productions in communities to demonstrate the feasibility and benefits of a low salt 
diet. Other strategies that were suggested included the use of persuasive salt reduction 
messages, the engagement of role models and opinion leaders to act as ambassadors for salt 
reduction as well as a national educational campaign on salt reduction.  
Several recommendations and associated action plans emerged from the meeting, as 
summarized in Box 1. These resulted from consensus reached by participants in plenary 
report-back sessions from breakout groups, and represent views that were unanimously 





Box 1. Recommendations and action plans for salt reduction in Ghana 
1. Participants emphasized the urgent need to raise awareness of the relationship between excess salt intake and the occurrence of hypertension 
using various media channels. Given limited policy attention on salt reduction in Ghana, participants agreed on the need for public health 
education campaigns to reduce high intake of salt among Ghanaians. 
2. Foods that contribute large amounts of salt to the Ghanaian diet were to be identified alongside a massive consumer education to reduce the 
intake of such foods or use healthier alternatives.  
3. The Ghana government and the FDA were to negotiate with food industries and food vendors to voluntary reduce salt content in their products. 
4. The FDA was to initiate processes that will ensure that most food products have labels. 
5. Participants expressed the requirement to explore alternate funding sources to support the implementation of salt reduction interventions. 
Domestic funding sources from the state, private individuals and organizations should be explored to support hypertension prevention/control 
interventions. 
6. Participants emphasized the need for the provision of adequate resources/facilities for community hypertension screening and information 
programmes.  
7. The GHS and MOH as well as corporate bodies were urged to facilitate the establishment of modern laboratories with the capacity to analyze 
the Na content and other nutrients in food.  
8. Adequate and accurate salt consumption monitoring and surveillance data are required through national research studies. Periodic capture of 
data at both community and population levels must be prioritized. A current national nutrition survey is needed to support salt intake data to 
enhance policy formulation. 





 8.7 Conclusion  
The importance of using multi-sectoral engagement to promote NCDs has been recognized 
in the Global Action Plan for the Prevention and Control of NCDs. The outcomes of a high-
level stakeholder meeting held in Ghana has demonstrated the feasibility of such an 
approach in population level salt reduction intake in the country, with nine action items 
identified for inclusion in Ghana’s national NCD policy. 
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Conclusions and Recommendations 
 
9.1 Overview of core findings 
Hypertension is a major burden of disease in many LMICs, including Ghana, a country on 
the West coast of Africa [1, 2]. The increasing prevalence of hypertension is largely 
attributed to adoption of unhealthy dietary behaviours resulting from the widespread 
availability of energy dense nutrient poor (EDNP) foods that are typically high in salt 
associated with the nutrition transition that accompanies urbanization [3].  
The theoretical framework for the thesis was based on the World Health Organization 
(WHO)’s “SHAKE the Salt Habit” (SHAKE) resource which guides countries that are 
beginning to address salt reduction strategies. SHAKE recommends firstly identifying 
quantities and dietary sources of salt intake in the population of interest, as well as 
determining salt use behaviours and consumer awareness of the adverse health effects of 
excessive salt intakes. SHAKE also strongly urges intersectoral engagement with key 
stakeholders to develop policy action to drive governmental efforts towards the reduction 
of salt intake and to result in a population shift to the left in blood pressure distribution and 
thereby a lower burden of hypertension [4]. One of the foremost approaches to population 
salt reduction recommended by SHAKE is the monitoring and evaluation of diets that 
contribute the most salt to food. Data provided in this thesis is the first step in that process 
and provides a baseline measure from which further monitoring can be compared.  
The body of work in the thesis began with a substantial critical review of existing evidence 
to identify modifiable determinants of hypertension with a focus on dietary sources of salt 
in LMICs (Chapter 1). Identified dietary risk factors for hypertension included both a high 






strategies and the involvement of food manufacturers in setting of voluntary targets and/or 
maximum limits of salt in a variety of foods. Additionally, the review identified the key 
roles played by governments, institutions and private organizations in population salt 
reduction efforts.   
A primary aim of this thesis was to obtain a reliable estimate of current population salt 
consumption levels, and their relation to blood pressure, in Ghana, for the development of 
a road map for advocacy, support and policy formulation towards salt reduction.  In order 
to achieve this, the thesis comprised five original studies, which culminated in a high-level 
stakeholder meeting to obtain consensus on strategies required to address the high 
prevalence of hypertension and other NCDs in the country.   
By leveraging data collected in various waves (1-3) of the large WHO-SAGE prospective 
study, this novel study adds new knowledge about trends in BP, hypertension prevalence, 
awareness, treatment, control.  In addition to the main survey data, much of this thesis 
relates to findings of a nested sub-study in which 24hr urinary sodium and potassium 
collections were obtained to provide much needed information on the salt intake of the 
Ghanaian population (Chapter 4). This is the first such national data and provides essential 
evidence to drive policy, planning and further research on salt reduction. The doctoral 
candidate was involved in all aspects of the data collection and execution of the salt sub-
study and worked closely with WHO-SAGE Ghana Primary Investigator, Professor Richard 
Biritwum to this effect. 
Comparison of data from Ghana with that of the WHO-SAGE South African sample (Waves 
2 and 3) has provided an opportunity to learn from a country that has adopted a mandatory 
salt reduction policy that limits maximum salt levels permitted in a wide range of processed 
foods. WHO-SAGE South Africa Wave 2 was completed immediately prior to 






conducted in the interim period between Phase I and the more stringent Phase II 
(implemented in June 2019) stages of South Africa’s salt reduction policy.      
The gold standard method to assess population salt intake, namely 24hr urinary sodium 
excretion, was used in both Ghana and South African salt sub-studies (Chapter 4). This 
method provides an overall quantitative estimation of daily salt intake but does not provide 
information on dietary sources of salt, and what proportion of salt comes from discretionary 
(i.e. salt added to food at the table or in cooking) versus non-discretionary (salt inherent in 
foods, and added to foods during commercial processing) sources. It was not logistically 
feasible to include a detailed dietary assessment in the WHO-SAGE surveys, however the 
research team did include validated questions on discretionary salt use behaviours in the 
main surveys included in both Waves 2 and 3. This allowed comparison between the salt 
use South African samples as reported in Chapter 3. Interestingly, South Africans were 
almost five times more likely than Ghanaians to add salt to food at the table but less likely 
to add salt to food during cooking. To date, little attention, if any, has been given to mass 
media health education efforts to encourage salt behaviour change in Ghana. These findings 
support a need for efforts in Ghana to raise consumer awareness on discretionary salt use 
and provide insight into how to tailor health education and health promotion campaigns on 
salt use in both countries.  
Due to a lack of detailed dietary intake data, a systematic literature review was undertaken 
to identify major sources of salt intake in LMICs (Chapter 3). Processed foods including 
breads, meat and meat products, bakery products, instant noodles, salted preserved foods, 
milk and dairy products, as well as bouillon cubes, were identified as sources of high salt 
intake in LMICs. The review also identified that drinking water, particularly in drought 
affected areas, could be a potentially significant source of salt intake. Findings from the 
review can be used by countries beginning to consider which foods to target for 







In order to identify changes in blood pressure that occur with age participants aged 50+y 
that were present in the WHO-SAGE Ghana Wave 1 (2007/8) cohort and were again 
followed up in the Wave 3 survey conducted twelve years later in 2019, comprised an 
analysis to determine the trajectory of BP and its determinants (Chapter 6). Somewhat 
surprisingly, in these individuals, a fall in diastolic BP was observed but no change in 
systolic BP which resulted in a consequent increase pulse pressure. Increasing pulse 
pressure may indicate a higher risk for internal organ damage, myocardial infarctions and 
cardiovascular events [5, 6]. A decrease in DBP was associated with increasing age, living 
in rural settings and having health insurance. Though no differences existed over time 
between the proportion of hypertensives who were receiving antihypertensive treatment, 
nor the proportion who had their hypertension controlled, the awareness of having 
hypertension (i.e. diagnosis) increased significantly between the two time periods. Residing 
in rural areas, having a higher BMI and having voluntary health insurance were associated 
with increased hypertension awareness. This suggests that health services have become 
better at diagnosing hypertension, but that hypertension remains poorly managed, once 
diagnosed. The findings from this study confirm a need to implement non-pharmacological 
population-based strategies to reduce blood pressure.   
To build advocacy and support for salt reduction intervention in Ghana, a population 
estimate of salt and potassium (K) intake, and their relationship with BP was investigated 
(Chapter 5). A high salt intake coupled with a low K intake, a relatively higher Na: K and a 
steeper slope between the high Na: K ratio and age for SBP and DBP in Ghana, indicated 
both a need for salt reduction strategies in the country but also dietary interventions to 
increase K intake, commonly found in fruit and vegetables, dairy and animal flesh products. 
The chapter also highlighted the tendency for populations to underestimate their salt intake 






objective 24hr urinary collections. National dietary surveys are important to elucidate food 
sources of salt but these should also be accompanied by an updated Ghanaian food 
composition database that will allow determination of salt from dietary reports.  
Due to universal salt iodization (USI) being implemented in Ghana, as in many other 
countries, to prevent iodine deficiency, the WHO recommends that any assessment of salt 
intake should be accompanied with determination of adequacy of iodine intakes since both 
metrics can be determined from urinary outputs. For the first time in Ghana, urinary iodine 
excretion was compared with salt intake. A novel comparison of iodine-salt intake 
associations was undertaken between Ghana and South Africa (Chapter 6) because both 
countries have adopted USI but only South Africa has implemented salt reduction. Since 
table salt is required by law in both countries to be iodized, it is possible that efforts to lower 
salt intake may inadvertently lower iodine intake too. Data from participants included in 
the salt sub-study in both countries for WHO-SAGE Wave 3 identified an overall adequate 
intake of iodine in Ghana and South Africa, but that urinary iodine excretion differed 
significantly across salt intake categories in both countries but in opposite directions. In 
Ghana, a moderate, inverse correlation was observed, compared to a moderate, positive 
association in SA. Participants with salt intakes <5g/day in South Africa did not meet WHO’s 
recommended iodine intake of 150µg iodine per day, but this was not the case in Ghana. 
This study suggests that monitoring and surveillance of iodine status is recommended in 
countries that have introduced salt reduction strategies (such as South Africa) in order to 
prevent re-emergence of iodine deficiency. This important finding highlights a need for 
LMICs to consider salt iodization programmes alongside salt reduction strategies to ensure 
optimal levels of both iodine intake and reduced salt consumption can be achieved. 
The final part of this thesis comprises a high-level stakeholder engagement conference that 
was held in Ghana in February 2019 to share the findings of the body of work, and to build 






(Chapter 8). The two-day conference concluded with a 9-point recommendation that is 
currently being considered for inclusion in the revision of Ghana’s national NCD policy. The 
outcomes of the conference have been published in an open access international, peer 
reviewed journal and are available for widespread access by government officials, 
academics and community-based organizations alike. Bringing together a wide range of 
important stakeholders has allowed an immediate translation of the research findings into 
a tool for advocacy for policy change.   
Overall, the findings of these study support the hypothesis that salt consumption and 
hypertension are both high in Ghana. While no direct association was found between salt 
intake and BP, a higher Na: K ratio was associated with increasing BP with age. This 
suggests that salt reduction strategies need to be pursued but alongside dietary 
interventions to increase dietary potassium intake. Such efforts will require collaboration 
between directorates for NCD Prevention and Nutrition.   
9.2 Strengths and Limitations 
Methodological strengths and limitation of the study have been briefly outlined below. 
Specific strengths and limitations for each study have been comprehensively described in 
each thesis chapter.  
The WHO-SAGE study selects a national sample of predominantly older participants, as 
such findings can be generalized over a large proportion of the population. This cohort of 
the population form a large number of the vulnerable group in society, as such, this study 
provides unique and valuable information about this cohort for policy formulation and 
planning purposes.  
The WHO-SAGE study makes use of internationally certified instruments and protocols for 
data collection. Field workers are extensively trained by WHO experts prior to the 






The longitudinal nature of the study offered a rare opportunity to understand the trajectory 
of BP and its determinants in Ghana. The study was also the maiden attempt to measure 
population salt, iodine intake, and salt use behaviours in Ghana. The study provided 
population hypertension prevalence, awareness, treatment and control estimates. The 
nested sub study utilized the gold standard of 24hr urine collection with volume and 
creatinine as a marker of urine completeness. Comparison of constructs between Ghana and 
SA offered a unique learning opportunity and data for planning and further research in 
LMICs.  
The limitations of this thesis include the design of the WHO-SAGE study. The sampling 
strategy of the study meant that younger people (18-49) were under-represented, thus 
limiting the ability to generalize findings to the entire adult population. Nevertheless, 
hypertension is a disease that mostly affects middle-aged and older adults therefore the 
importance of the findings should not be minimized.  Given the complex nature of 
population-based studies such as WHO-SAGE conducted in LMICs that often have poor 
infrastructure such as roads, data management issues can be expected and did indeed occur 
in some cases where missing data was a challenge. Regardless, the overall large sample size 
still allowed meaningful and statistically relevant analyses to be conducted. Another 
limitation is the lack of a comprehensive dietary assessment in the WHO-SAGE surveys 
which limits interpretation about food sources of population salt and potassium intake.  
9.3 Future directions 
While this thesis makes a substantial and novel contribution to the literature, it also 
emphasizes the need for more research to strengthen the evidence base and break new 
grounds.  
Based on the findings, the following recommendations from the analysis from Ghana and 






1. Identification of food products that contribute most salt in respective LMICs is required; 
2. Governments in LMICs should engage food manufacturers to discuss the upper limits 
of salt used in processed foods. Food manufacturers should be encouraged to 
voluntarily reduce salt in their food products in the absence of mandatory salt reduction 
legislation; 
3. Government in collaboration with NGOs and CSOs should intensify public health 
education on consumption of excess salt, with particular reference to processed foods; 
4. Mass consumer health education is required to sensitize the public on mechanisms to 
reduce or make healthier alternative choices to high salt foods, particularly for breads, 
processed meat products, bakery products, instant noodles, salted preserved foods and 
bouillon cubes; and 
5. Public health campaigns on the implications of excess salt intake, should take a settings-
based approach, such as health places, schools and health centers. 
 
Recommendations for Ghana and/or South Africa specifically 
1. Interventions are needed to reduce population salt and to increase K intake in Ghana. 
It is imperative to identify and increase the intake in order to change dietary Na: K 
ratios. 
2. Current or updated food frequency tables are required in Ghana for better monitoring 
and evaluation of dietary intakes;  
3. There is a need to intensity health promotion programmes that will increase knowledge 
and instill positive attitudes and behaviours related to lower salt use in both Ghana and 
South Africa; 
4. There is a need to increase BP screening services within communities in Ghana. 
Community centers and marketplaces in Ghana could be additional avenues for BP 
screening services to obtain hard-to-reach persons; 
5. There is the need to regularly monitor iodine intake in both Ghana and South Africa to 






6. A further study is strongly recommended to ascertain the effectiveness of the more 
stringent (Phase II) salt legislation in South Africa. 
9.4 Summary 
In conclusion, this thesis has provided and addressed gaps in data on population salt intake 
and hypertension in Ghana, and made useful comparisons with South Africa. A total of five 
studies and one conference report addressed the overarching research question and added 
new knowledge to the existing body of scientific evidence. The thesis contributes to the field 
of nutrition, ageing, dietetic and public health with each study uniquely designed to address 
a specific public health issue. Translational aspects of the research have been addressed 
through a stakeholder consultation meeting held in 2019 that resulted in a road map of 
activities that are required for policy formulation on population salt reduction. 
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Appendix B – Instruments for data collection and consent forms 
               https://www.who.int/healthinfo/sage/cohorts/en/index2.html 












































Appendix E - Supplementary Materials 
 
Supplementary Table 3.1 Included articles and their 
regions of origin 
 







Americas     
Ferrante et al., 
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2013 [49] 
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al., 2010 [55] 
China 1996-1999 Dietary 
Behaviour 
Descriptive 
Zhao et al., 
2015 [50]  
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Silva et al., 
2015 [43] 





Charlton et al., 
2005 [54] 








































Supplementary Table 5.1: Na, K, Cl and Cr of original and repeat  
           data in the same participants in Alajo EA 


















Minimum 64.40 65.45 10.70 25.20 61.40 37.95 0.68 1.51 
Median 249.40 126.33 78.85 65.43 269.40 93.85 1.94 4.24 
Maximum 741.20 250.45 356.00 141.20 951.60 206.80 5.91 15.03 
Mean 311.69 135.63 108.23 67.39 355.73 110.20 2.38 4.61 
Sd 238.20 53.01 93.32 30.94 271.09 47.95 1.61 3.11 
























Supplementary Table 5.2: Urine results for electrolytes, 
creatinine and iodine by sex (urine data considered valid if 
volume > 300ml), WHO-SAGE Ghana Wave 3 
 All  




(n = 566) 
P 
24hour Urine Analysis     




n = 267 
126.6 
(125.7) 




   Salt excretion, g/day  n = 829 
8.3 (7.5) 
 
n = 267 
7.5 (7.4) 




   Achieving salt target 
(<5g/day), n (%) 
n = 836 
203 (24.3) 
 
n = 276 
72 (27) 
n = 560 
108 (19.3) 
0.01 
   Potassium (K), 
mmol/24hr 
n = 835 
65.9 (79.5) 




n = 566 
65.8 (77.4) 
0.38 
   Achieving K target (≥90 
mmol/day), n (%)  
n = 835 
357 (42.7) 
n = 269 
91 (33.8) 
 
n = 566 
200 (35.3) 
0.67 
   Sodium-to-potassium 
ratio 
n = 829 
2.1 (1.7) 
n = 267 
1.9 (1.5) 
 
n = 562 
2.1 (1.7) 
0.06 
   Achieving Na:K ratio 
(≤1.0), n (%) 
n = 825 
59 (6.3) 
 
n = 267 
21 (7.9) 
n = 558 
31 (5.6) 
0.20 
   Cr, mmol/24h n = 835 
3.4 (2.4) 
n = 269 
3.6 (2.6) 
 
n = 566 
3.3 (2.3) 
0.15 
   24hr Iodine, µg/l n = 799 
140.8 
(140.1) 
n = 255 
154.6 
(152.3) 
n = 544 
137.8 (137.8) 
0.02 
Data are presented as median (IQR) unless otherwise stated; Mann-Whitney Test used to 









Supplementary Table 5.3: Urine results for electrolytes, creatinine and 
iodine by age (urine data considered valid if volume > 300ml), WHO-SAGE 
Ghana Wave 3 
 ≥50 years  
(n = 661) 
18-49yrs  
(n = 174) 
P  
24hour Urine Analysis     
   Sodium, mmol/24hr n = 656 
136.4 (120.3) 
 
n = 173 
164.3 (138.2) 
< 0.01 
   Salt excretion, g/day  n = 656 
8.1 (7.1) 
 
n = 173 
9.7 (8.2) 
< 0.01 
   Achieving salt target 
(<5g/day), n (%) 
n = 654 
159 (24.3) 
 
n = 173 
21 (12.1) 
< 0.01 
   Potassium (K), 
mmol/24hr 
n = 661 
61.7 (66.8) 
 
n = 174 
80.4 (93.3) 
< 0.01 
   Achieving K target 
(≥90 mmol/day), n (%) 
n = 661 
212 (32.1) 
 
n = 174 
79 (45.4) 
< 0.01 
   Sodium-to-potassium 
ratio 
n = 656 
2.1 (1.6) 
 
n = 173 
2.1 (1.8) 
 0.33 
   Achieving Na:K ratio 
(≤1.0), n (%) 
n = 653 
39 (6.0) 




   Cr, mmol/24h 
 
n = 661 
3.4 (2.2) 




   24hr Iodine, µg/l n = 629 
144.2 (141.6) 
n = 170 
146.5 (137.5) 
0.63 
Data are presented as median (IQR) unless otherwise stated; Mann-Whitney Test used to 







Supplementary Table 5.4: Salt knowledge, attitudes and behaviour and fruits and vegetable consumption by age category, sex 
and location (n = 837), nested sub study; WHO-SAGE Ghana Wave 3. 
 All  
(n = 837) 
Age Category 
(n = 837) 
p 
value 
Sex (837) p 
value 
Location (837) p 
value 
  50+ yrs 18-49 yrs  Men Women  Urban Rural  
Add salt to food at the 
table, frequently n (%) 
107 (12.8) n = 664  
78 (11.7) 
 
n = 173  
28 (27.3) 
0.02 n = 270 
39 (14.4) 
n = 568 
68 (12.0) 
0.41 n = 456 
46 (10.1) 
n = 381 
61 (16.0) 
<0.01 
Add salt to cooking at 
home, frequently n (%) 
671 (80.1) n = 664 
520 (78.3) 
n = 173 
150 (86.7) 
0.03 n = 270 
219 (81.1) 
n = 568 
452 (79.6) 
0.69 n = 456 
358 (78.5) 
n = 381  
312 (81.9) 
0.24 
How much salt 
consumed, just the right 
amount n (%) 
508 (60.9) n = 662 
387 (58.5) 
n = 171 
120 (70.2) 
< 0.01 n = 269 178 
(66.2) 
 
n = 565 
330 (58.4) 
0.10 n = 455 
265 (58.2) 
n = 378 
242 (64.0) 
0.09 
Can high salt diet cause a 
serious health problem, 
yes no (%) 
651 (77.8) n = 643 
517 (80.5) 
 
n = 170 
134 (78.8) 
0.65 n = 264 
216 (81.8) 
n = 549 
435 (79.2) 
0.39 n = 444 
362 (81.5) 
n = 368 
288 (78.3) 
0.25 
Do you do anything on 
regular basis to control 
salt consumption, no (%) 
394 (51.5) n = 643 
320 (49.8) 
n = 169 
74 (43.8) 
0.17 n = 259 
136 (52.5) 
n = 553 
282 (51.0) 
0.69 n = 445 
216 (48.5) 
n = 366 
201 (54.9) 
0.72 
Fruits and vegetable 
intake,  did not meet 
recommendation  
n (%) 
396 (47.2) n = 644 
312 (47.0) 
n = 173 
83 (48.0) 
0.82 n = 270 
126 (46.7) 
n = 568 
270 (47.5) 
 
0.81 n = 457 
209 (45.7) 
n = 381 
186 (48.8) 
0.37 







Supplementary Table 6.1: Odds ratio showing the predictors of decrease in 




p-value 95 CI 
Sex     
Male  Ref    
Female  
 
1.08 0.759 0.66-1.76 
Age 0.99 0.422 0.98-1.01 
Location    
Urban  Ref    
Rural 0.48 < 0.01 0.30-0.77 
Marital Status    
Married  Ref    
Not married 1.80 0.125 0.45-1.10 
Years of education  1.04 0.076 0.99-1.09 
Mothers education    
  Less than  
  secondary/high school  
  completed 
 
Ref    
  Secondary/high school  
  and above completed 
 






Note: Ref represents reference category used for the comparison. Voluntary refers to contributors to health insurance who 
were not captured by the insurance scheme as public or civil service workers, while mandatory refers to contributors who 
were employees within the public, civil and private sectors. Overall physical activity represents all activities including 
vigorous, moderate, walking/cycling, vigorous fitness and moderate fitness completed in a typical week. Multivariate 
regression was adjusted age, sex, marital status, years of education, mother’s education, father’s education, health insurance, 




p-value 95 CI 
Fathers education    
  Less than  
  secondary/high school   
  completed 
 
Ref    
  Secondary/high school  
  and above completed 
 
0.91 0.727 0.55-1.52 
Health Insurance    
  No Ref    
  Yes 1.33 0.138 0.91-1.01 
BMI 0.98  0.135 0.96-1.01 
Ever used alcohol    
  No  Ref    
  Yes  
 
0.97 0.885 0.67-1.40 
Diabetes    
  No Ref    
  Yes  
 
0.57 0.122 0.27-1.16 
Ever used tobacco    
  No  Ref    
  Yes  
 
0.78 0.284 0.49-1.22 






Supplementary Table 6.2: Characteristics of Wave 1 participants included in the study 
(50+y, n = 820) and those excluded (n = 3,904) 





Age in years, Median (IQR) n = 820 
59 (13) 




Location: Urban, n(%) n = 820 
364 (44.4) 
n = 3904 
1561 (40.0) 
0.0196 
Gender: Male, n(%) n = 820 
433 (52.8) 
n = 3904 
1920 (49.2) 
0.2080 
Education: Schooled, n (%)  n = 817 
398 (48.7) 
n = 3476 
1539 (44.3) 
0.0217 
Marital status: Married/ 
cohabiting, n (%) 
n = 817 
489 (59.9) 




SR Hypertension, n (%)  n = 820 
95 (11.6) 




SR Diabetes, n (%)  n = 820 
17 (2.1) 




SR Depression, n (%) n = 820 
13 (1.6) 




SR Health, very good n (%) n = 820 n = 3481 0.1893 
  39 (4.8) 131 (3.8)  










Supplementary Table 6.3: Characteristics of Wave 1 participants included in the study 
(50+y, n = 820) and those followed-up but excluded from analysis (n = 79) 







Age in years, Median (IQR) n = 820 
59 (13) 
 





Location: Urban, n(%) n = 820 
364 (44.4) 
n = 79 
30 (38.0) 
0.2724 
Gender: Male, n(%) n = 820 
433 (52.8) 
n = 79 
31 (39.2) 
0.0210 
Education: Schooled, n (%)  n = 818 
398 (48.7) 
n = 25 
11 (44.0) 
0.6422 
Marital status: Married/ 
cohabiting, n (%) 
n = 817 
489 (59.9) 




SR Hypertension, n (%)  n = 820 
95 (11.6) 




SR Diabetes, n (%)  n = 820 
17 (2.1) 




SR Depression, n (%) n = 820 
13 (1.6) 




SR Health, very good n (%) n = 820 n = 25 1.0000 
  39 (4.8) 1 (4.0)  







Supplementary Table 7.1 Demographic profile of SAGE Ghana and South Africa W3 survey respondents and 
subsample with urine valid data (urine data considered valid if Volume ≥ 300ml & creatinine ≥3mmol). 
                                                                                 Ghana                                                                                                             South Africa 













Age        
   Years 60 (20) 57 (18) 0.0002  58 (19) 61 (15) <0.0001 
   18-49 years, n (%) 
717 (23.5) 133 (26.9) 0.0159 
 
399 (26.6) 112 (15.8) 0.0140 
   50 plus years, n (%) 
2336 (76.5) 362 (73.1) 0.0001 
 
1102 (73.4) 595 (84.2) 0.2393 
Sex, n (%)    0.074    0.019 
   Men 1183 (38.8) 171 (34.6)   539 (35.9) 218 (30.8)  
   Women  1870 (61.2) 324 (65.4)   962 (64.1) 489 (69.2)  
Ethnicity, n (%)   <0.002    <0.0001 
   Akan 1544 (50.6) 280 (56.6)     Black 1034 (68.9) 516 (73.0)  
   Ewe 216 (7.1) 34 (6.9)     Coloured, mixed race 296 (19.7) 157 (22.2)  
   Ga-Adangbe 224 (7.3) 29 (5.9)     Indian 72 (4.8) 15 (2.1)  
   Gruma 30 (1.0) 3 (0.6)     White 98 (6.5) 18 (2.6)  
   Grusi 76 (2.5) 7 (1.4)     Other 1 (0.1) 1 (0.1)  
   Guan 38 (1.2) 10 (2.0)      
   Mande-Busanga 63 (2.1) 1 (0.2)      
   Mole-Dagbon 174 (5.7) 16 (3.2)      
   Other 612 (20.0) 112 (22.6)      
Residence, n (%)    0.001    0.001 
   Urban 1301 (42.6) 262 (52.9)   1076 (71.7) 456 (64.5)  






                                                                                 Ghana                                                                                                             South Africa 













Marital status, n (%) 
  0.324 
 
  0.027 
   Never married 208 (6.8) 29 (5.9)   484 (32.2) 202 (28.6)  
   Married/cohabiting 
1760 (57.7) 302 (61.0)  
 
495 (33.0) 213 (30.1)  
   Separate/divorced 
369 (12.1) 48 (9.7)  
 
132 (8.8) 69 (9.8)  
   Widowed 715 (23.4) 116 (23.4)   390 (26.0) 223 (31.5)  
Never been to school, n (%) 
1119 (36.7) 125 (25.2) <0.0001 
 
127 (8.5) 79 (11.2) 0.041 
Education (Years) 10 (5) 10 (4) 0.0098  12 (5) 10 (5) <0.0001 
Body Mass Index (kg/m2) 
24.2 (6.8) 25.7 (6.9) < 0.0001 
 
29.4 (8.9) 29.8 (10.3) 0.0771 
Waist to height ratio 
0.54 (0.11) 0.56 (0.12) 0.0001 
 
0.56 (0.13) 0.59 (0.14) <0.0001 
Never used alcohol, n (%) 
1865 (61.3) 283 (57.2) 0.084 
 
1049 (70.3) 511 (72.3) 0.342 
Never used tobacco, n (%) 
2739 (90.0) 453 (91.5) 0.287 
 
1106 (74.1) 528 (74.7) 0.782 
Systolic BP (mm Hg) 
124 (26.5) 125.5 (28) 0.3214 
 
130 (23.5) 133.5 (29) 0.0001 
Diastolic BP (mm Hg) 
76 (17) 76.5 (17) 0.7475 
 
83 (19) 83.5 (20.5) 0.4369 
Hypertension, n(%) 1132 (37.6) 208 (42.2) 0.052  831 (58.8) 447 (65.2) 0.005 
Diabetes, n(%) 157 (5.2) 38 (7.7) 0.023  182 (12.2) 119 (16.9) 0.003 
Frequently add salt to food 
at table, n(%) 642 (21.1) 58 (11.7) <0.0001 
 






                                                                                 Ghana                                                                                                             South Africa 













Frequently add salt to food 
during cooking, n(%) 2527 (83.0) 399 (80.6) 0.189 
 
965 (64.7) 460 (65.1) 0.860 
Believe they consume too 
much salt, n(%) 265 (8.8) 48 (9.7) 0.503 
 
156 (10.9) 59 (8.6) 0.104 
Believe a high salt diet is bad 
for health, n(%) 2247 (75.9) 378 (78.3) 0.266 
 
1121 (82.9) 506 (81.6) 0.480 
Regularly control of salt 
intake, n(%) 
1243 (42.1) 235 (48.9) 0.005 
 
552 (41.1) 255 (42.7) 0.514 
Subsample: all respondent with CAPI data and valid urine, sex and age recorded. Some variables may contain missing data. Data are presented as median (IRQ) 
unless otherwise indicated. Hypertensive by mesured BP≥140 and/or 90 mm Hg or previous self-reported treatment in the past two weeks prior to the survey. 
Ethnicity, marital status, education, alcohol/tobacco use and diabetes prevalence by self-report. Mann-Whitney Test used to compare medians, Pearson Chi-Square 






Appendix F – Dietary Sources of Salt in Low- and Middle-Income Countries: A 


































































































Appendix G - Salt Use Behaviours of Ghanaians and SouthAfricans: A Comparative 
















































































Appendix H - Salt and low potassium intake among adult Ghanaians: WHO-SAGE 









































































































Appendix I - Determinants of change in blood pressure in Ghana: Longitudinal data 













































































































































Appendix J - Salt reduction strategies may compromise salt iodisation programmes: 











































Appendix K - Towards Population Salt Reduction to Control High Blood Pressure in 
Ghana: A Policy Direction 
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